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ABSTRACT 
Estimates from the WHO indicate that Trichomonas vaginalis (TV) infection is the 
most common curable sexually transmitted infection world wide. Unfortunately 
compared to other curable sexually transmitted infections, not much attention has 
been given to its control. This, however, is changing due to recent reports linking 
Trichomonas vaginalis infection to adverse birth and reproductive health outcomes 
and also its facilitation of acquisition of the Human immuno deficiency virus. 
Studies in this thesis address aspects of the epidemiology of Trichomonas vaginalis 
infection with a view to enhancing control programmes. 
Pregnant women attending antenatal clinics in Kumasi, Ghana, participated in the 
study. Data on socio-demographic characteristics, sexual behaviour, ano-genital 
hygiene, and partner behaviour were taken. Genital examinations were also done. 
Vaginal swabs were taken for the detection of Trichomonas vaginalis by 6 methods; 
latex agglutination, wet prep microscopy, culture, enzyme immuno-assay, 
polymerase chain reaction, and lateral flow. Women infected with TV were treated 
with standard 2g metronidazole single dose and had tests of cure done after a week. 
Four main findings are highlighted; 
socio-demographic, behavioural and clinical factors independently 
associated with TV infection were; young age, neither being of Akan nor 
northern origin, having no religious faith, and douching. Also, not using 
toilet roll for menstrual hygiene, complaining of a vaginal discharge, 
clinical detection of vaginal discharge and a vaginal pH more than 5 were 
independently associated with infection. However, these factors either 
singly or in combination, could not predict TV infection. 
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using a combination of morphologically based traditional TV diagnostics 
(wet prep and culture) and molecular techniques (PCR), no evidence for 
the involvement of rectal and oral trichomonads in the aetiology of 
vaginal trichomoniasis as speculated recently, was found. 
Ili. a developing country- friendly TV diagnostic, the latex agglutination test, 
compared favourably with culture, the gold standard in TV diagnosis. 
With 91% sensitivity and 99% specificity, it is easy to train to use,, easy to 
use, enables same day treatment, and does not require any equipment. It is 
apparently stable in field temperatures and relatively cheap. 
iv. the use of 2g single dose metronidazole therapy by a directly observed 
strategy is feasible. It was well tolerated and had a cure rate of 99.4% 
after I week. 
These findings contribute some new information to the epidemiology of TV 
infection. Such attributes of the latex agglutination test and the excellent clinical 
efficacy of single dose metronidazole therapy should make the control of TV 
infection feasible. 
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1.0 INTRODUCTION 
1.1 Background to the study 
Trichomonas vaginalis (TV) is one of the commonest sexually transmitted 
pathogens, with an estimated annual incidence of 170 million cases worldwide 1- It 
causes a wide spectrum of infections in men and women leading to great morbidity. 
Sequelae of infection with this flagellate include adverse pregnancy and perinatal 
outcomes. The Vaginal Infections in Prematunty (VIP) study in the United States 
(US) found that infection with T vaginalis resulted in a modest increase in the risk of 
premature labour (relative risk 1.3 )2. The attributable risk of T vaginalis infection 
associated with low birth weight was 1.5 % in white populations, but I I% amongst 
black women. The study also found that Trichomonas vagi . nalis infection in 
pregnancy was significantly associated with preten-n delivery of a low birth weight 
infant (Odds ratio, 1.3). 
Trichomonas vaginalis infection has also been reported as a nsk factor for the 
transmission of Human immuno deficiency virus (HIV) infection. In a prospective 
study among female sex workers in Kinshasa, Laga et al 3 found trichomomasis to be 
a risk factor for the acquisition of HIV. There have also been reports of higher 
concentrations of HIV in the semen of men with symptomatic trichomoniasis 4. In 
HIV infected women who are concomitantly infected with Tvaginalis, treatment of 
the trichomoniasis has reduced the HIV viral load by a factor of four 5. Strategies that 
incorporate treatment of trichomomasis could be important in HIV control. 
The control of any infectious disease depends on a sound understanding of its 
epidemiology. There are however some gaps in the epidemiology of Trichomonas 
vaginalis infection!, which data could be important for Its effective control. Important 
amongst these is whether other human trichomonads apart from Tvaginalis are 
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involved in the aetiology of urogenital trichomoniasis. Conventional wisdom dictates 
that these other trichomonads cannot colonise the vagina. This follows from earlier 
studies which reported that all human trichomonads are site specific and that one 
could not find the other human trichomonads i. e. Pentatrichomonas hominis and 
Trichomonas tenax (which are found in the large intestine and oral cavity 
respectively), in the urogenital tract. Most of these studies utilised diagnostic 
methods relying on the morphology of the organism. In recent times, it has been 
reported that morphological differentiation of human trichomonads is difficult 6 as 
they all look morphologically alike at microscopy. Also, trichomonads have been 
reported from non traditional body SIteS 
7,8,9 
using mostly more sensitive molecular 
methods, thus questioning the postulates that they are site specific. 
The finding in a community survey of 40% adolescent girls in Zambia with vaginal 
trichomoniasis ( based on morphology) who deny ever having had sexual intercourse 
10, and a report finding Rhominis in vaginal swabs (by polymerase chain reaction) 
from a similar population 11 leads to speculations of whether the trichomonads found 
in the adolescents in Zambia are those supposedly not transmitted sexually, but 
getting into the vagina from a rectal reservoir (the traditional site of 
Pentatrichomonas hominis). The control of Tvaginalis infection is based on 
measures against sexual transmission. Involvement of other trichomonads (not 
transmitted sexually) in the actiology, would have a bearing on measures which help 
control the spread and sequelae of infection. 
Modem molecular diagnostic methods should make a study of which trichomonad 
species is found in women diagnosed with Trichomonas vaginalis possible. 
in analysing a model of treatment interventions for Tvaginalls, Bowden and Garnet 
12 
demonstrated that screening populations for infection and treating those found 
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infected would have a far greater impact on reducing rates of infection than the 
present syndromic management approaches used in many developing country 
settings which have the highest burden of infection. Such screening programmes 
would however depend on the availability of diagnostic tests not only with good test 
perfonnances, but also tests which can be done with less technologically demanding 
equipment, performed with less skilled labour, at low cost, and under conditions as 
found in developing country settings. The tests would also have to be rapid to enable 
same day treatment. Some presently available tests could fulfil this purpose. 
Laboratory tests presently available for the detection of Tvaginalis are either 
insensitive or relatively expensive for use in resource poor countries. Finding socio- 
demographic, biologic, sexual, genital hygiene and clinical factors which could 
predict infection would be useful in selecting subjects for further investigation and , 
treatment of infection. 
Work presented in this thesis investigates the above problems and hopefully should 
help our understanding of the aetiology of vaginal trichomoniasis in relation to other 
human trichomonads. The choice of laboratory diagnostic tests for effective 
screening and control of disease would also be aided by work presented. 
1.2 Purpose, Aims and Objectives of Study 
The purpose of the study is to improve the understanding of the epidemiology of 
Trichomonas vaginalis and other related human trichomonads in the aetiology of 
vaginal trichomoniasis and evaluate laboratory diagnostic tests with a view to 
improving the control of infection. 
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1.2.1 Aims of study: to study the epidemiology of trichomoniasis in Kumasi, Ghana. 
1.2.2 Primary objective: ascertain whether human trichomonads other than 
Tvaginalis are involved in the aetiology of urogenital thchomoniasis. 
1.2.3 Secondary objectives: 
I. investigate factors related to sociodernographic, biologic, ano-genital hygiene 
practices, sexual practices, and partners' sexual habits that are associated 
with vaginal trichomoniasis in pregnant women. 
ii. ascertain clinical correlates of Tvaginalis infection in pregnant women 
iii. compare different laboratory diagnostic methods (latex agglutination, wet 
prep examination, culture, enzyme immunoassay, lateral flow and polymerase 
chain reaction) for T vaginalis infection. 
iv. investigate the involvement of human trichomonads other than Trichomonas 
vaginalis in the actiology of vaginal thchomoniasis. 
v. determine the species of trichomonads found in the vagina, rectum and oral 
cavity of study participants. 
vi. determine the clinical efficacy of single 2g dose metronidazole therapy in 
vaginal trichomoniasis in Ghana. 
1.3 Outline of work to be presented 
Relevant published literature relating to the biology of T vaginalis, its pathogenicity, 
epidemiology and clinical disease in men and women, the probable role of extra- 
genital trichomonads in the aetiology of genital trichomoniasis is presented in the 
first part of chapter 2. The second part of the chapter presents literature on the 
laboratory diagnosis of Tvaginalis infection and treatment issues. Methods for all 
aspects of the study are described in chapter I Chapter 4 details results and 
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discussion of socio-demographic, behavioural, biologic, sexual practices, genital 
hygiene factors associated with infection. Results and discussion of Clinical 
correlates of Tvaginalis infection are written up in Chapter 5, and a combination of 
both the socio-demo graphic etc factors and clinical correlates of Tvaginalis infection 
written up in chapter 6. Write up of the results and discussion of Comparison of 
Tvaginalis diagnostic methods is presented in Chapter 7. Chapter 8 presents results 
and discussions relating to the involvement of human trichomonads other than 
Tvaginalis in the aetiology of vaginal trichomoniasis. Work on species of 
trichomonads found in the vagina, rectum and mouth is presented in Chapter 9. 
Chapter 10 is on the results and discussion of the Clinical efficacy of 2g single dose 
metronidazole in the treatment of vaginal trichomoniasis. Study conclusions, with 
suggestions for further research are found in Chapter 11. 
1.4 Collaborating Institutions and Ethical Clearance 
Collaborators for this study comprise the School of Medical Sciences of the Kwame 
Nkrumah University of Science and Technology, Kumasi, Ghana, The Komfo 
Anokye Teaching Hospital, Kumasi, Ghana, the Ghana Health Service, the Clinical 
Research Unit of the London School of Hygiene and Tropical Medicine, and the 
Institute of Tropical Medicine, Antwerp. 
Ethical and Research clearance for the study was obtained from both the Committee 
on Human Research, Ethics and Publicatlons of the School of Medical Sciences and 
The Research Ethics Committee of the London School of Hygiene and Tropical 
Medicine. 
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The study has been supported with funds from the Department for International 
Development (DFID), UK, through the DFID Knowledge Programme. The 
Commonwealth Scholarship Commission supported the author with a Scholarship. 
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2.0 LITERATURE REVIEW 
Search strategy 
A search of English language literature in electronic databases including Pub Med, 
Web of Knowledge, Embase, BIDS, Africa Heathline and the WHO Reproductive 
Health Library was conducted, using the key words Trichomonas vaginalis and 
trichomomasis. Access to personal hard copy libraries of my Research Advisory 
Panel was granted and searched, and the abstracts of recent meetings of the 
Intemational Society for STD Research were also scrutinised. 
2.1 Trichomonas vaginalis and Trichomoniasis 
2.1.1 The organism 
2.1.1.1 History 
Trichomonas vaginalis is a protozoon parasite found in the urogenital tract. The 
organism has been implicated in many genitourinary conditions, commonly 
including vaginitis in women, and non gonococcal urethritis in men. It is one of the 
commonest sexually transmitted pathogens worldwide, with an estimated annual 
incidence of 170 million cases worldwide 1. In 1975, T vaginalis was estimated to 
have caused approximately 3-4 million infections in the US and over 1.5 million in 
Great Britain 13 . The epidemiology of the 
disease is still not well understood and 
some practitioners continue to question its importance. There is growing evidence 
however of its importance in its morbid role in conditions such as vaginitis and non 
gonococcal urethritis and its likely role in facilitating the transmission of HIV. 
T vaginalis was first described by Donne in a preparation of fresh vaginal exudates 
in 1836 
14. It was long regarded as a hannless inhabitant of the vagina 
15,16. When 
Kunstler 16 found it in the female urinary tract in 1883 and Marchand 16 also from the 
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male urinary tract in 1884, its designation as harmless still did not change. In 1916, 
Hoehne 17 demonstrated a relationship between Tvaginalis and symptomatic vaginal 
discharge. It was not until 24 years later that Trussel and Plass 18 fulfilled Koch's 
postulates by transmitting the disease to volunteers by the intravaginal inoculation of 
axenic cultures of the organism. This was confirmed 2 years later by Hesseltine and 
colleagues 
19 
. 
Even with publication of reports of many cases of this organism, clinicians did not 
give it much significance as they were more interested in the diagnosis and treatment 
of gonorrhoea and syphilis. However, by 1950, the significance of sexually 
transmitted infections other than gonorrhoea and syphilis had become apparent 20, 
and investigators began to view T. vaginalis as important 21. Yet still today, not much 
importance has been given to it compared to Neisseria gonorrhoeae and Chlamydia 
trachomatu. On today's market are commercial kits for the diagnosis of chlamydia 
and gonorrhoea based on nucleic acid amplification technology (Polymerase chain 
reaction). There is none for T vaginalis, the diagnosis of which is still based on the 
same 1836 wet preparation method of Donne 14 . At many conferences on sexually 
transmitted infections, delegates fill sessions where new diagnostics for Chlamydia 
trachomatis and N. gonorrhoeae are showcased, while only a handful are seen at 
sessions for T vaginalis diagnostics. One rapid diagnostic test for T vaginalis, the 
Kalon TV latex test 22 with a purported sensitivity and specificity of 95 and 97% 
respectively, has, since evaluations in the UK in 1988, not seen much routine use and 
discussion of it. Why would people want to invest in a test for a disease which to 
them is so uncommon and associated with minimal morbidity and sequelae? 
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2.1.1.2 Taxonomy and biology 
Together with other human trichomonads described later, Tvaginalis is a member of 
the zoomastigophorean order of the phylum Sarcomastigophora and belongs to the 
protozoan order Trichomonadida. The order contains more than 100 species most of 
which are commensals found in the intestinal tract of mammals and birds. Although 
a eukaryote, Tvaginalis has properties similar to bacteria; it lacks mitochondria, 28s 
nbosomes and regulated glycolysis. Like higher eukaryotes, it possesses DNA 
sequences and peptides related to cell division. 
The organism, which is flagellated, varies in size and shape, with an average length 
of 10itm and width of 7 AM 23 . The appearance tends to be more uniform in axenic 
cultures Le, pear shaped or oval, and it takes an arnoeboid shape when attached to 
vaginal epithelial cells 
24 
. 
The protozoan possesses 5 flagellae, four of which are located at its anterior portion. 
The fifth is incorporated within the undulating membrane of the parasite. The 
flagellae and the undulating membrane give the parasite a characteristic quivering 
motility 
23 
. The cytoskeleton 
is composed of tubulin and actin fibres. The nucleus of 
the parasite is located at its anterior end, and as in other eukaryotes, is surrounded by 
a porous nuclear membrane. A slender hyaline rod-like structure, the axostyle, runs 
'r- - from the nucleus and bisects the protozoan horizontally. It protrudes the posterior 
end and tenninates in a sharp point. The axostyle is thought to anchor the parasite to 
vaginal epithelial cells. 
Glycogen granules can be observed in living cells under light microscopy. These are 
catalase negative and produce hydrogenosomes, which are important in metabolism. 
The hydrogenosomes generate hydrogen which combines with oxygen to form water, 
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thus removing oxygen fTom the vaginal ecosystem and creating an anaerobic 
enviromnent in which Tvaginalis and other anaerobes thrive. 
In keeping with its anaerobic status, Tvaginalis derives its carbon from the reduction 
of glucose and glycogen into succinate,, acetate, malate and hydrogen. It also 
produces some carbon dioxide, but not through the Krebs' cycle. 
2.1.1.3 Life cycle 
Tvaginalis reproduces by mitotic division and longitudinal fission which occurs 
every 8-12 hours in optimal conditions. The parasite exists only in trophozoite forrn, 
lacking a cystic stage 25 . Its 
life cycle is poorly understood. The parasite lives on the 
epithelium of the uro-genital tract to which it is anchored by its axostyle. Infection is 
usually transmitted by sexual intercourse and continual re-infection of a sexual 
partner býy an untreated partner is common. 
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Figure 2.1 Life cycle of T. vaginalis 
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2.1.1.4 Pathogenicity 
The cell surface of T voghialis plays a major role in adhesion, host-parasite 
interaction and nutrient acquisition. Proteins and glycoproteins displayed on its 
surface are used for these ftinctions. 
The mucous layer of the genital tract is the first host surface encountered by 
trichomonads. Mucins, large glycoproteins with sizes between 1-35 x 106 Da, are the 
major proteins found in mucus ". Its size, gel-like property and heavy glycosylation 
make mucin a formidable barrier to pathogens colonising the underlying epithelium. 
The outcome of the interaction between trichomonad and the host mucous membrane 
determines the success or otherwise of T vagmall, ý colonising a host. 
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Adhesion of trichomonads to the vaginal epithelial cells is chtical in the pathogenesis 
of the parasite 27,28 . Adhesion is time, temperature and pH 
dependent and is mediated 
by four adhesion proteins, AP65, AP51, AP33 and AP23 29 which act in a specific 
ligand-receptor fashion. Trichorrionad cysteine proteinase activity is also necessary 
for adhesion 30 . Adhesion proteins are upregulated during times of abundant iron 
sources such as during menstruation. Leliker et al 31 have suggested that increased 
adherence during menstrual flow prevents loss of the parasite. Adherence thus allows 
the parasite to persist in the vagina, avoiding the flushing action of mucosal 
secretions. 
Adhesion is followed by the secretion of mucinases (most of which are cysteme 
proteinases) which solubillse the mucous matrix and then detaches the parasite from 
the mucous layer. Flagella movement of the parasite then allows it to penetrate the 
solubilised matrix and colonise the underlying epithelial cell 32 
Thus, adherence, proteinase activity and motility are the major mechanisms 
necessary for Tvaginalis to traverse the vagina mucosa and establish pathogenicity. 
2.1.1.5 Immune system evasion 
Ability of the parasite to evade the immune system is important for its survival. 
Avoidance of complement is the main strategy used by Tvaginalis to overcome the 
human immune system. Tvaginalis activates the alternative complement pathway 
33 
. 
The organism takes advantage of a habitat with very little complement activity such 
as cervico-vaginal mucus 
34 
. Menstrual 
blood is the main source of complement 
available to the vagina. Even then, the complement activity of menstrual blood is 
only about half that of venous blood, and about a third of menstrual blood samples 
have no complement activity at all 34 . Again, iron contributes 
to complement 
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igh resistance in Tvaginalis as resistance to complement is dependent upon a hi 
concentration of iron 34 ,a nutrient abundant 
in menstrual secretions. Iron seems to 
upregulate the expression of cysteine proteinases, which have been found to degrade 
the C3 portion of complement on the surface of the organism, allowing it to evade 
complement mediated destruction 
34 
. 
Another means of immune system evasion is the possession of all Tvaginalis isolates 
of the high molecular weight immunogen, P230 on their surface. This immunogen 
undergoes confonnational changes (epitope phenotypic variation) that allows 
evasion 
35 
. 
Other mechanisms of immune evasion by the trichomonad include degradation of 
IgG, IgM, and IgA by cysteine proteinases secreted by the parasite 36 1 the secretion of 
large amounts of soluble antigens which may neutralise antibody or cytotoxic T 
lymphocytes, thus short-circuiting specific anti-T. vaginalis defence mechanisms 37 9 
and the parasite coating itself with host plasma proteins, a form of immunological. 
mimicry 
38 
. 
2.1.1.6 Transmission. 
Evidence from epidemiological and human inoculation studies indicate that 
urogenital trichomoniasis is transmitted almost exclusively by sexual intercourse. 
There is a high prevalence rate in male sexual partners of infected women 39,40 , and 
, 41 vice versa4O . In such cases recurrent trichomonas vaginitis 
has been cured only 
after the parasites had been eradicated from the genital tract of the sexual partner. 
The infection has also been seen more frequently in patients attending sexually 
transmitted diseases (STD) clinics and in commercial sex workerS42,43 . 
Trichomoniasis is also often associated with other STDS 
44,45. Tvaginalis has also 
36 
been isolated almost exclusively from urogenital sites i. e. vagina, cervix, bladder, 
urethra and Bartholin and Skene's glands in women and the anterior urethra, external 
genitalia, prostate,, epididymis and semen of men. 
Human inoculation studies to fulfil Koch's postulates were carried out between 
1940-1955. Intravaginal 19 and intraurethral 46 inoculations led to infection of 75% of 
women and five of five men respectively and none of controls. However, like other 
sexually transmitted agents e. g. gonococcus and herpes simplex 2, that can survive 
outside the human host, there has been speculation about non sexual transmission 
especially in prepubertal girls. Charles 47 reported 27% of girls below 12 years with 
leucorrhoea having trichomonas vaginitis. He speculated transmission through 
communal use of water tanks and ponds. Adu-Sarkodie 48 also reported infection in a 
mother and 3 daughters, speculating transmission through joint family use of bathing 
sponge and towel. Recently in a study looking at reasons for the differential spread of 
HIV in different African sub regions, Buve 10 and colleagues reported 40% of 
adolescent girls in Ndola, Zambia to be infected with Tvaginalis. These girls denied 
ever having had sexual intercourse and the authors could not explain this finding by 
under-reporting of sexual behaviour by the girls. They suggested that this infection 
could be due to intestinal tnchomonads (P. hominis), that these faecal trichomonads 
could have contaminated the self administered vaginal swabs or that intestinal 
trichomonads do really colonise the vagina via the perineum. Even though the 
authors dismiss under-reporting of sexual behaviour by these girls, it could be so in 
reality. In many African societies, non consensual sex as in rape or sexual defilement 
especially if perpetrated by a family member may be counted as no sex by the 
teenagers, to correspond to perceived social norms. Also, sight should not be lost of 
problems in the reporting of sexual behaviour in adolescent surveys. There is 
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evidence that the type of question asked and the mode of survey administration (face 
to face interviews, paper and pencil self administered interviews or computer assisted 
self interviews) significantly affect the responses of adolescents to sensitive 
quesions 
49 
. 
Non sexual transmission of Tvaginalis by contaminated douche nozzles, specula and 
toilet seats has been speculated 40 
Between 2-17% of female infants born to infected mothers have developed 
urogenital trichomoniasis at birth 13 . In the presence of matemal oestrogens, the 
neonatal vaginal epithelium resembles that of the adult and is therefore susceptible to 
Tvaginalis infection. When the neonate's vaginal epithelium assumes a prepubertal 
state after maternal oestrogens have been metabolised within 3-4 weeks of birth, it 
becomes rellatively resistant to Tvaginalis infection and there is resolution of 
infection and discharge 
13 
. 
Though there has been no cogent proof of non sexual transmission, the theoretical 
possibility exists. 
2.2 Epidemiology of Trichomonas vaginalis infection 
2.2.1 Introduction 
Trichomonas vaginalis (TV) infection has been encountered world wide, in every 
climate and with no seasonal variability. It has a cosmopolitan distribution and has 
been identified in all racial groups and socioeconomic strata. 
Humans are the only natural hosts for T. vaginalis. To perpetuate itself, T. vaginalis 
depends on the host for survival. It has no cyst phase and is susceptible to desiccation 
50 and high temperatures, but can survive for long periods outside conditions of high 
humidity. T vaginalis has been isolated from swimming pools, baths, and poorly 
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chlorinated water 
51,52,53 
. The organism 
has survived in vaginal exudates at I OOC for 
up to 48 hours 54 , 
in voided urine for as long as 3 hours, in semen ejaculates for 6 
hours 55 and in 350C water in wet washcloths for up to 24 hours 
20,39. About one third 
of contaminated washcloths yielded viable organisms after 2 or 3 hours and 10% 
even after 24 hours 20 . Viable organisms have also been isolated in vaginal exudates 
56,57 that have been allowed to dry for 3-6 hours . Whittington has suggested that 
moisture is essential for the survival of the organism 54. Viability of TvaginaliS has 
been preserved in Stuart's transport medium at room temperature for up to 3 days 
and at refrigerator temperature for 9 days 40 . 
Tvaginalis has been found to contaminate toilet seats 
40,58. In a unique experiment, 
Whittington 40 found that II of 30 (37%) infected women left urine on toilet seats 
after use and that 4 (36%) of these samples yielded viable trichomonads. After 
seeding toilet seats with thchomonas-laden vaginal exudates, WhitIt-ington again 
found that the organisms survived from less than 10 minutes to up to 45 minutes 40. 
2.2.2 Is trichomoniasis uncommon? 
As far back as 1947, Trussel estimated that between 20-25% of the female 
population in the US were infected with Tvaginalis 59 . Before that, a study of women 
attending a US Naval hospital in 1938 showed that 24.6% had T vaginalis 60 , and 
14% of male recruits to the US Army in 1943 were also infected 61 .A US vaginal 
cytology survey in the 1950s showed infection in 60.9% of black women and 8.1% 
of white women 39 . An investigation of Pap smears of 
38,000 "healthy women" in 
the US in the 1960s demonstrated infection in 30.4% black women and 10.7% white 
women 62 . These studies, predating the 
introduction of metronidazole to the US in 
39 
1959 and the early 1960s, show unequivocally, the high prevalence of Trichomonas 
vaginalis infection in that society then. 
The situation improved with the introduction of metronidazole. However the 
disparity in risk between ethnic groups and people with different socio-economic 
standing has continued into the post metronidazole era. While infection was seen in 
0.5% of antenatal clinic attenders in an Australian urban setting 63, it was seen in 
25% indigenous women in rural northern Australia, 64 , and 45% Melanesean women 
in Papua New Guinea 
65 
. While 0.7% of European men with a urethral discharge 
66,67 
had trichomonas urethritis in the 1990s, the parasite was reported from 10% of 
Melanesean men with urethritis 65 . Differential prevalence among black and white 
women in America still remains, with infection rates of 22.8% compared to 6.1% 
respectively -2. Prevalences of 20-65% in women in various population groups have 
been reported from AfTica 
10,68,69,70,71,72,73. 
Even though these prevalence data cannot be directly compared due in part to 
different diagnostic methods and inherent biases in all studies, they nevertheless 
show unequivocally that Trichomonas vaginalis infection is common especially in 
economically disadvantaged populations in both developed and developing countries. 
2.2.3 Epidemiology in women. 
Most studies on the distribution of trichomonas vaginitis are biased by the lack of 
random sampling and have a bias towards populations likely to be diseased (e. g. STD 
clinic attenders) or a convenience population such as antenatal clinic attenders. 
Studies also vary in the sensitivity and specificity of testing procedures employed. 
infection rates of 0.5% - 65 
% 2,63,64,65,73 have been reported from antenatal clinics, 
with the highest prevalence coming from poor under resourced communities. 
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High risk sexual behaviour i. e. high rates of sexual partner change and/or sex in 
exchange for money increases the risk of female acquisition of Tvaginalis 
infection 
69,74,75 
, as does low socioeconomic status 
76. In Cotonou, women who 
exchange sex for money have significantly higher prevalence of Tvaginalis infection 
than those who do not (18.2% vs. 3%) 10. 
Trichomoniasis has also been associated with the presence of other sexually 
transmitted infections (STI) 69,77, the likely explanation being confounding by sexual 
behaviour. In Yaound6,, Cameroon,, infection was significantly associated with 
gonorrhoca (p=0.02) while in Ndola, Zambia infection was associated with 
Chlamydia infection (p=0.02). 10 
A high prevalence in multiparous women, women married at an early age, and 
pregnant women has also been reported 
10,78 
Being from a black ethnic backgound has also been consistently associated with T 
vaginalis acquisition in the US 2, with black/white case ratios as high as 8: 1 reported. 
Some commentators attribute this to confounding by poor socioeconomic 
circumstances. 
In most studies, the prevalence of trichomoniasis seems to increase with increasing 
10,79 20,39 
age, with peak rates occurring in women in their thirties and forties . This 
may not suggest that older women are at any higher risk of disease than younger 
ones. It may indicate a disease with a relatively long duration, prone to chronicity, 
and not cured by inadvertent antibiotic use. 
It has been postulated that the use of oral contraceptives is associated with a 
decreased risk of trichomoniasis. In a study of 23,756 patlents, the relative risk of 
trichomoniasis for oral contraceptive users compared to non users was 0.49 (95%C1 
0.46-0.53 ) 80, suggesting that non user women are twice more likely to acquire 
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Tvaginalis infection than users of oral contraception. This effect has not been seen 
with gonorrhoea. The biologic nature of this is difficult to explain. It may be due to 
confounding by socio-economic standing, in that low contraceptive use is prevalent 
in communities of poor soCio-economic standing in whom high T vaginalis 
prevalence is also found. Lossick suggests that high levels of oestrogen are not 
conducive to Tvaginalis infection 81. This view however contrasts the explanation of 
transient colonization of infants born to Tvaginalis infected women, that this 
transient state is due to maternally transferred oestrogens to the infant, and that 
colonisation is lost after degradation of the honnone in the infant 13 . 
2.2.4 Epidemiology in men. 
Just like trichomonal vaginitis in women, prevalence studies in men suffer from 
biases -of patient selection and diagnostic methods. ýTrichomonas infections are also 
not routinely diagnosed in men because of the apparent limited ability of traditional 
tests ie wet prep and culture to detect the organism in the male genital tract. 
Prevalences of 3-18% have been reported in various populations of men around the 
86 
world 
82,83,84,85 
. The highest reported prevalence 
has been 68% in men In Chile 5 
and the lowest, I% among men in Seattle 
87 
. 
In a population based study of men aged 15-54 years from Tanzania, Watson-Jones 
et al reported a prevalence of 11 % using direct microscopy and culture 
88 
. Using a 
combination of culture and the polymerase chain reaction (PCR), Hobbs and 
colleagues reported a prevalence of 17% in men attending a sexually transmitted 
diseases clinic in MalaWi 4. In determining the aetiologic role of pathogens other than 
N. gonorrhoeae and C trachomatis in urethral discharges among men from West 
42 
Africa,, Pepin et al found Tvaginalis in 13.4% of subjects as against 13.8% and 10% 
of N. gonorrhoeae and Ctrachomatis respectively 89 . 
Krieger 90 
. studying 447 men at risk of sexually transmitted diseases, found a 
prevalence of 6% for Tvaginalis infection. In these men, risk factors significantly 
associated with infection were sexual exposure to a woman with trichomoniasis 
(odds ratio 3.7,95%Cl 1.9-7.4), and a history of previous treatment for 
trichomoniasis or urethritis (odds ratio 3.1,95%Cl 1.4-6.9). 
The importance of T. vaginalis as a cause of genitourinary syndromes in men has 
been the source of controversy. Investigators interested in sexually transmitted 
diseases in women, especially in the US, believe that asymptornatic transmission is 
the rule for men infected with Tvaginalis 87 . In contrast, European investigators have 
found that T. vaginallS infection in men is a major. cause of morbidity 91 Clinical 
conditions in inen that have been associated with trichomoniasis include non 
gonococcal urethritis, prostatitis, balanoposthitis, epididymitis and infertility. The 
strongest epiderniologic association is between Tvaginalis and non gonococcal 
urethritis. 
Though studies have demonstrated an aetiological link between Tvaginalis and non 
gonococcal urethritis, the precise proportion of cases of non gonococcal urethritis 
attributable to trichomoniasis has not been established. This may vary in different 
populations and also with different diagnostic tests. Whilst Bakare et al found 
Tvaginalis in 18 out of 215 men (8%) with non gonococcal urethritis in Nigeria 
using wet prep and culture 92 , Schwebke et al 
found infection in 19.9% of American 
men with non gonococcal urethritis, using PCR 
93 
. 
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2.2.5 Partner Infection studies 
Rates of partner infection in men are different from that in women. While most 
female sexual partners of infected men are infected with trichomoniasis (67-100%) 
40,90 
, investigators have reported only 14-60% 
39,84,90,94,95 
infection of male partners 
of women with tnchomoniasis. The low infection rate in men may be due to 
transmission inefficiency from female to male, poor sensitivities of current TV 
94 diagnostics in men, or spontaneous resolution of infection in the male . Some 
authors have ascribed spontaneous resolution in men to be the result of the constant 
washing action of the urethra by urine and the anti-trichominicidal property of zinc 
found in prostatic secretions 
96 
. 
In summary, the epidemiology of trichomoniasis is characteristic of a sexually 
transmitted infection. The infective dose of the organism-in women appears small, 
and the incidence rate is high. Asymptomatic disease is common in both sexes and 
almost the rule in men. The infection also resolves spontaneously in some men. 
Trichomoniasis shares many of the risk factors of the other sexually transmitted 
infections, but also differs in other respects. 
2.3 Clinical features of T. vaginalis infection 
2.3.1 Is T. vaginalis infection clinically trivial? 
The symptoms of trichomonas vaginitis are troubling. Before the era of 
metronidazole, women were subjected to prolonged and often unpleasant treatment 
courses, some of which were quite toxic 
97 
. Their willingness to undergo these 
treatments suggests the degree of discomfort associated with infection. Again, 
because most of the treatments at that time were topical and administered by 
physicians, most of whom were men, women must have suffered the indignity of 
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exposing themselves for such treatments, which they did because they needed relief 
from the distress of the vaginitis. 
Keighley, reminiscing over the huge success of oral metronidazole in the treatment 
of female trichomoniasis after 10 years of use, said, "it is good to pause and 
contemplate the change that oral medication for trichomonal vaginitis has made in 
women's lives. Flagyl is now taken as a matter of course and a whole generation has 
no knowledge of the suffering of women with trichomomasis before its introduction 
- the indignities and discomfort of the perpetual local treatments, douches, paintings, 
insufflations and insertion of pessaries. All these things women suffered for months 
and sometimes years on end, only to relapse when the treatment was di 1 98" i scontinued 
2.3.2 Clinical presentation and disease in women. 
Although many studies have looked at the epidemiology and clinical disease of 
human urogenital trichomoniasis, most of these concern various aspects of the 
disease in women. 
20,99,100 
. Possible explanations can be deduced. Trichomoniasis in 
women is associated with well described clinical syndromes, considerable morbidity, 
and standard diagnostic algorithms 10" 1 
02,103 
. In contrast, trichomoniasis in men is 
associated with poorly delineated clinical syndromes, uncertain morbidity and there 
is no familiar algorithm with respect to its diagnosis. The presentation of 
trichomoniasis in females is considered in many clinical textbooks, unlike that of 
men. It is not surprising that medical disciplines outside the practice of specialist 
Genitourinary medicine and Urology do not consider male trichomoniasis a clinical 
entity. 
Trichomonas vaginalis principally infects squamous epithelium in the genital tract 
104 
. In the adult 
the ectocervix is much more affected and disease is rarely reported 
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from the endocervix. Trichomonads have been recovered from the urethra and 
Skene's glands in 90% of infected women 20,40 . Infection at these sites may cause 
dysuria or discharge from the urethra or Skene's ducts. 
The spectrum of infection ranges from the asymptomatic carrier state to flond 
vaginitis. Factors responsible for this are not clear but could include differences in 
intrinsic virulence of individual strains and individual host susceptibility. Clinical 
evidence for the latter includes the observation that even among infected female 
sexual partners of an individual man, the spectrum of disease ranges from mild to 
severe. Since these epidemiologically linked women are most likely infected with the 
same strain of trichomonad, differences in clinical expression is probably related to 
host factors. 
About 9-56% 20,50,101,105,110 . of trichomonal infections in women are asymptomatic 
in various population groups. 75% women in Zimbabwe denied any symptoms on 
questioning, out of which 16% had trichomoniasis 
106 
. 
A third of asymptomatic women have been observed to become symptomatic within 
6 months 1 07 . However, one cannot 
discount re-infection or the probable co-InfectIon 
with a more virulent strain after initial infection with a less virulent strain. A number 
of studies have reported exacerbation of trichomomasis symptoms during or 
immediately after a menstrual period 
20,50,108 
. This could 
be due to the presence of 
iron in menstrual blood. Iron upregulates the virulence of Tvaginalis 
31 
. 
The incubation period for trichomonal vaginitis has been estimated to range between 
3-28 days 
20,50,109 
. Vaginal discharge and vulvo-vaginal irritation are 
the most 
common complaints. Discharge is described by 50-75% of symptomatic women 
101, 
107,110. A study in 200 symptomatic Nigerian women demonstrated 74% had 
T vaginalis infection 
70. The discharge is perceived as malodorous by only about 
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10% of infected women 
111,112 
. Vulvovaginal irritation which can be severe enough 
to awaken the patient at night is noted in a quarter to a fifth of women 
101,110,113,114 
Up to a fifth of women report some degree of dyspareunia 110, and lower abdominal 
pain by only 5-12% 
65,113 
. Dysuria is described by about 30% of patients 
115,116,117 
. 
There is no evidence that trichomoniasis is more symptomatic in pregnancy or 
66,115,121 
among users of oral contraceptives 
Pastorek and colleagues 118 studied over 13,000 pregnant women in the US and 
reported that clinical findings significantly associated with Tvaginalis infection were 
a yellow, green or bloody vaginal discharge, abnonnal odour, a vaginal pH>5, 
increased amount of discharge, and abnormal consistency of the discharge. However 
the clinical usefulness of these features either alone or in combination were minimal 
in the prediction of infection, not having sufficient sensitivity and specificity. In 
Cameroon, a clinician"s ability to predict vaginal infection with Tvaginalis based 
119 
solely on clinical grounds was shown to have a positive predictive value of 42% 
Serbian researchers have also reported poor correlation between clinical features and 
120 diagnosis of infection 
Cervical pathology in the form of colpitis maculans or strawberry cervix results from 
microscopic punctate haemorrhages of the cervix. Tvaginalis has been significantly 
associated with this clinical finding 
118. 
2.3.3 Clinical presentation and disease in men. 
Clinical presentation of trichomomasis in men has been described in many studies. 
These studies have been conducted in sexual partners of infected women and men 
presenting genitourinary tract complaints. The majority of sexual contacts of infected 
20,84,112 
women are asymptomatic . Among 23 East African men with trichomoniasis, 
47 
126 19 were asymptomatic . Jirovic and 
Petru comment that "in the male , infection is 
mostly latent or persists in subdinical form 20 9ý . 
The incubation period of trichomonal urethritis has been reported severally to be 
between 3-8 days 94 ' 127 . Much wider variability however, has been reported by Czech 
researchers, according to whom this varies fTom I day to 3 months 
6,127. 
Clinical symptomatology of infected men varies widely. Weston and Nicol 
94 
evaluated 93 men with trichomoniasis - 52% had obvious urethral discharge, 26% 
complained of dysuria, and 5% noted increased urinary frequency, while 21% had no 
symptoms. Wisdom and Dunlop 128 described 92 men with symptomatic 
trichomoniasis. Urethral discharge was found commonly in 64%, urethral irritation in 
62%, urethral pain in 24%, increased urinary frequency in 5%, lower abdominal pain 
in 4% and balanoposthitis in 3%. Only 7% of the 92 cases had evidence of prostatitis. 
Catterall 129 described clinical findings in 108 symptomatic men out of 126 with 
trichomoniasis. 83% complained of urethral discharge, 26 (24%) noted urettiral 
imtation, 14% had dysuria, 4 (4%) experienced increased urinary frequency, 3% 
noted haernaturia, and 1% had epididymitis. Clearly in all these cases urethritis was 
the predominant syndrome. Kuberski, in contrast, found that majority of his patients 
86 
(77% of 26 men) with trichomoniasis had clinical evidence of prostatitis 
2.3.3.1 Spontaneous resolution of male urethral trichomoniasis 
Spontaneous resolution of male trichomonal urethritis has been reported by several 
investigators, with the most convincing work coming from Weston and 
Nicol 94 
(Table 2.1). They investigated the prevalence of trichomomasis among male sexual 
partners of infected women as a function of the interval between last sexual exposure 
and examination. When the interval between examination and exposure was 2 days, 
48 
T vaginalis was found in 70% of patients. After 2 weeks, infection could be 
identified in only 30%. Beyond this period, it became difficult to evaluate the 
presence of Tvaginalis as the numbers of patients examined became small. Other 
workers suggest however that spontaneous resolution of untreated Tvaginalis in men 
is highly unusual. In this wise, Coutts et al 130 stated that "chronic infection of the 
male genitourinary tract is very common". Watt and Jennison 84 found that 13 of 15 
men with Tvaginalis were still infected after 2 weeks, but these men were apparently 
not instructed to refrain from sexual intercourse with their infected partners. In an 
accident of history, Catterall 129 treated 12 men who had urethral trichomoniasis with 
oxytetracycline (known to be totally ineffective today) for 5 days. Follow up after 3 
months showed that 10 patients (83%) still harboured the protozoa. Similar findings 
have been reported by Whittington 40 and other Eastern European workers 20 
Not many studies have utilised semen as source material for TV diagnosis in men. 
The above studies utilised urine and/or urethral swab samples from the men. In a 
recent study using semen as diagnostic material, 75% male sexual partners of 
infected women have been reported to be concurrently infected. This may indicate 
344 
the supenority of the use of seminal fluid in the diagnosis of TV infection in men 
The long tenn consequences of untreated trichomoniasis in men are not known. 
49 
Table 2.1. Prevalence of urogenital trichomoniasis among male sexual partners of 
infected women (data from Weston and Nicol 
94) 
Interval between last 
sexual exposure and 
evaluation (days) 
Tvaginalis 
identified/contacts 
examined 
Prevalence 
2 16/23 70 
4 16/29 55 
6 7/27 26 
8 10/25 40 
10 8/21 38 
14 9/30 30 
20 8/15 53 
30 3/13 23 
40 1/4 - 
50 2/2 - 
60 1/4 - 
60+ 7/8 - 
Unknown 7/8 
Total 93/207 Mean 45 
2.4 Sequelae of infection with T. vaginalis. 
Compared to infection with N. gonorrhoeae and Ctrachomatis, many clinicians have 
considered infection with Tvaginalis to be without sequelae and less of a public 
health problem, but merely a nuisance to the sufferers. However recent data on the 
association of Trichomonas vaginalis and premature labour and low birth weight and 
its facilitation of HIV transmission may question this. 
The Vaginal Infections in Prematurity (VIP) study in the US found that infection 
with T. vaginalis was associated with a modest increase in the risk of premature 
labour (relative risk 1-3) 
2. Though this may be of minor importance in populations at 
low risk of Tvaginalis infection, the attributable nsk could be substantial in endemic 
populations, such as Africa. In the VEP study cited, the attributable risk of T. 
vaginalis infection associated with low birth weight was 1.5% in white populations, 
but 11% amongst black women. The VIP study 2 also found that Trichomonas 
vaginalis infection in pregnancy was significantly associated with preterm delivery 
50 
of a low birth weight infant (Odds ratio, 1.3). Unfortunately recent trials have found 
that the treatment of Tvaginalis infection in pregnancy does not improve pregnancy 
outcome and may be harmful 
131,132,133 
. In one of the studies 
131 
, as much as 8g 
metronidazole (recommended dose 2g) was given to the women. Probable toxicity 
from this could be responsible for the excess adverse pregnancy events in the women 
who took the drug. 
In addition to its role in adverse pregnancy outcomes, T vaginalis has been 
associated with endometritis, infertility, ectopic pregnancy, and non human 
papillomavirus (HPV) associated cervical neoplasia 1 
34 135,136,137 
. It has also been 
linked to respiratory disease among infants delivered vaginally to infected mothers 
138 
In men,, an association between Tvaginalis and. epididymitis, prostatitis, and 
infertility has been reported 
21,139,140 
Most of the studies on the HIV /STI co-factor link have looked at genitoulcerative 
conditions and bacterial inflammation STI such as, gonorrhoea and chlamydia 
infection. Only a few studies have specifically looked at Tvaginalis and HIV. These 
have shown an association between trichomoniasis and HIV infection, suggesting a 
3,141,142 
two to three fold increase in HIV transmission .A cross sectional study 
conducted among 1209 female sex workers in Cote d1voire found an association 
between HIV and trichomonas infection in bivariate analysis (crude odds ratio 1.8, 
141 
95% CI 1.3-2.7) . In another cross sectional study in 
Tanzania, among 359 women 
admitted to a hospital for gynaecological complaints, TV was more common in 
women with HIV infection in multivariate analysis (odds ratio 2.96,95% CI not 
provided, p<0.001). While these cross sectional studies are limited by temporal 
ambiguity, i. e. lack on information on whether TV infection preceded HIV, one 
51 
prospective study by Laga et al, reinforced such findings. In this study which 431 
HIV negative female sex workers in Zaire were evaluated over time, prior TV 
infection was associated with almost a2 fold increased rate of HIV seroconversion in 
multivariate analysis even though this was of borderline significance 3. Sorvillo and 
Kemdt 143,144 have pointed out that even a modest increase will translate into an 
attributable fraction for H1V of nearly 20% in areas where the prevalence of T 
vaginalis infection is 25%. The prevalence of gonorrhoea and chlamydia infection in 
many African countries is low compared to trichomoniasis. In the Rakal study of 
mass STD treatment to reduce HIV incidence,, the prevalence of gonorrhoea and 
chlarnydia infection was 2.1% and 4.0% respectively in a subgroup of the study 
145 
population . In the Mwanza survey, the prevalences were 2.2% and 0.7% 
respectively 1.46 . The attributable fraction of JITV cases caused by N. gonorrhoeae and 
Ctrachomatis in these populations will therefore be small, even though the relative 
risk of transmission to the individual may be substantial. T vaginalis prevalence is 
however consistently higher on the continent with reports of 24% in Uganda. It is 
thus possible that the control of T vaginalis could be effective in reducing the 
incidence of HIV. 
Hobbs et al 4 report finding a6 fold concentration of HIV in the semen of men 
symptomatic for T vaginalis infection. They did not find this in men asymptomatic 
for T vaginalis infection or men who were symptomatic for other conditions of 
unknown aetiology. This may mean men with symptomatic trichomonas infection are 
more infectious for the transmission of HIV. Wang and colleagues 
5 noticed a 4.2 
fold reduction in the vaginal HIV-1 load after treating Tvaginalis infected women 
who also concomitantly were HIV infected. These findings suggest that HIV-1 
52 
intervention strategies that incorporate the treatment of T vaginalis infection could 
be important in the control of HIV infection. 
The adverse pregnancy events, negative reproductive health events and increased 
susceptibility to HIV infection as shown by the studies above indicate the seriousness 
of the sequelae of T vaginalis infection, and thus necessitate as much attention and 
action as given to infections due to Neisseria gonorrhoeae and Chlamydia 
trachomatis. 
2.5 Extragenital Trichomonads 
2.5.1 Human Trichomonads 
There are 3 species of the family Trichomonadidae that are found in humans - 
Trichomonas vaginalis, Pentatrichomonas hominis, and Trichomonas tenay.. 147 . All 3 
species can be found outside the genitounnary tract. 
2.5.1.1 Trichomonas vaginalis 
In human clinical studies, most cases of findings of T vaginalis extra genitally have 
involved contact between the genitalia and the mouth. Rebhun in 1964 148 reported a 
case of pulmonary trichomoniasis in a man presumably infected after oral sex with 
his infected female partner. The flagellate was identified based on the case history 
and its morphologic characteristics on microscopy and not on its cultivation. 
Trezhalmy 149 and Brenner and Simon 1 50 also reported finding trichomonads which 
they said were T vaginalis based on morphology, in foul smelling purulent lesions 
from the mouth and tongue scrapings of patients with sore throat, dysphagia and 
severe glossitis. These patients recovered on metronidazole therapy. 
53 
There have also been documented cases of bronchitis, pneumonia and rhinitis 
presumably caused by Tvaginalis in new born babies 
138,151 
. Sources of these 
152 trichomonads have been traced to infected mothers with vaginal trichomoniasis 
Colonisation of neonates with Tvaginalis from infected mothers has been reported. 
The babies are known to rid themselves of these trichomonads when the level of 
matemal hormones transferred to them dunng pregnancy wanes 152 . 
Most of these findings as mentioned above have been based on direct microscopic 
findings of T vaginalis and sometimes by culture. However, there needs to be 
caution in delineating these isolates as Tvaginalis just because there has been contact 
in a way with the genitalia. Differentiating between individual trichomonads by wet 
film examination is difficult as all trichomonads morphologically look alike under 
the microscope 6. It is not improbable that other species could be mistaken to be 
Trichomonas vaginalis and reported as such. Indeed Hersh 6 writing about T. tenax in 
1985 indicated, "because of their morphological resemblance to other trichomonads 
and their marked protoplasmic plasticity and the environmental and genetic variation 
in organism size and shape, identification of flagellate species using only the wet 
preparation is unreliable" 
In recent times, using nucleic acid amplification techniques, T vaginalis has been 
recovered from the pharynx of 3 men. Only one of them was symptomatic for 
pharyngitis. In another, T vaginalis was additionally identified from his genital 
secretions. All three men admitted to oro-genital contact with their female partners. 
The T vaginalis infection status of their partners was not reported and TV strain 
typing not done 8. Another study using genomic amplification and sequencing of the 
small-subunit rRNA of Tvaginalis reported finding Tvaginalis together with 
54 
Ptieumocyslis sp In bronchoalveolar lavage of an adult African patient in France 153 
with respiratory disease. No history of oro-genital contact was indicated. 
Figure 2.2 Giemsa stain, Tvaginalis 
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These reports of findings of 7' vqginali. ý apparently causing disease in sites other 
than genitourinary, especially using molecular techniques suggest that Ti, cigincilis 
can establish itself in mucosae other than the genitourinary mucosa. 
2.5.1.2 Pentatrichomonas hominis 
This can be found in the large intestine of man. However, flagellates structurally 
indistinguishable from this species have been reported from the caecum of non 
human primates, cats, dogs and a variety of rodents 
154.155 
Morphological ly, it is pear shaped, 15-18um lon(y, 14-15um wide. Its undulating 
membrane is about half the I ength of its body. As with T vogincilis and 1. lenax, it has 
a single nucleus and the axostyle conforms to that of the trichomonidadae. 
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Rhominis is transmitted faeco-orally and is more prevalent in tropical and 
subtropical environments than temperate regions. The warm and humid environment 
and unhygienic conditions in the tropics favour the transmission of this protozoon 156, 
157 
The pathogenicity of this trophozoite has been the subject of controversy, like that of 
Ttenax. Many early investigators held the view that at least under favourable 
conditions prevailing in the host's digestive tract, P. hominis strains could express 
158,159 their inherent virulence, causing intestinal symptoms with varying severity 
Estonian workers considered this parasite as pathogenic, finding it in many cases of 
intestinal disease 1 60. Manson-Bahr 16 1 and other workers 
162 
asserted that it is often 
difficult to decide if the presence of P. hominis in stool is the cause or consequence 
of the disease. That, the presence of high numbers of flagellates migtit be due in ia-cg.,. 
part to their swanning in an abnonnal liquid enviroinment, as for example in the case 
of bacillary dysentery. Though Manson-Bahr has often been cited as opposed to the 
pathogenicity of P. hominis, he does concede that inflammatory states associated 
with a variety of intestinal disturbances resulting in the secretion of mucus by goblet 
cells provide excellent culture medium for the trichomonads. Others have supported 
that although in some instances serious prolonged intestinal disturbance is due to P. 
hominis, this parasite would cause little damage in a generally healthy host 163 . 
Response to metronidazole therapy leading to the elimination of symptoms and 
manifestation of disease has also been used by the proponents of the inherent 
164 
pathogenicity of P. hominis . It 
is difficult however, to accept as proof of 
pathogenicity, metronidazole elimination of trichomonads in a milieu inhabited by 
mixed organisms many of whom are susceptible to metronidazole (e. g. anaerobic 
bacteria). 
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Figure 2.3 Giemsa stain, Phominis 
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Outside the gut, P. honfitils has been reported from diseased states of the respiratory 
tract of humans 9,165 . 
Apart from one report where identification was by nucleic acid 
amplification techniques 9, others were based on morphologic, antigenic and 
physiologic characteristics, insufficient for differentiation between the 3 human 
trichomonad species. A liver abscess caused by Rhonnnis has also been described 
166 
.A case of mixed 
bacterial meningitis with Rhonnnis subsequent to a fistula from 
the gastro-intestinal tract has also been described 
167 
Recently, Crucial el al have developed a sensitive and specific PCR for the detection 
of Rhonunis in biological samples ". Using this assay, they identified 2 cases of 
Rhonwils in vaginal swabs from Mwanza, Tanzania. 
These extra-intestinal reports of P. honfims suggest it too, could establish in mucosae 
other than intestinal. 
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Trichomonas tenax 
Figure 2.4 Giemsa stain, Ttenax 
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156 Tlelwx is a parasite of the oral cavity . In 
humans, T lenax is found in the 
periodonturn and adjacent areas including alveolar gingivae, gingival pockets, 
maxillary sinuses and paranasal sinuses, especially in people with poor oral hygiene. 
Morphologically, it is pear shaped, has a single nucleus, and its undulating 
membrane runs the entire length of the organism. Its axostyle is typical of all 
trichomonads. Distinguishing Tlenax from other human trichomonads can be 
difficult as underpinned by Hersh 
Opinions about the pathogenicity of Tlenctx vary widely. While some investigators 
eve consider it a true pathogen, others say it is an oral commensal. Yet others bell this 
oral flagellate is an opportunistic saprophyte, favoured bv congenital and acquired 
diseases of the oral cavity. Proponents of its pathogenicitV argue that even though 
Tieiiax has been found in the oral cavity of people with evidently healthy mouths, 
58 
the prevalence is higher in those with diseases of the oral cavity. Jaskoski found 
Ttenax prevalence at 66% in people with poor oral conditions 168 in the US. This has 
been corroborated in other studies 
169,170,171 
. These workers strengthen their stand 
with the good recovery from disease after metronidazole therapy 
172,173 
. However., 
Blake 174 . and Abramova and Voskresenskaia 
175 in their contribution on this issue 
suggested that the interactions between oral protozoa, bacteria and yeasts in the 
aetiology of oral disease which is often polymicrobial, was important in the 
pathogenicity of the disease, stating that an oral environment altered by the metabolic 
products of these organisms could cause the appearance of pathologic states by a 
hitherto commensal. Hence it is not the inherent pathogenicity of Ttenax producing 
the periodontal diseases, but a breakdown of oral defences by the combined 
metabolic products of protozoa, yeasts and bacteria that enabled Ttenax to act as an 
opportunistic pathogen. Their reasoning concurs with the thinking on the 
176 
pathophysiology of bacterial vaginosis, another polymicrobial disease state 
Again, the metronidazole therapeutic response, although plausible, should be taken 
with care, as metronidazole, apart from its anti-protozoal activity, has a wide action 
spectrum against anaerobic bacteria incriminated in disease of the oral cavity. 
Significant numbers of Ttenax were recovered from lung aspirates in 2 studies from 
77 
Russia where it was found in 10- 17% of patients with lung disease 
1. Other cases of 
6,178 
respiratory infection with Ttenax have been described , thus underpinning the 
fact that this oral trichomonad can establish itself outside the oral mucosa. There 
have been no reports of T tenax colonisation of the genitourinary tract. Could It be 
seeded into the genitalia during oro-genital contact? 
Molecular based techniques using primers specific for the 3 trichomonads, could be 
helpful in elucidating species of trichomonads found in the vagina, mouth and gut. 
59 
2.6 Trichomonads and Immunodefficiency 
The possible link between trichomonads and immunodeficiency remains unclear. 
Several cases involving different trichomonad species have been reported. This 
includes peritonitis in an immunocompromised patient, oesophagitis in a man with 
AIDS,, and lymph node trichomoniasis in an elderly woman with refractory anaemia 
166 
. Tvaginalis 
has recently been shown to be associated with pelvic inflammatory 
disease in women infected with HIV 179 , noted in the pharynxes of HIV infected men 
with histones of oro-genital activity 8, and in the bronchoalveolar lavage of an AIDS 
patient 153 . Again, trichomoniasis has been implicated 
in the acquisition and 
transmission of HIV infection, and the prevalence of vaginal trichomoniasis is higher 
in HIV positive women 3. In the 4 city study looking at the differential prevalences of 
HIV, in Africa, trichomoniasis was associated with high IIIV prevalent countnes. 10 
Although cause and effect are not clearly delineated, immunosuppression per se is 
not believed to facilitate trichomonads infection 1 80 , and trichomoniasis 
is not yet 
recognised as an opportunistic disease. 
2.7 Could extra genital trichomonads (i. e. Trichomonas tenax and 
Pentatrichomonas hominis) be involved in the aetiology of urogenital 
trichomoniasis? 
Honigberg 147 indicates that there is overwhelming data based on morphologic, 
immunologic and physiologic evidence that distinct species of trichomonads are 
limited to the oral cavity, large intestines and urogenital tract of man. Also, cross 
infection studies done by Westphal and others, suggest that these 
3 species are 
unable to establish lasting infections in any part of the 
body other than the ones in 
156,181 
which they are traditionally found . However work 
done by later investigators 
60 
ff CUlt 
6 show that morphological differentiation between the 3 species is di I, and while 
Rhominis and Tvaginalis need different media for optimum growth, both do grow 
82 183 
on conventional media 1. Wenyon , one of the respected authorities on parasitic 
protozoa was not convinced that there existed in humans 3 different trichomonad 
species because they all looked and behaved similarly in culture media. This lack of 
clear differentiation between the trichomonads is commented on in Walton and 
Bacharach's review of the literature when reporting on 3 cases of pulmonary 
178 trichomoniasis . Commenting on this diagnostic dilemma, they state, "no reliable 
identification is available from the earlier investigators. Half of these reports assign 
the organism (T. tenax) to the genus Trichomonas, and half of these presume it to be 
the same species which inhabits the intestines of man". 
The difficulty in differentiating between trichomonads by morphology has also been 
highlighted in veterinary medical practice. RomatoWski 184 initially reported isolating 
P. hominis -from the gut of kittens. Later, Levy et at' 185 , reported that these flagellates 
had been misdiagnosed, that rRNA gene sequencing had identified the isolates as 
Tritrichomonas foetus. The practice of culling bulls with positive preputial cultures 
for the sexually transmitted pathogen Tritrichomonasfoetus due to economic reasons 
(causes infertility in herds of virgin bulls), has been questioned in recent studies. 
Until recently, the diagnosis of Tfibetus preputial infection had been by microscopic 
examination and culture of preputial scrapings and/or washings. Using a combination 
of culture, Tfoetus specific primers PCR assay and pan-trichomonad primers PCR 
assay, workers have observed the existence of easily mis-identified non-T. foetus 
trichomonads (most of which originate from the gut) in the bovine prepuce. They 
recommend that culture of preputial scrapings or washings should be augmented with 
specific PCR assays in confirming infection 
186,187 
. 
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It is clear from both human and veterinary medical practice, that differentiating 
individual trichomonad species on morphology and physiologic criteria may not be 
easy as stated by earlier investigators. 
Even though vaginal trichomoniasis has traditionally been thought to be caused by T 
vaginalis, some recent reports suggest the probable involvement of other 
trichomonads. Buv6 10 and colleagues report finding T. vaginalis in 40% of 
adolescent girls who denied ever having sexual intercourse. They (Buve et ao 
thought this finding could not be explained by under-reporting of the sexual 
behaviour of the girls. Could it be that in situations of poor ano-genital hygiene or 
certain genital hygiene practices (wiping forward after defecation i. e. cleaning from 
the anus towards the vagina, douching, etc) gut related P. hominis is transmitted into 
the vagina and reported as T. vaginalis at microscopy due to similar microscopic 
morphology? Could some TV strains have their origin in the rectum? These are not 
novel suggestions. As far back as the 1940s, some investigators regarded the 
intestine as the source of infection in the vagina, believing that intestinal 
trichomonads could become adapted to the vagina 
188,191. Also, explaining why 
vaginal trichomoniasis was twice more common in black than white women in the 
US in 1947, Trussell attributed this to poor anogenital hygiene practices in the black 
women 100. 
The plausibility of finding Rhominis in the vagina has been highlighted by a recent 
report detecting 2 cases in vaginal swabs using nucleic acid amplification techniques 
The clinical significance of this finding is not known. It is not improbable that 
faecal contamination of the perineum picked up by the self administered vaginal 
swabs is responsible. Also, transient colonisation of the vagina by Rhominis cannot 
be ruled out. That the vagina may be contaminated with faecal matter is not unusual. 
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Hegner 189 and Dobell 190 claimed to have successfully introduced Rhominis into the 
vagina of monkeys for 20 days and 3 years respectively. Kamaky in 1934 claimed to 
have established Rhominis in human vagina for 4-5 days 1 91 . This assertion of 
Kamaky was ridiculed by his peers when in a subsequent declaration, he said the 
intestinally implanted Rhominis had later changed into Tvaginalis! Importantly, this 
underpins the difficulties in making a morphological difference in diagnosis of these 
trichomonads. 
Could poor ano-genital hygiene or the practice of oro-vaginal sex or rectal 
intercourse followed by vaginal penetration introduce oral or gut related 
trichomonads into the vagina? The practice of oral sex has been speculated as the 
possible mode of transmission of T vaginalis found in the pharynx of men admitting 
oro-vaginal contact with their partners. 8. 
Lurie et al 1,92 postulate that short ano-vaginal distances could influence conditions 
that promote microbial colonisation of the vagina. This was after the), had isolated 
significantly more gut related microbes (including Trichomonad sp - they failed to 
mention which species) from the vagina of women with recurrent vaginitis than 
controls. Probable seeding of organisms from the rectum into the vagina is 
recognised in the practice of Genito-unnary medicine where chronic or recurrent 
Candida infection of the vagina is thought by some practitioners to come from a 
126,193 
rectal reservoir of the yeast . 
Could this happen for Rhominis which later is 
misdiagnosed as Tvaginalis on morphological criteria? 
Some investigators working with T vaginalis have reported observing different sized 
and shaped trichomonads from genital secretions. As to whether these are different 
strains of T vaginalis or different trichomonad species thought to be T vaginalis is 
not known 
194 
- 
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With modem nucleic acid amplification techniques using specific primers for the 3 
human trichomonad species, it is possible to study this phenomenon. 
2.8 Laboratory Diagnosis of Trichomonas vaginalis 
2.8.1 Introduction 
Due to the sometimes asymptomatic nature of urogenital trichomoniasis in both men 
and women, and the poor predictive value of symptoms and signs for infection,, 
laboratory detection of the protozoon is important. This chapter reviews laboratory 
tests available for the diagnosis of Trichomonas vaginalis infection. 
2.8.2 Wet mount microscopy 
The most cost effective method for the laboratory diagnosis of T. vaginalis is the wet, 
14 
mount Microscopy described by Donne in 1836 . In this, technique, also called the 
, saline wet mount, vaginal or cervical secretions are mixed with 0.9% saline and 
observed under the microscope where the characteristic motility and morphology of 
the protozoon is seen. This technique has a variable sensitivity, with reports ranging 
from 38% - 82% 
195,196,197 
. The wide variation 
in sensitivity may be due to different 
culture media used as reference tests in the studies. Tvaginalis culture media are 
known to have different sensitivities 198 . 
The low sensitivity has been ascribed to the loss of motility by the organisms after 
they have been taken away from body temperature 21 - Delays 
between specimen 
collection and microscopic examination reduce viability of the organism. Kingston 
and colleagues reported that 20% of wet mount positive samples became negative 
within 10 minutes of the initial reading, increasing to 35% and 78% by 30 minutes 
199 
and 2 hours respectively . Also, the abundance of epithelial cells and 
64 
polymorphonuclear leucocytes present in the vaginal or cervical exudates can 
obscure the visualisation of the protozoon, particularly movement of its flagella. Low 
numbers of protozoa in the exudates as may occur after douching 101 can also reduce 
the sensitivity of wet mount microscopy. 
Interpretation of the smear can be limited if the microscopist is inexperienced or 
scans the field too quickly. This notwithstanding, the saline wet mount has a high 
specificity and is the accepted routine procedure in many clinics for clinic based 
diagnosis in many settings. Specificities ranging from 75% to 100% have been 
101,195,200 reported, with most ranging from 95 -100% . At least 44% of Genitourinary 
Medicine clinics in the UK 201 and many in the developing world diagnose infection 
by this method alone. 
2.8.3 Culture 
Successful -axenic cultivation of Trichomonas vaginalis in the 1940s 
202,203 
paved the 
way for the development of culture media to grow Tvaginalis. Presently, this is 
judged to be the most sensitive method for the diagnosis of Tvaginalis. It is the 
reference "gold standard" test. Low numbers of organisms present in exudates can 
grow and be identified 204 .A swab of the sample 
is immersed in the culture broth and 
incubated at 37'C. The culture is observed daily for the characteristic motility of the 
trichomonad. If this is not seen usually by day 7 of cultivation, the culture is declared 
negative. 
Different culture media for Tvaginalis exist which allow for axenic cultivation of the 
parasite. Basically the media consist of buffered salt solutions, protein hydrolysates, 
liver digests or yeast extracts, reducing agents and serum. Axenic cultivation, which 
eliminates bactena and fungal contaminants that inevitably accompany T vaginalis 
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when transferred from a patient source, is achieved by the addition of antibiotics and 
antifungals to the culture medium. Antibiotics such as penicillin,, streptomycin, 
gentarnicin, neomycin and chloramphenicol and antifungls as nystatln, amphotencin 
and miconazole have been used in axenisation. 
Examples of Tvaginalis culture media are Feinberg Whittington (FW), Stenton, 
Simplified trypticase medium (STS), Cysteine peptone liver maltose (CPLM), 
Diamond's (also known as TYM- trypticase yeast maltose), Hollanders, Kupferberg 
Tnchosel, Oxoid, Lumsden, Lowe's and vanous modifications of these media. 
Media may either be liquid ( eg. Feinberg Whittington, Lumsden and Oxoid), or semi 
liquid by the addition of 0.05%-0.1% agar (eg CPLM, TYM or Lowe's). The agar 
reduces the diffusion of oxygen into the medium and allows better growth. In 
general, Trichomonas vaginalis grows better when incubated under partial or 
complete anaerobic conditions. 
Sensitivities of these media vary, with reports of 71-100% 
198. Cox and NiColl 
205 
found in a comparative study that Feinberg Whittington and Bushby media were 
more sensitive than Oxoid and Stenton Media. Rayner 206 detected over two times the 
number of Tvaginalis infections when using CPLM than FW. In recent times, 
Diamond's modified medium has been shown to be the most sensitive medium for 
the culture of T vaginalis 
207,208. 
Culture methods are more sensitive than wet prep microscopy, especially in 
situations where there are low numbers of organisms. However in situations where 
there are non-viable organisms in exudates, culture cannot detect them. Other 
limitations to the use of culture are that it takes 2-7 days to identify the 
trichomonads, by which time infected patients may continue to transmit the infection. 
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Personnel costs, daily examination, and limited availability to clinicians are other 
limitations to its use. 
In order to improve the acceptability of culture and reduce time spent in the 
preparation of media, a plastic envelope system (PES), acting as one self-contained 
system and permitting both immediate microscopic examination and culture was 
devised 209 . This has been reported to give equivalent results to traditional culture 
methods discussed above,, but significantly more sensitive than wet prep methods. Its 
long shelf life (at least I year) and contents of dry medium in tablet form which are 
reconstituted just before use, are additional advantages 209 . 
Another system, the 1nPouch system, is a two-chambered bag allowing one to 
perform immediate wet mount microscopy through the bag, as well as culture 
without daily sampling. In a comparison of the performance of the InPouch against 
other culture media, Draper et a, 2 10 reported that it performed as well as Diamond's 
modified medium, InPouch with a sensitivity of 88.25% and Diamond's with a 
sensitivity of 91.12%. Levi et al reported similarl y 211. In a study in 2 sexually 
transmitted diseases clinics, the InPouch detected 15 more patients with Tvaginalis 
infection (all of whom were wet prep negative) as against 12 by Hollander's culture 
medium. The sensitivity of Hollander's medium compared to InPouch was thus 80% 
212 
. In all these studies, culture of specimens 
in the various media did not detect all 
positive specimens i. e. Tvaginalis grew in some media and not in others. The reason 
for this differential growth is believed to be Trichomonas vaginalis strain variation 
due probably to differences in nutritional requirementS210 . 
The InPouch system offers a lot of advantages over other T. vaginalis traditional 
culture systems. Once the specimen is placed in the chamber, microscopic 
visualisation can be done directly through the bag and daily sampling, which may 
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introduce contamination and also takes up time, is avoided. Again about 200ýil of 
culture is screened with the clip-on microscopy mount whereas only about 10ýtl of 
media can be observed with the traditional wet mount microscopy. A positive culture 
with lower organism counts will therefore be easier to find with the InPouch system. 
Also, whilst unused prepared traditional media have to be refrigerated, the unused 
InPouch can be stored at room temperature, thus appealing to centres with limited 
refrigeration facilities. Whereas the shelf life of the unused InPouch system is one 
year, a tube of Diamond's medium has a shorter expiration date (2 months at 4'Q. 
The InPouch system has been used in studies in Africa 
10,88,125 
. 
The main differences between the plastic envelope system and InPouch system are 
that while the 1nPouch has 2 chambers,, the PES has one. InPouch already contains 
liquid Medium whilst that of the PES is dry and has to be reconstituted with watet- 
before use. 
2.8.4 Staining techniques 
To improve the sensitivity of direct smear by wet mount microscopy and also benefit 
from the prompt observation unlike culture, staining of parasites in fixed and unfixed 
smears was introduced. Stains such as safranin, methylene blue, malachite green and 
brilliant cresyl blue do not stain Tvaginalis directly. They stain cellular material in 
the background and permit Tvaginalis to stand out against the coloured background. 
This indirect staining method has not been shown to improve the detection rate of 
213 
T vaginalis in secretions and thus has not been much used 
Fixed smear staining of T vaginalis with Romanowsky stains (Leishman and 
Giemsa), Gram's stain, acridine orange stain, Papanicolau stain and periodic acld - 
schiff stain has been done. 
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2.8.4.1 Acridine orange stain 
Acridine orange, a fluorochrome dye, stains the nucleic acid and differentiates DNA 
from RNA in cells. DNA stains yellow green and RNA brick red under ultra violet 
light. Tvaginalis appears as pear shaped with a yellow green nucleus against light 
green fluorescence of epithelial cells and polymorphs. Acridine orange stain results 
compare favourably with culture, detecting 97 out of 120 samples as against 93 of 
culture 
214 
, and 44 out of 100 samples against 51 of culture in another series 
215. 
However, the staining procedure is lengthy and the requirement of a fluoresecent 
microscope puts it out of the reach of many settings. Also, fluorescence of the 
trichomonads may be difficult to differentiate from cellular matter, thus posing a 
problem with specificity 
216. 
2.8.4.2 Romanowsky stains 
Leishman and Giemsa stains have been used in fixed smears for over half a century. 
The trichomonads stain bright blue with darker staining nuclei. More infections have 
been diagnosed with these than wet film and in a series in which 5 infections were 
detected by culture, these stains detected the same number, thus equalling the 
sensitivity of culture 
217 
2.8.4.3 Gram's stain 
The Gram stain procedure, used routinely in bacteriological diagnosis in many 
settings including STD clinics has also been used in the diagnosis of Tvaginalis. 
Cree 218 detected Tvaginalis in Gram stained smears of 66% of subjects with culture 
proven trichomoniasis. The false positive rate was 7%. This method detected twice 
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219 as many patients with trichomoniasis than wet film examination in another study 
However, the sizes and shapes of the parasites vary, sometimes resembling 
polymorph leucocytes. Not many workers have thus found it useful. 
2.8.4.4 Papanicolau stain 
Papanicolau (Pap) staining is routinely used in gynaecology settings to detect 
cytologic abnormalities of the cervix. In Pap stained smears, Tvaginalis in secretions 
appear ovoid with a grey-green cytoplasm and a blue stained nucleus. The efficacy of 
Pap smears in the diagnosis of Tvaginalis infection remains conflicting. While some 
workers have found the sensitivity comparable to wet preparation 
220,221 
, others have 
222 found it to be more reliable and superior to culture . The specificity of the Pap 
stain has been questioned by Per, 223 . He could not confinn infection (by culture) in 
37% of 666 women whose Pap smears were thought to contain trictiomonads. Mason 
and colleagues could also not confirm infection by other diagnostic methods in 126 
women whose Pap smears had been reported as positive for Tvaginalis 71 . Pap smear 
microscopy for the detection of trichomoniasis suffers in general from high rate of 
224,225,226 false positives (30-48%) . Pap smear microscopy as indeed in all 
microscopy depends on the experience of the microscopist. The routine staining 
procedure takes time and the organisms are often difficult to see and distinguish from 
other cells. Its use solely for the detection of Tvaginalis and as the sole method for 
the diagnosis of trichomoniasis is questionable. In Western urban societies where 
cervical cytology screening is routine, opportunistic detection of Tvaginalis by Pap 
smear has helped in treating many women infected by the parasite. Bowden has 
proposed that in urban Australia, introduction of this routine procedure In the 1970s 
70 
and 1980s could be responsible for a reduction in prevalence of Tvaginalis in those 
124 
populations 
A major limitation of staining methods is that Tvaginalis does not always appear in 
its typical pear-shaped form with flagella. It may be seen as rounded fonns 
resembling polymorphonuclear leucocytes or dysplastic epithelial cells 
223,226 
. 
Sometimes, the typical morphology is lost during fixation and staining, thus making 
identification difficult. 
2.8.5 Serological techniques 
2.8.5.1 Serum antibodies 
The search for serological diagnosis of Trichomonas vaginalis antibodies in the sera 
of infected patients has gone through many phases. Complement fixing antibodies as 
used by Trussel 100 and Hoffinan 227 detected 48-80% of women with trichomoniasis. 
It had a poor specificity however, detecting similar antibodies in the blood of 10- 
40% uninfected patients. McEntegart, described a passive haemagglutination test for 
Tvaginalis detection in 1952 228 . It detected infection in 42 of 50 infected women 
and 3 of 50 uninfected women. Using an indirect immuno fluorescent test, antibody 
reactive to T vaginalis was detected in sera of 19 subjects with trichomonlasis but 
not in 9 uninfected subjeCtS 
229. 
Detection of serum antibodies to Tvaginalis using Enzyme immunoassays (EIA) has 
also been described. IgG antibodies were detected in 68% of 41 infected and 12% of 
128 uninfected women. IgM antibodies, denoting recent infection was found in 22% 
230 
and 3% of infected and uninfected women respectively 
Serological antibody diagnosis has a lot of inherent disadvantages. Serum antibody 
production depends on the nature of the antigen or its pathogen, whether it is live or 
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inactivated, its local concentration, and the frequency and length of immune system 
stimulation. An antibody response may not be observed because the test system is 
too insensitive to detect low levels of specific antibodies,, or because the serum 
humoral response has not yet been elicited. Trichomonal antibodies may also persist 
for a long time after treatment or spontaneous cure 231 . The persistence of this 
serological response and the lengthy procedures involved militate against the use of 
serum antibody diagnosis in routine trichomonas diagnostic work. 
2.8.5.2 Secretion based antibodies 
The use of trichomonas specific antibody in secretions has been studied. After 
various unsuccessful attempts to demonstrate local antibodies in persons harbounng 
Tvaginalis, Ackers et al 232 demonstrated the presence of IgA antibody to T 
vaginalis in vaginal secretions employing 115 I-labelled radioimmunoassay. They 
detected 76% of 29 infected and 42% of 1.9 apparently uninfected women using their 
assay. Using antigens prepared from 3 isolates of Tvaginalis in an EIA forinat, 
Street et al 230 detected IgA, IgG or both in cervicovaginal secretions of 73% infected 
women and 41% uninfected women attending an STD clinic. Su in1982, also 
233 detected IgG in 70.8% infected and 23.3% uninfected women respectively . Anti- 
parasite IgA, IgE, and IgM was also found in 2,3, and I patient(s) respectively, in 
Su's series. 
The persistence of antibody from previous or latent infections could explain the high 
proportion of antibody positive uninfected women, as also seen for serum antibody 
230 
The possibility of cross reacting antibodies to Pentatrichomonas hominis cannot be 
ruled out. Common antigens existing between P. hominis and T vaginalis have been 
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reported 
234,235 
. Natural antibodies against T vaginall'S and P. hominis in sera of 
non-nal uninfected people have also been reported by Honigberg 
236 
and SU 
233 
respectively. 
The poor sensitivity and specificity of these tests and the failure to detect antibody in 
male secretions 237 does not make these secretory antibodies useful in the diagnosis 
of thchomoniasis. 
2.8.5.3 Antigen based tests 
Demonstration of antigenic variation in the surface carbohydrates of Tvaginalis 238 
and earlier reports identifying type specific antigens of Tvaginalis using polyclonal 
and monoclonal antisera 
235,239 
, stimulated the development of tests to directly 
identify Tvaginalis antigens in clinical specimens. Using 2 broadly reactive 
monoclonal, antibody panels, Krieger et al, identified 88 strains of Tvaginalis 
obtained from diverse geographic areas in the United States and Canada 240 . Lisi and 
colleagues employed a monoclonal antibody specific for a 65kDa surface peptide of 
T vaginalis as capture antibody in a sandwich EIA forniat, and reported a sensitivity 
and specificity of 89% and 97% respectively compared to culture in vaginal 
exudates 241 . Other surface peptides to which monoclonal antibodies can 
be raised and 
used in such assays are the 200kDa cell detaching factor and cysteine protease, both 
242 
of which are found on all isolates of Tvaginalis 
Diagnostic formats using monoclonal antibodies to identify antigens of Tvaginalis in 
vaginal secretions include latex agglutination, enzyme immunoassay (EIA), 
immuno fluorescence, and lateral flow techniques. 
Carney et al compared latex agglutination with saline wet mount, culture and enzyme 
immunoassay (with T vaginalis antibody in the solid phase). With culture and/or wet 
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prep as expanded gold standard, results of the latex agglutination were identical to 
the EIA at 95% sensitivity compared to74% for wet mount microscopy. Specificities 
of the EIA and latex test were 99% 22 . Another antigen based point of care test in 
lateral flow format, approved by the FDA purporting to be more sensitive than 
culture using vaginal swab eluates has been developed by Xenotope Diagnostics Inc, 
US. In the documentation submitted for FDA approval, the company reported a 100% 
sensitivity and 98.1 % specificity using a composite reference standard (compared the 
test to wet prep, and resolved discordant samples with culture results). However an 
evaluation in 2 other centres in the US reported sensitivities of 76.7% and 79.4% and 
specificities of 99.8% and 97.1%. Culture was the reference standard 243 . The 
performance of this test in warin and humid environments where the stability of the 
gold conjugate would be tested is awaited. 
Krieger et al compared conventional wet mount examination with cultures, 
monoclonal immuno fluorescent antibody staining of direct specimens and cytology 
in the diagnosis of Trichomonas vaginalis 244. With culture as gold standard, the 
sensitivities of the wet mount, Pap smear and monoclonal staining were 60%, 56% 
and 80% respectively, and specificities 99-100%. Comparing the perfonnance 
characteristics of direct fluorescent antibody (DFA) staining, acridine orange staining 
and microscopy to culture of vaginal wash specimens in consecutive patients 
attending a sexually transmitted diseases clinic, Bickley et al reported a sensitivity of 
83% by DFA, 66% by acridine orange and wet mount. Specificities ranged from 98- 
105 245 100% . 
Smith has reported a similar sensitivity of 80.6% for the DFA 
While the specificities of these tests, with culture as gold standard, have been 
comparable, the fluorescent staining method surpasses all in its sensitivity. 
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Unfortunately these tests have not been adapted for routine use. Some of these eg 
DFA are technically demanding and costly, precluding their use in resource poor 
settings. 
2.8.6 DNA amplification techniques 
These are techniques that amplify minute amounts of nucleic acids, to make 
detection easy. The polymerase chain reaction (PCR), one such technique, is being 
used for TV detection. 
PCR uses the enzyme DNA polymerase, a vanant of which is found in the nucleus of 
all replicating cells. DNA polymerase duplicates DNA during the cells' preparation 
for divison. In 1983, Mullis reallsed that exponential growth in the number of copies 
of a target DNA sequence could be achieved in vitro if several rounds of repeated 
DNA-polymerase catalysed duplication were made to occur back to back 246 . To 
undertake PCR, sample is added to a reaction mixture containing an excess of 
deoxynbinucleotide triphosphates (dNTPs), heat stable DNA polyrnerase, and 2 
primers. These primers are short synthetic oliginucleotides that flank the target 
region to be amplified. One primer is complimentary to the sense (+) strand, and one 
to the anti-sense (-) strand at the opposite end of the target sequence. 
PCR involves 3 phases, all of which take place in the same reaction vessel, but at 
different temperatures. The mixture is first heated to temperatures between 90-95 0C 
to denature the target DNA. The temperature is then lowered to allow primers to 
anneal to their respective binging regions. The mixture is heated again to enhance the 
activity of the thennostable DNA polymerase, which catalyses the extension of each 
chain from the 3' end of its annealed primer to produce 2 double stranded copies of 
the target sequence. Both of the 2 newly synthesised primer extension products 
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contain the appropriate primer-binding regions, and after further heat-induced 
separation from the target, can themselves function as templates, alongside the 
original templates, in the next round of duplication. Repetitions of this denaturation, 
annealing, and extension process, results in exponential accumulation of the target. 
Even though the optimal extension temperature for the DNA polymerase is 
approximately 72'C, the polymerase has activity at room temperature 247 Thus non- r' 5 
specific products are often generated during PCR set up as well as at the start of 
then-nal cycling, when reactions are briefly incubated at temperatures well below the 
annealing temperature 248. Once these non-specific products are forined, they can be 
efficiently amplified. To prevent this from happening, a hot start procedure is 
adopted. The hot start procedure delays DNA synthesis by withholding one of the 
essential, components until the thermal cycler. reaches the denaturation temperature. 
This can be done by delaying the addition of the polymerase or using wax barriers to 
, encapsulate essential components such as magnesium or polymerase. Melting of the 
wax during thermal cycling releases and mixes all of the components together. 
PCR is now automated in a therinal cycler which rapidly and reliably changes the 
temperature of the reaction vessel to provide appropriate conditions for each stage of 
the amplification process. It is best suited to the detection of DNA of fastidious and 
non-culturable infectious agents, as it does not rely on the presence of viable 
organisms in the samples. The first STI related pathogen for which a PCR-based 
249 
detection system was developed is Chlamydia trachomatis 
PCR is susceptible to contamination because it is a sensitive amplification technique. 
Small amounts of contaminating DNA from an exogenous source can be amplified 
along with the desired template. A common source of contamination occurs when 
previously amplified products are introduced into new amplification reactions. This 
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is called carry-over contamination. Purified DNA from other samples and cloned 
DNA are also sources of contamination. Carry-over contamination can be minimised 
by using good laboratory procedures during PCR. This includes the use of aerosol 
barrier tips to prevent aerosols from reaching the pipette barrel, designating separate 
areas for PCR sample set-up and post amplification analysis, and the changing of 
gloves before preparing new reactions. The use of premixed reaction components 
instead of addition of each reagent to individual reactions does also limit 
contamination. To check for contamination, a negative control without template is 
always perfon-ned. 
Several assays using nucleic acid amplification techniques for the diagnosis of 
Tvaginalis infections have been published. 
Using primers (TVI/2) targeting a region of the 18S rRNA gene in a polymerase 
chain reaction (PCR) assay, Mayta et al 250 reported a sensitivity of 100% and 
specificity of 98% with culture as the reference test. This result was obtained by 
examining 372 clinical vaginal swabs, in which culture detected 24 TV isolates 
whilst PCR was positive for 31 samples including the 24 detected by culture. 
Madico and colleagues 25 1 designed a primer set (BTUB 9/2) targeting a well 
conserved region in the beta-tubulin genes of Tvaginalis. All strains of Tvaginalis 
tested were successfully detected by PCR, giving a single predicted product of 112 
bp in gel electrophoresis. There was no cross reaction from other trichomonads and 
N. gonorrhoeae and Ctrachomatis which were tested for specificity. 
Primers specific for a 102bp region of Tvaginalis genome were used by Heine et al 
252 to detect 91.8% of 61 women with Tvaginalis infection (detected by wet prep or 
culture or PCR) compared to 80.3% by wet mount and culture. Specificity of the 
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primers for TV diagnosis was 95.2%, also with wet prep and culture as gold 
standard. 
Riley et a, 253 used a primer pair, TVA5-TVA6, to positively identify 15 cultured 
clinical isolates of Tvaginalis and nine vaginal swab eluates that were wet mount 
positive for Tvaginalis. The clinical isolates were from symptomatic and 
asymptomatic cases from diverse geographic areas in the US. The TVA5/6 primer 
pair detects an A6p target sequence which is conserved in Tvaginalls. 
Shaio, Lin and Liu 254 developed a colorimetric one tube nested PCR assay to detect 
Tvaginalis in clinical specimens. Their assay targeted a family of 650bp specific 
DNA repeats in the genome of the organism. Out of 378 clinical vaginal specimens 
tested for Tvaginalis, the PCR assay detected 31 as did culture of the specimens. 
Only 17 of these patient samples were positive by wet mount examination. No 
specimens negative by this PCR assay were positive by culture or wet mount. 'There 
was no cross reaction with human DNA or from other infectious specimens 
containing P. hominis and Giardia lamblia. 
A set of primers which has been used in many studies from Africa was described by 
Kengne et al (TVK3/TVK7) 255 . This targets a conserved region 
in the 2000bp 
repeated DNA fragment of Tvaginalis producing a 300bp product. 
Defining a true positive as wet mount, culture or 2 PCRs positive, Wendel et al 256 
reported sensitivities of 52 %, 78%, and 84% for T vaginalis in a study comparing 
wet prep, culture and PCR respectively on clinical vaginal swabs. Their study 
indicated that if the women had been offered metronidazole treatment based on PCR 
results instead of the traditional test results, 84% as against 69% of 97 women would 
have been treated. They reported lower sensitivities for the PCR primer pairs 
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(BTUB9/2,, TVK3/7 and AP65 A/B) than onginally described, ascribing the 
difference to extended storage of the swabs and repeated thawing. 
In a comparison of culture and 5 different primer sets (TVK3/TVK7 255 
TVA5/TVA6 253 , BTLJB9/13TLJB2 
251 
, TVE650- 1 
254 
, TV I /TV2 
250 ) (expanded gold 
standard- culture and/or 2 PCRs positive) for the diagnosis of trichomonas vaginitis 
using self collected vaginal samples from female sex workers in Cote d'lvoire, 
Crucitti et al 257 obtained much lower sensitivities (59-88%) than reported by studies 
from the original developers of the assays. They ascribed this difference to different 
study populations and probably strain variation. The primer sets of Kengne 255 and 
Madico 251 performed much better than those of Riley 
253 
and Mayta 
251 
. The 
sensitivities of all primer sets improved with the use of enzyme immunoassay 
'k , amplicon detection compared to gel electrophoresis. 
While Trichomonas vaginalis PCR assays are not yet, commercial as those for 
Neisseria gonorrhoeae and Chlamydia trachomatis, they nevertheless hold promise 
for molecular based diagnosis of Trichomonas vaginalis infections. 
Table 2.2 Trichomonas vaginalis PCR primer sets 
Pnmers Target Product 
Size(bp) 
Reference 
TVK3/K7 2000bp DNA 300 232 
repeats 
TVIPI/2 650bp DNA 290 231 
repeats 
TVA5/A6 A6p 102 234 
TVI/2 18S rRNA 312 228 
BTUB 9/2 fl tubulin gene 112 229 
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Some of the above discussed laboratory diagnostic tests have the potential for use in 
resource constrained settings. An evaluation of their diagnostic perforinance would 
be helpful in informing choice. 
2.9 Treatment of Trichomoniasis 
2.9.1 History of treatment of Trichomonas vaginalis 
Though Trichomonas vaginalis as a pathogen was discovered in 1836 14 and known 
to cause vaginitis in 1916 17 , it was not until half a century later that an effective 
treatment was found for its cure. Before this, the infection was left untreated or 
treated with a variety of intravaginal preparations including agyrol, kaolin, lactic 
acid, arsenical compounds, maphasen, mepacrine, aureomycin and trichomycin 258 
Some of these preparations apart from being toxic were cumbersome to use b-v betb . 
patients and physicians. In 1959, a woman died in a London hospital from wi 
overdosage of these treatments 
258. 
Forgan, writing about the difficulties women went through with these preparations 
noted, "patients suffered much at the hands of many physicians, and if the last state 
258 
of the woman was not worse than the first, it was not much better" . 
comparative study by Clark et al of these treatments showed cure rates of only 
between 22% - 
40%259. The treatments also did not eradicate infection in periurethral 
glands, indicating the necessity for the use of systemic therapy. There was no 
treatment for men then. 
The French Pharmaceutical company, Phone Poulenc in 1954, screened various 
antibiotics, antimalarials and anioebicides in search for an anti-trichomonicide. A 
strain of the mould Streptomyces, which produced a substance with anti- 
trichomonicidal activity, was found in a soil sample from the island of Reunion. 
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Further manipulation of the chemical structure of this substance called azomycin (2- 
nitro-imidazole), led to the synthesis of metroniclazole ( 1-(2-hydroxyethyl)-2- 
methyl-5-nitroimidazole) which was found highly active against Trichomonas 
vaginalis in 1956 260 . This was followed soon by clinical reports of its use in France 
and England 
261,262 
. Durel and colleagues, who reported this use, did not fully 
comprehend its value, modestly claiming that its oral use was an adjunct to any local 
application! 
Rhone Poulenc marketed metronidazole in France in 1960 under the proprietary 
name Flagyl. Concerns about potential toxicity led to a delay in its use in America. 
These concerns were related to the presence of a nitro group in the drug that was 
similar to that in chloramphenicol and also to reports of leucopaenia associated with 
its use 263_ A-nother reported reason for non use. by Ameri. caDphysicians was the fear 
that with its ýuse, the treated women would get better thus preventing the physicians 
258 from making money from repeat visits by these women I Thus , it was not until 
1963 that it was licensed for use in the US. Today, metronidazole is the drug of 
choice recommended in many countries for the treatment of both male and female 
trichomoniasis. It is cheap, easy to produce and a safe and effective drug. 
2.9.2 Treatment regimens 
Various treatment regimens of metromdazole have been used in the therapy of 
genital trichomoniasis. The commonly studied and used regimens have been the 
multiple 200/250 mg, 8 hourly for 7 days dosage and the single 2g dose. Durel and 
colleagues 262 recommended the 200/250mg, 3 times a day for 7 days treatment. This 
was shown by Rodin et a1264, McGill et al 
265 
and Watt and Jennison 
266 to give cure 
rates of 85-98% in outpatient female populations. In incarcerated female groups, cure 
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rates are higher at 90-98% 
98,267,268 
probably due to better compliance and/or fewer 
opportunities for re-infection. The lower cure rates in outpatient populations can be 
ascribed to problems with compliance or re-infection from untreated partners. Moffet 
and colleagues 269 considered that only half those on the multiple dose oral regimen 
adhere correctly to treatment. Even in clinical trials of this regimen, the percentage of 
patients failing to attend follow up to ascertain cure and compliance tended to be 
high - 21%, 22% and 17% respectively 
269,270,271 
To simplify treatment and improve compliance, the single 2g regimen was studied 
and compared to the multi dose regimen. Cure rates between 82-88% 
114,272,273,274 
for the 2g regimen has been reported in women. Although lower than that for the 
multi dose regimen in most of the studies, this did not approach statistical 
significance. Cure rate reports of -the 2g regimen in *men has vaned between 
investigators. While many report it as good, there is one report of a 43% failure from 
Zimbabwe 275. Presently, both the tjK276 and CDC277 guidelines for the treatment of 
male and female trichomoniasis recommend the single dose as treatment of choice. 
This regimen minimises non-compliance, uses 62% less drug, and seems more 
practical for treatment of sexual partners. It does not however provide protection for 
prompt re-infection by untreated male sexual partners and is associated with slightly 
more side effects. 
The standard treatment guidelines of the Ministry of Health, Ghana 278 recommends 
the use of the multi-dose regimen. The clinical efficacy of the single dose regimen 
has not been evaluated in the country. 
2.9.3 Sexual partner management 
Due to the high efficacy of the nitro-imidazoles in the treatment of vaginal 
trichomoniasis, and also high compliance with the metronidazole 2g single dose 
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(this can be given as directly observed therapy), failure to treat sexual partners is 
thought to be the main reason for re-infection in women 279 . Thus cure rates in 
women have been reported in observational studies to be higher (up to 95%) when 
the male partners are concurrently treated and only 82-88% when partners are not 
treated 
114,272 
. This is an improvement of 7-13% in women whose partners are treated 
over those whose partners are not traced and treated. 
The CDC guidelines 277 on partner management recommends treatment of all male 
partners of infected women without recourse to any investigation while the UK 
guidelines 276 recommends to investigate the partner for other STDs but go ahead and 
treat for trichomoniasis irrespective of the result of the investigations. Both 
guidelines thus recommend epiderniologic treatment of all partners of women who 
have trichomoniasis. However, in Dyker's observational study 272 which is often 
cited to support epidemiologic treatment, no simgificant difference was found in 
reports of sexual partner treatment between patients who failed treatment compared 
to those who were cured. Likewise, whether women admitted to sexual intercourse or 
not during treatment was not significantly more common among women who failed 
therapy than those who were cured. With the knowledge of the natural history of 
trichomoniasis in men i. e. that spontaneous resolution of infection can occur in up to 
80% of infected men, 
94,280 
this recommendation of epiderniologic partner treatment 
for partners of women with trichomoniasis without recourse to results of laboratory 
investigation may need a re-think. In many developing countries, partner notification 
for sexually transmitted infections is difficult and may expose index cases, especially 
women to the risk of violence and marital discord. The knowledge of a male spouse 
of a partner having a sexually transmitted infection which can be ascertained he does 
not have (due to spontaneous resolution) can bring untoward social problems to the 
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woman . Partner notification should only 
be attempted when it has 
unequivocally been shown to reduce the risk of re-infection and sequelae. 
Though metronidazole is cheap and associated with only minimal side effects, its 
unwarranted administration to an uninfected partner could have psychological 
implications. 
In another observational study comparing men with Tvaginalis infection receiving 
either metronidazole or tinidazole (another nitroimidazole) at 2 different time points 
(39 given metronidazole initially and another 34 given tinidazole at another time), 
Kawamura reported 100% cure rates for these men and that wives of these men cured 
of trichomoniasis, were less likely to have recurrence of infection after their 
husbands had been given either drug 
283 
. 
Only one randomised control trial using. tinidazole in the epidemiologic treatment of 
male partners of women with trichomoniasis has been reported 284 . This trial showed 
a significant difference (5% vs. 24%, p<0.05) in re-infection in women whose 
partners received tinidazole as against placebo. However, 9 women in the final cured 
group had had no sexual intercourse between initial test of cure (when they were 
found negative for TV infection) and the final evaluation test of cure. So they had not 
been exposed to any re-infection. Also, there were differences in the observation 
times (4-6 weeks) for the women from partner treatment to the final evaluation test 
of cure. This study is also often cited to support epidemiologic treatment of partners 
of women infected with Tvaginalis. While both metronidazole and tinidazole are 
nitroimidazoles, and there is no reason to suggest metronidazole will not produce 
similar results, a trial using metronidazole in which subjects have same observation 
times and whether or not subjects have sexual intercourse between initial and final 
evaluation is taken into account could be important. This could also be important as 
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there have been anecdotal reports of success in treating metronidazole resistant 
TvaginaliS isolates successfully with tinidazole 285 implying that tinidazole could 
have a better cure rate than metronidazole. In countries where metronidazole is the 
only licensed drug for the treatment of trichomoniasis e. g. the US, this could inform 
choice. 
2.9.4 Trichomonad drug resistance to metronidazole 
Antimicrobial resistance to metronidazole was first reported soon after its use in 
286 1962 . The responsible Tvaginalis isolate showed decreased In vitro susceptibility 
to metronidazole, and the patient was eventually cured with double the usual dose. 
Pereyra and Lansing 268 reported metronidazole resistant trichomonas vaginitis in a 
prison population, eventually treating these with a repeat oral multi dose regimeP 
supplemented by intravaginal tablets. 
It took physicians sometime before associating altered metronidazole susceptibility 
to intractable clinical disease. The reason had always been ascribed to poor 
286 
gastrointestinal absorption of the drug and drug inactivation by bacteria 
To date, there have been over 100 metronidazole resistant Tvaginalis isolated from 
the US and over 20 from Europe 
287,288,289,290,291 
- Some preliminary reports have 
also come from Nigeria 292 , Africa. Many of these 
infections ultimately resolved with 
larger doses of metronidazole orally, and intravaginally 293. It appears that 
metronidazole resistance in T vaginalis strains is relative and not an "all or none" 
phenomenon. Resistance varies from low to high level, and most cases can be cured 
with increased dosages of the drug. Concomitant intravagInal treatment with 
pessaries or suppositories could be helpful in the resolution of infections. 
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In many developing countries including Ghana, metromdazole can be bought over 
the counter,, and suboptimal doses are often consumed by patlents. It would not be 
unusual for antimicrobial resistance to develop to it. There is a high rate of abuse of 
antimicrobials used in sexually transmitted infections clinical practice in Ghana 294 11 
with resulting high drug resistance profile of the gonoCOCCUS 
295. The continued 
clinical efficacy of metronidazole against T. vaginalis warrants studying. 
2.10 Summary 
Recent studies indicate that the control of trichomoniasis could be important at the 
community level in the control of HIV/A1DS in countries where both conditions are 
endemic. It could also be important in reducing adverse pregnancy outcomes in such 
endemic countries. Presently, control measures depend on the sexual transmission of 
Tvaginalis. There have been speculations in recent times that gut related human 
trichomonads may play a role in the aetiology. Information is needed on the role if 
any of the gut related P. hominis in this aetiology and also that of the oral T tenax. 
Such information could be important as these human trichomonads to a large extent 
may not be transmitted sexually. Whether or not some TV strains have their origin in 
the rectum could be important in prevention programmes. 
Statistical modelling indicates that the control of Tvaginalis infection would be 
better served by screening and treating populations of the infection instead of the 
present syndromic management approaches used in many resource-poor settings. 
This however depends on the availability of a diagnostic test with good test 
characteristics that could be used under conditions in these settings. The evaluation 
of some of these diagnostics would inform choice. 
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In the absence of a good and cheap diagnostic for Tvaginalis infection, elucidating 
epidemiological and clinical factors that could predict infection would be helpful in 
selecting patients for screening and treatment of infection. 
These issues are examined in these case-control and diagnostic comparison studies. 
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3.0 METHODS 
3.1 Study sites 
The study was carried out in the Kumasi metropolis of the Ashanti Region, Ghana 
(Fig. 3.1). Kumasi is the capital of the Ashanti Region in Ghana and it is the second 
largest city in the country. It is located in the tropical rainforest of the country. With 
an area of 150 sq km, it is 275 kilometres up north from the capital. Kumasi has a 
rich ancient traditional history and culture. 
Kumasi is the largest of the 18 political districts in the Ashanti region, and is 
bounded by Kwabre district to the north, Bosumtwe- Atwima- Kwanmoma district to 
the south and Ejisu-Juaben and Atwima districts to the west and east respectively. 
Politically, the city is divided into four sub-metropolitan areas namely, Manhyia, 
Asokwa, Bantama and Subin. For health service delivery, the Manhyia sub- 
metroplitan area is divided into Manhyia North and Manhyla South. 
The 2002 population census in Ghana estimated the population of Kumasi at 1.2 
million inhabitants, with an annual growth rate of 2.6% 296 . The daytime population 
could be much higher as Kumasi is the hub of trading activities within the region, 
between the northern half of the country and the south, and lies on the main highway 
linking the capital, Accra to other West African countries such as Mali, Burkina 
Faso,, and Cote d'lvoire. 
As a cosmopolitan city, Kumasi attracts people of major ethnic groupings in West 
Africa. The indigenous Asante people and other Akans dominate life in general, 
especially in commerce and industry. It is believed the Asantes dominate business 
and trading activities in the country. People originating from the north of Ghana 
(northerners) have over many years lived and maintained identifiable communities in 
Kumasi. Their population has increased in recent times with rural-urban migration. 
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Clearly defined areas of the city are also inhabited by migrant communities from the 
Volta region of Ghana and other neighbouring West African countries. Although 
these non indigenous Akan communities maintain their language and cultural 
identity, Asante Twi, the language of the Asantes, is universally spoken. 
Health Services in Kumasi are organised around 5 sub-metro Health teams,, each with 
a recently upgraded hospital. These are the Manhyla South sub-metro with the 
Manhyla hospital, Manhyla North Sub-metro with the Tafo hospital, Subin sub- 
metro with the Maternal and Child Health Hospital and the Bantama sub-metro with 
the Suntreso Hospital, and also the Kumasi South Hospital. The sub metropolitan 
health teams, led by a Metropolitan Director of Health Services, have the 
responsibility of planning, implementing, monitoring and evaluating health services 
in the Kumasi Metropolis. 
The Komfo Anokye Teaching Hospital (KATH), one of 3 public autonomous 
teaching hospitals in the country is sited in Kumasi. It is a national tertiary referral 
hospital which serves the northern half of the country. 
Apart from these public hospitals, there are other health facilities in the quasi 
Government and private sector in the metropolis including 50 hospitals, 79 clinics, 
18 matemity homes, and 20 homeopathy clinics. 
The study was located in 4 sites; the Suntreso, Manhyla and Tafo Hospitals where 
study subjects were recruited, and KATH where some of the laboratory work was 
carried out. 
The Suntreso and Manhyia hospitals are the largest of the 4 Govenunent hospitals in 
the city (KATH excluded). Services in both facilities include general outpatient 
clinical care, Maternal and Child health services including daily antenatal and post 
89 
natal clinics , infant growth monitoring and nutritional support clinics, and chIld 
immunisation clinics. General and Obstetric surgery is also carried out. 
The antenatal clinics of the 3 study hospitals see an average of 100 clients each a 
day, and these were the facilities used by the study. For study purposes, a mobile 
microscopy service for vaginal wet preparation microscopy (wet preps) between 
these centres was set up. 
Cultures for Trichomonas vaginalis, Gram staining and the reading of gram stains of 
vaginal smears for the study, and storage of study swabs and T vaginalis isolates 
was done at KATH. Quality assurance of all the laboratory tests done in-country was 
camed out at KATH. 
Further laboratory work was undertaken at the London School of Hygiene and 
Tropical Medicine and the Institute of Tropical Medicine, Antwerp. 
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3.2 Study Population 
VOLTA 
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GULF OF GUINEA 
These were pregnant women attending the antenatal clinics of the Suntreso, Manhyia 
and Tafo Hospitals. This population was chosen for convenience and ease to reach. 
Also, the clinics and their staff have been involved in previous reproductive health 
research, thus making it easier to launch study protocols there. Results obtained from 
this population may not be generalisable to other female populations. 
3.2.1 Inclusion criteria 
Below were inclusion critereia for the studv- 
1. Study subjects must be pregnant and attending the antenatal clinic of the 
relevant health facility 
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They should be able to attend the cli I inic for at least a week after first being 
seen 
They should be able to gIve informed consent independently. 
IV. They should live within 10 miles radius of the Kumasi metropolis 
3.2.2 Exclusion criteria 
Exclusion criteria for the study were: 
1. known hypersensitivity to metronidazole 
2. has been referred to the clinic due to pregnancy and/or birth related problem 
3. needs cardiopulmonary resuscitation 
3.3 Study design 
The study was conducted in 2 stages. Cases of Tvaginalis infection were 
identified by screening of the women attending the antenatal clinics, and then an 
unmatched case-control study carried out. This was to determine the association 
between infection and vanous socio-demographic, maternal, genital hygiene, and 
sexual behavioural factors. It also looked at the association between infection and 
various clinical parameters for the diagnosis of infection. 
Using swabs obtained for the diagnosis of TV infection, a comparison of various 
diagnostic methods for the detection of TV was done. 
3.4 Sample size calculations 
In calculating sample size for this study, it was assumed that the minimum odds ratio 
of T vaginalis infection to be detected would be 1.7 
10. Thus, a sample size of 210 
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cases and 420 controls would have an 80% power to detect a significant effect 
(p<0.05) for a risk factor to which 25% of controls are exposed. 
The prevalence of Trichomonas vaginalis in the antenatal clinics after pilot study 
averaged 10%. Thus 2,100 women would have to be screened. Allowing for a 10% 
loss to follow up, approximately 2400 women would be screened. 
3.5 Training 
Prior to the commencement of the field work, field workers were recruited and 
trained in study procedures. 
Three main groups of fieldworkers were involved; nurse interviewers, midwife 
examiners and laboratory technicians. 
Training for the midwife examiners involved genital. examination, the insertion of 
specula, visualisation of the vagina and cervix and, their reporting and the adequate 
insertion of swabs and taking of samples from the posterior fomix. The 2 day 
training was supervised by the study gynaecologist/obstetrician and included 
discussions and practical hands on sessions with patients. As the examiners were 
midwifes by training and had been doing this routinely, there was no difficulty with 
this training. 
Training in study laboratory procedures was supervised by the author of this work. 
The InPouch culture (BioMed Diagnostics, San Jose, Ca) had not been used in the 
study laboratory previously, so opportunity was taken to train all lab staff in the use 
and examination of the InPouch. A training video supplied by the manufacturer 
augmented the training. Staff were trained in wet mount microscopy and the latex 
agglutination test according to manufacturer's instructions. 
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The author and Principal investigator of the study had undergone training in London 
on the reading of Gram films to score bacterial vaginosis according to Nugent's 
criteria. This training was passed on to one of the technicians. 
Three laboratory technicians were trained, who independently and blinded to each 
other, read the latex agglutination, wet mount and InPouch cultures respectively. 
The Principal investigator supervised training of the study interviewers using the 
study questionnaires. Culturally inappropriate questions were deleted, and agreement 
reached on uniformity in asking sensitive questions related to sexual practices. 
Results of the piloting and pre-testing were used to adapt the questionnaires and 
organisation of data collection. 
To check the quality and consistency of reporting responses from study subjects 
during the study, the consent of 60 randomly selected participants (about a tenth of 
, participants) was sought to enable all the 
3 nurse interviewers sit-in and record 
responses during their sessions. Responses were then checked. 
3.6 Recruitment Methods 
Recruitment of study participants began in mid October 2002 after a two week 
piloting and pre-testing study and ended in August 2003. 
At each antenatal. clinic, the antenatal. cards of the women were examined to check if 
they had not been recruited previously (a label marked "Trichomoniasis Study" was 
stuck on the card of all previously recruited women). 
Study interviewers (nurse/midwives) read out the study information sheet in the local 
Twi language to potential study participants. Verbal witnessed consent was then 
obtained from those who met inclusion/exclusion criteria and agreed to participate in 
the study. Written informed consent was not taken because of the poor literacy rate 
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among the women. Even though immediate consent was sought from the women, 
they were nonetheless assured that non-paticipation would not affect the care they 
received at the clinics. Study interviewers then instructed women consenting to 
participate in the study on how to collect self administered vaginal swabs (SAVS). In 
brief, they were instructed to gently insert the swab into the vagina and swab the 
vaginal walls. Participants were given dacron swabs (Quelab, Canada) for this 
purpose. After collection, the SAVS were sent to the on-site study laboratory where 
the swabs were screened for T. vaginalis with the Kalon TV latex test (Kalon 
Biologicals, Surrey, UK). 
A sticker with the label, "Trichomoniasis study" was placed in the antenatal card of 
these consenting women. This was to prevent re-screening during subsequent visits. 
I: After, screening for Trichomonas vaginalis, the laboratory personnel passed on all 
women positive for Trichomonas vaginallS infection (by the TV latex I-est) and the 
next 2 consecutive women who were negative for infection in a random order to the 
interviewers. The interviewers were blinded to the results of the Trichomonas 
vaginalis screening test. 
Confidential interviews were conducted with a structured questionnaire (Appendix 1) 
which sought infonnation on a variety of sociodemographic and maternal factors, 
sexual practices, and ano-genital hygiene practices of study patients, after which the 
interviewees were passed on to other study staff for genital examination. 
3.7 Clinical Procedures 
3.7.1 Genital examination and sampling 
This was done by trained, experienced midwifes who were also blinded to the results 
of the TV screening test. 
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The nature of the examination and the swabs to be taken was explained to study 
participants. A total of 6 swab samples per subject was taken -I oral, I rectal and 4 
vaginal. 
The women were asked to undress and lie on the examination couch. Examination 
was done in good light. 
A dacron swab was used to take material from the periodontum and gingival areas of 
the oral cavity. The swab was placed in a white labelled tube. 
The external genitalia were examined for any discharge, genital ulcer and/or vesicles, 
and other pathologies. A vaginal speculum was carefully inserted, and discharges 
and/or ulcers in the vagina and cervix looked for. The cervix was also examined for 
any pathology, especially punctate haernorrhages (strawberry cervix). 
'C- 
-,,. our 
(4) swabs from the posterior fornix were taken per subject and put in blue 
labelled tubes. 
On withdrawing the speculum, the pH of any discharge was checked using pH 
indicator strips (Color-pHast, MC/B Manufacturing Chemists Inc, Cincinnati) and 
the amine test performed with in-house prepared 5% potassium hydroxide (KOH). 
Finally, with care and having told the subject, a rectal swab was obtained by 
inserting a dacron swab about 2 cm. into the rectum an ro ing it. 
All specimens were sent immediately to the on-site laboratory bench. 
Examination findings were recorded on the "Female Clinical Examination Form" 
(Appendix 2). 
3.7.2 Definitions of characteristics of discharge 
An abnormal vaginal discharge was defined as one with an abnormal odour, any 
colour other than clear, any amount other than normal, or yeast-like. The amount of 
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vaginal discharge observed was categonsed as nonnal (no obvious discharge seen), 
discharge seen within the vagina only and discharge seen at the introitus. 
3.8 Metronidazole therapy 
At the end of recruitment for each day, standard metronidazole therapy (2g stat) was 
given to all study subjects in whom Trichomonas vaginalis had been detected by wet 
prep microscopy. This was also given to women (visiting the clinic a month after the 
initial examination) who at the initial visit were wet prep negative, but whose 
InPouch culture results were positive during the week. The women were counselled 
to stay off alcohol for 48 hours after ingestion of the metronidazole and also abstain 
from sexual intercourse for a week until after the test of cure. A prescription for 
metronidazole was also written to be given to their sexual partners. 
All these women were asked to return to the clinic a week after treatment for a final 
test of cure. 
3.9 Final test of cure questionnaire 
At the one week follow up visit, the women answered a questionnaire on the 
frequency, if any, of sexual intercourse during the intervening period, whether or not 
their partners had taken the metronidazole and any adverse reactions to 
metronidazole intake (Appendix 4). 
A SAVS was then obtained for the test of cure. This was done by InPouch culture as 
descnbed in 3.11.3. 
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3.10 Storage of swabs 
The oral, rectal and fourth of the four vaginal swabs were kept dry in sample tubes at 
the recruiting clinics and sent to the KATH within 30 minutes to an hour of 
collection where they were stored at -200C. These were subsequently shipped on dry 
ice to London and Antwerp, and used in nucleic acid amplification tests. 
Figure 3.2 Flow chart of study procedures 
Women attending antenatal clinic 
Recruited into study if inclusion/exclusion fulfilled and consent given 
SAVS obtained for TV screening by latex agglutination test 
All latex positives and the next 2 coasecutive latex negative women 
selected 
Questionnaire on socio-demographic, sexual practices, genital hygiene etc factors 
administered 
Genital Examination 
Oral, rectal and 4 vaginal swabs taken 
Wet prep examination of first vaginal swab done and standard 2g metronidazole 
therapy given to all wet prep TV positive women. 
TV cultures inoculated, Smears for Gram stain done. Fourth vaginal swab, oral and 
rectal swabs kept dry for PCR assays. 
Follow up after I week for all those given metronidazole therapy for TV test of cure 
by culture 
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3.11 Laboratory Methods 
3.11.1 Latex agglutination testing 
SAVS from recruited patients was screened for Trichomonas vaginalis by a latex 
agglutination kit (LAT) according to manufacturers' (Kalon Biological Ltd, Surrey, 
UK) instructions. 
The TV latex kit consists of the following in dropper bottles; 2.5ml test latex, 1.5ml 
positive control, and 1.5ml negative control, all in 0.1% sodium azide preservative. 
Also in the kit are sterile swab sticks, sample tubes containing 50OItl phosphate 
buffer in sodium azide, wooden mixing sticks, and a reusable glass slide. 
The test latex is sensitised with rabbit anti-Tvaginalis IgG. If the test latex is mixed 
on a slide with eluate from a vaginal swab, any Trichomonas vaginalis antigen 
present causes cross linking (agglutination) of the sensitised latex. Agglutination, 
which can be observed against a dark background is indicative of the presence of 
Tvaginalis. 
All the TV latex reagents were brought to room temperature from 40C storage. The 
TV latex reagent was shaken to give a good mix to the particles. 
The SAVS were eluted into the manufacturer- supplied sample tube containing 
phosphate buffered saline (PBS). 501tl of swab eluate were added to a reaction zone 
on the glass slide. One drop of latex was added to the eluate. This was stirred and 
mixed to a completely homogenous mixture that covered the entire surface of the 
reaction zone. The glass slide was tilted with a rotating action continuously 
for 2 
minutes. The degree of agglutination obtained, was read after 
2 minutes and scored 
as follows; 
Latex has agglutinated and much has collected around edge of reaction zone 
Agglutinated particles can clearly be seen against a granular latex background 
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Agglutination can just be discerned when compared to negative control 
No agglutination compared to negative control - negative 
Positive and negative controls were run each day before study subject samples were 
run. 
All tests scored with any degree of + were recorded positive. 
The left-over swab eluates were stored at - 20'C and later shipped to London. 
3.11.2 Wet prep examination 
The first of the 4 vaginal swabs obtained during the genital examination was 
immediately agitated into 0.9% saline solution. A drop of this was placed on the 
centre of a clean microscope slide and covered with a cover slip. The slide was 
initially carefully scanned at xIO0 with a light microscope for motile trichomonads, 
pus cells, yeast cells and epithelial cells,, and then at x400, to confinn motility, 
flagella movement, and morphological features of Trichomonas vaginalis. This was 
done on site in the respective hospitals. 
3.11.3 InPouch inoculation and culture 
Culture for Trichomonas vaginalis for the study was undertaken using the InPouchTm 
system (BioMed Diagnostics, San Jose, Ca, USA). 
The second of the 4 vaginal swabs was inoculated into the InPouch system within 5 
minutes of specimen collection. It was observed under the light microscope 
immediately for any motile trichomonads and then sent to the KATH Clinical 
Microbiology laboratory within 30 minutes of specimen collection, where it was 
incubated at 370C, and observed daily for up to 5 days for any motile trichomonads. 
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Microscopy was carried out at xIO0 and then x400. Pouches not registering the 
growth of trichomonads after the fifth day were declared negative. 
3.11.4 Reading of above laboratory test results 
The latex agglutination test, wet mount examination and InPouch culture results were 
read independently, each by different technician who were all blinded to each others' 
results. 
3.11.5 TV Enzyme immunoassay test 
This was carried out on stored left over PBS eluates used originally for the latex 
agglutination testing and transported to London. A commercial kit, TV screen (Kalon 
Biological, UK)., was used. The kit has polystyrene inicrotitre plate wells supplied . 
pre-coated with affinity purified polyclonal antibodies to Trichomonas vaginalis. 
Testing was carried out according to manufacturer's instructions. 
Vaginal swab eluates stored at -20'C were brought out to thaw at room temperature. 
I 001A eluates and controls were dispensed into designated wells and incubated at 
37'C for 30 minutes. After a wash step with distilled water (4 times washing and 
tapping plate dry), the surface of each well was probed for antigen by incubation at 
37'C with 100ttl enzyme conjugated anti-TV tracer. Following a second wash step (4 
times washing and tapping plate dry), I 001d enzyme substrate/TMB chromogen was 
added to the wells. The plates were incubated at room temperature for 30 minutes 
and the enzyme incubation then stopped with IN 100ttl sulphuric acid. Addition of 
the stop solution changed the colour of the reaction whose optical density (OD) was 
then measured in a photometer at 450rim. The optical density is proportional to the 
amount of TV antigen present in the original eluate. 
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Assay validation was done for each run according to the manufacturer's criteria i. e 
cut-off positive control OD is greater than 0.4, the negative control O. D is less than 
0.3 and the ratio of the cut-off positive control to the negative control is greater than 
1.5. 
All samples with an OD greater than cut-off X 1.1 were considered positive and 
those with OD less than cut-off X 0.9 considered negative. Results with OD between 
0.9Xcut-off and IA Xcut-off were considered equivocal and repeated. 
3.11.6 Lateral flow test (Kalon TV dipstick) 
This kit has not been manufactured for commercial use. Kalon Biological Ltd sent in 
a quantity of the strips to be evaluated with the left over archived swab eluates. 
The lateral flow test is a dipstick made from nitrocellulose membrane with mesh I- 
sizes of 10 microns. The dipstick has 4 distinct areas; a sample pad area containing 
dried down phosphate buffered saline on which the vaginal swab eluate is put, a red 
gold conjugate pad, a diffusion area at the end of which 2 invisible lines are found; 
an anti-goat antibody control line and an anti-TV control line, and a 'data' area, 
where sample numbers may be written. 
150AI of swab eluate was applied to the sample pad area and allowed to diffuse 
through the length of the dipstick, over the gold conjugate and the 2 invisible lines 
for 20 minutes. The anti-goat internal control line shows up red with a valid run. A 
positive test shows up as 2 red lines, whilst a negative test shows up with the internal 
control line. The absence of the internal control line indicates an invalid test. 
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3.11.7 Polymerase Chain Reaction (PCR) for TV 
3.11.7.1 Primers 
For the detection of Trichomonas vaginalis, 2 different oligonucleotide primer pairs, 
based on their use in clinical and epidemiological studies were employed; one pair 
designed by Kengne 255 , and the other, an internal primer reported by Shaio 
254. 
These primers amplify independent targets in the Tvaginalis genome, producing 
amplicons of different sizes. 
The Kengne pair of primers, TVK3/TVK7 amplify a target within the 2000bp repeat 
region in the TV genome, producing an amplicon of size 300bp. The Shaio internal 
pair of primers, IPl/1IP2 produce a product with size 290bp after amplifying a target 
in the family of 650bp specific DNA repeats in the T vaginalis genome. Reports from 
,ý the literature suggest the Kengne pair of primers to have better sensitivity than the 
Shaio primer pair 254 . Also Studies from Africa have utilised the Kengne primers and 
reported their favourable sensitivity. All samples were first screened with Kengne 
primer pair. All those positive, were then further tested with Shaio pair of primers. 
Primers used in Rhominis amplification are as reported by Crucitti et al ". These 
(Th3 and Th5 primers) amplify a unique region of the l6s-like nbosomal RNA gene 
of Rhominis producing a 339 bp fragment. 
For Trichomonas tenax, a primer pair, PT3/PT7 designed by Kikuta et a, 297 was 
used. The primer pair amplify a 776 bp fragment from the 18S rRNA gene of T. 
tenax. 
Amplification of the human B2 gene was also done on all the vaginal and oral swabs 
to check for the quality of material on the the swabs. Primers used were the PC04 
and GH20298 . These produce a 
268bp amplicon. 
All the primers were synthesised by Sigma-Genosys Ltd, UK 
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3.11.7.2 DNA extraction 
DNA extraction from the swabs was done using commercial kits from Qiagen, UK. 
These were QlAmp DNA mini kit (extraction from vaginal and oral swabs) and 
QlAmp DNA stool mini kit (extraction from rectal swabs). Extractions from vaginal, 
rectal and oral swab specimens utilised a similar protocol. 
Extraction was done in a Class 2 safety cabinet. Standard precautions against cross 
contamination were employed. Bench tops, hood and discard pots were cleaned with 
a 10% hypochlorite solution (Hays Chemical disti-ibution Ltd, Leeds, UK), and 70% 
alcohol (Sigma UK). Sample racks, and pippettors were similarly cleaned. Aerosol 
barrier tips were used throughout. Gloves were liberally changed as and when 
necessary. 
The QlAmp kits contain 3 buffers - Al., AWI,. and AW2 - used at different stages of 
the extraction process. Added to the lysis buffer (AL) of the DNA stool mini kit is 
InhibitEX9, a commercial polysaccharide mixture which removes PCR inhibitors of 
faecal ongin such as bile salts, break down products of haemoglobin and complex 
polysacchandes often found in food 
299,300 
. 
The fourth vaginal swab (or the rectal or oral swab) was thawed from -20'C storage 
and eluted in 5001A PBS by vortexing for 10 seconds and squeezing the swab against 
the inside of the polypropylene sample tube. 2501A of swab eluate was aliquoted into 
2ml sample tubes. To this was added 600 Itl AL buffer and vortexed for 15 seconds. 
201A Qiagen proteinase K was then added and the mixture incubated in a heating 
block at 560 C for 10 minutes. After cooling, it was centrifuged briefly and 600ul of 
96-100% ethanol was added. 7001A of this lysate was aliquoted onto QlAmp spin 
columns placed in 2ml tubes. The spin columns were centrifuged at 60OOg for a 
minute after which filtrate in the 2ml tubes was discarded. The column was put in a 
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new 2ml tube. A further 700AI of lysate was dispensed onto the column which was 
similarly centrifuged and the filtrate discarded. The column was placed in a new 2ml 
collection tube. 5001A of AWI buffer was added to column and spun at 60OOg for a 
minute. Filtrate was discarded and column was placed in another collection tube. 
AW2 buffer (500ttl) was added to the column, spun for 2 minutes at 20,000g and 
filtrate discarded. The Qlamp columns were finally eluted with 200itl TE buffer. The 
resulting eluate, containing any extracted DNA was stored at -200C until used. 
3.11.7.3 DNA Amplification 
Amplification of DNA was done in a programmed then-nocycler (GeneAmp PCR 
system 9700, Applied Biosystems, Norwalk, US). All the PCR reagents (buffer, 
MgC12, and polymerase), were obtained from. Applied Biosystems, UK, and the bases 
, (dNTPs) from Ai-nersham Corp., UK. 
3.11.7.3.1 Tvaginalis 
Preparation of the PCR master mix was carried out in a dedicated class 2 cabinet 
(separate from the one used in the extraction process). Similar precautions against 
cross contamination as above were taken. The master mix for the Kengne PCR 
consisted of 51tl IOX gold buffer, 7/A 2mM of each dNTP, 1.5AI each of 5uM 
primers, 4/d 25mMMgCI2, and 0.41AI 5U/ml amplitaq gold DNA polymerase and 
20.61tl distilled water. 40itl of this mix and 101tl of sample DNA extract were put in 
each of the PCR reaction vessels. A positive control of DNA from a known 
Trichomonas vaginalis reference strain (ATCC 3001) and a negative control of 
distilled water were substituted for samples in the last and penultimate reaction 
vessels. Cycling conditions were a pre-PCR heating at 95'C for 5 minutes (hot start), 
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and 35 cycles of denaturation at 94'C for I minute, primer annealing at 60'C for 30 
seconds, and product extension at 72'C for 2 minutes. 
The Shaio PCR mix consisted of 4ttl I OX gold buffer, 4/Al 2mM of each dNTP, 41AI 
each 5uM primers (IP I and rP2), 3.2ttl 25mM Mgcl2, and 0.41A 5U/ml amplitaq gold 
polymerase. 40ttl of this mix and 10ttl of sample or control DNA were used. Cycling 
conditions were 95'C for 45 seconds denaturation, 450C for I minute annealing, 
72'C for 1 minute extension. 35 cycles were run. This also involved a pre- 
denaturation hot start procedure at 95'C for 5 minutes. 
3.11.7.3.2 Rhominis 
The PCR master mix for P. hominis amplification consisted of 5[d IOX gold buffer, 
7ttl 2m. M of each dNTP, 1.5AI each of 5uM pnmers, 4/. tl 25mMMgCI2, and 0.4/ti 
5U/ml amplitaq gold DNA polymerase and 20.61il distilled water. 40til of this mix 
and 101tl of sample DNA extract were put in each of the PCR reaction vessels. 
Cycling conditions after a 95'C hot star procedure for 5 minutes, was I minute 
denaturation at 95'C, annealing at 64'C for I minute and product extension at 720C 
for 1 minute. 35 cycles were undertaken. 40ul of master mix and lOul sample DNA 
extract was used in the reaction vessels. 
3.11.7.3.3 T. tenax 
The Ttenax programme consisted of 37 cycles of denaturation at 95'C for a minute, 
annealing at 58'C also for a minute, and a product extension time of I minute at 
72'C. Cycling was preceded by a7 minute hot start procedure at 95'C. The reaction 
mix consisted of 101A buffer ( IOX strength), 101AI Mgc12 (25mM), 10ttl of each 
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dNTP (2mM), 31il of each pnmer (5uM of PT3 and PC), and Ijil Amplitaq gold 
polymerase. 901tI of master mix and I Oul of DNA was cycled. 
3.11.7.3.4 B-2 microglobulin 
Each swab eluate was checked for the presence of human DNA A microglobulin 
gene) by PCR for probable inhibitors and also the quality of sampling. All samples 
which appeared to have inhibitors were diluted ten fold and 82microglobulin run 
again. 
The B-2 PCR mix consisted of 4AI 1OX gold buffer, 41tl 2mM of each dNTP, 21tl 
each of 5uM pnmers (PC04 and GH20), 6.4gl 25mM Mgc12, and 0.41tl 5U/ml 
amplitaq gold polymerase and 1.2ftl distilled water. 201tl of this mix and 20[d of 
sample or control DNA were- used. The control DNA was a DNA extract from 
human lymphocytes (courtesy of Ms. Tania Crucitti, Institute of Tropical Medicine, 
Antwerp). 
The B2 cycling conditions were; pre-denaturation hot start at 95'C for 2 minutes, then 
35 cycles of denaturation at 94'C for 30 seconds, annealing at 50'C for 30 seconds, 
and 30 seconds extension at 720C. 
After the final cycles of all the PCRs a final extension period of 7 minutes at 72'C 
was undertaken. 
3.11.7.4 Amplicon detection 
Products from Tvaginalis and B-2 PCR were detected by colorimetry, using Enzyme 
immunoassay techniques (EIA) 257, whilst those of Rhominis and Ttenax were 
detected by agar gel electrophoresis 
11,297 
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3.11.7.4.1 Capture probes 
For detection of amplicons from the Kengne TVK3/7 TvaginallS PCR, a 25 bp DNA 
probe, SA3 
257 
was used while primers TVER-P2 designed by Ryu 
301 
was used to 
capture amplicons from the TV IPI/2 Shaio amplification. The 268bp PCR product 
from the B-2 microglobulin amplification was detected using a PC03 probe 302 . 
All the capture probes were synthesised by Sigma Genosys, UK. 
3.11.7.4.2 Coating of plates for EIA 
Coating buffer for the microtitre plates consisted of freshly prepared ammonium 
acetate and either 500ng/100[d SA3 probe, 300ng/100til TVER-P2 probe or 
300ngII00AI PC03. IOOAl of a IM ammonium acetate/probe solution was put in 
wells. of a. microtitre plate (Nunc, Denmark), covered with a microtitre plate sea] and 
incubated at 37'C overnight. After overnight- incubation, the wells were washed 
twice with 1: 10 Amplicor wash buffer (Roche Diagnostic Systems, NJ), tapped dry, 
covered with laboratory tissue and left to dry, at room temperature for 2 hours. Dried 
plates were used immediately or stored at 40C and used within a week. 
3.11.7.4.3 EIA run 
Similar protocols were used for amplicons from both Tvaginalis and the 132 
microglobulin reactions. 
Amplicons were heat denatured at 950C for 5 minutes. 15[d of this was added to a 
100itl hybridisation buffer in microtitre wells (above). The plates were covered with 
sealant and incubated at 37'C for an hour, after which the wells were washed 
five 
times with Amplicor wash buffer. I 00jil Horse Radish Peroxidase (HRP)-streptavidin 
was then dispensed into each well. The plate was again 
incubated at 370C for 15 
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minutes,, after which it was washed five times. I 00itl TMB substrate was added to 
wells in the dry plate and the plate incubated in the dark at room temperature for 10 
minutes, after which the reaction was stopped with IOOAI IN H2SO4. Absorbance 
was read in a spectrophotometer (MRX Dynatec, UK) at 450nm. 
Each plate had 2 positive control wells and 2 negative controls. The cut off was 
calculated as the mean of the negative controls +3 standard deviations. 
3.11.7.4.4 Agarose gel electrophoresis for A hominis and T. tenax 
PCR products from the Rhominis and Ttenax amplifications were analysed by 
electrophoresis in a 1.5% agarose gel (Life Technologies, UK) in Ths acetate EDTA 
buffer (pH 8) (Appendix 6). The gel was stained with ethidium bromide (CLP, 
London). 10p. 1 of product was mixed in 21tl of commercial loading buffer (Bioline 
Ltd. London) and loaded onto the agarose gel. Electrophoresis was done in a 12XI4 
horizontal, gel tank (Apollo, CLP, UK). After electrophoresis, the gel was visualised 
under ultraviolet light and photographed (Biolmaging Systems, UK). Sizes of the 
amplified products were assessed by comparing to commercial molecular weight 
markers (Ikb, Bioline Ltd, London). Positive and negative control samples were run 
alongside sample amplicons. 
All PCR analysis was carried out according to quality assurance guidelines for 
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molecular diagnosis 
3.11.7.5 Interpretation of results 
Any samples with values greater than the cut-offs in the EIA analysis were deemed 
positive, and those with values below the cut-off values, negative. 
109 
Samples negative for B2 microglobulin undiluted and diluted were considered to have 
PCR inhibitors or have inadequate sample. lf after the 1: 10 dilution step82 testing 
was still negative no further analysis was carried on those samples. Otherwise, 
further PCRs were camed out. 
All samples positive with Kengne primer pairs were tested again with Shajo primer 
pairs. A sample was adjudicated positive only if testing with both Kengne and Shaio 
primer pairs were positive. 
A positive gel product was one where electrophoresed product was of the expected 
size as judged by the molecular weight marker and the positive control. 
110 
Figure 3.3 Flow diagram of PCR testing of vaginal swab eluates 
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3.11.8 Gram Stain preparation and examination 
Tt PCR) 
A smear was prepared on a clean glass slide with the third of the 4 vaginal swabs at 
the on-site laboratory. The smear was allowed to dry in air. This was transported to 
the Microbiology laboratory of the KATH, where the smear was heat fixed by 
passing 2-3 times through a flame. Crystal violet stain was poured on the slide and 
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allowed to act for 1-2 minutes after which the slide was washed under running water. 
Excess water on the slide was tipped off. Gram's iodine was then applied for a 
minute, and washed off with water. Decolourisation of the slide was then done with 
an acetone-spirit solution for a few seconds and then washed off immediately with 
water. The slide was counter-stained with neutral red for 1-2 minutes, washed 
thoroughly with water and blotted dry. The stained, dried film was then finally 
examined under the oil immersion objective of a light microscope. 
The Gram stained slide was scored for Bacterial vaginosis according to Nugent's 
criteria 304 (Table 3.1). With this criteria, a score is assigned on the basis of the 
proportions of bacterial morphological types seen, ranging from lactobacillus- 
predominant flora (score 0) to Gardnerella, Bacteroldes and Mobilincus- 
predominant, lactobacillus-depleted flora (score 10). for each slide, scores are 
assigned depending on the number of each of the above individual morphotypes 
present; 0, no morphotype seen, 1, one morphotype seen, 2+, two to four 
morphotypes seen, 3+, five to thirty morphotypes seen, 4+, more than thirty 
morphotypes seen. A composite score of 7-10 from addition of the sub-totals is taken 
to be diagnostic of bacterial vaginosis, 4-6, an intennediate smear and 0-3, a normal 
smear. 
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Table 3.1 Nugent's criteria for Bacterial vaginosis scoring system (adapted from 
Nugent RP, Krohn MA, Hillier SL 304). 
Score Lactobacillus Gardnerella & Curved gram variable 
MoEphotype Bacteroides spp rods 
0 4+ 00 
1 3+ 11 or 2+ 
2 2+ 2+ 3+ or 4+ 
3 1 3+ 
4 0 4+ 
Any yeast cells and hyphae in the Gram stained smear were also noted 
3.11.9 Storage of Trichomonas vaginalis isolates 
This was carried out for all InPouch isolates of Tvaginalis. I ml of positive InPouch 
culture was. put in a cryovial. To this was added 150 p. 1 inactivated horse serurn and 
100 Itl DMSO. The resulting solution was mixed very well, and incubated at -2-00C 
for an hour and then transferred to a -70'C freezer thereafter for long tenn storage. 
All isolates were stored in duplicate, and subsequently shipped on dry ice to London. 
3.12 Data Management 
Data were pre-coded on the questionnaire and forms. Completeness of questionnaire 
responses and other forms was checked each day on-site at the hospitals. Data entry 
templates were created in Epi Info 6.03 (CDC, Atlanta) and data were double-entered 
by 2 clerks. Contradictory responses were identified using range and consistency 
checks in Epi Info. Validation of the double data entry was done at the end of each 
week by the Epi Info validate programme. 
Data was transferred to and analysed in STATA 8 (STATA Corporation, Texas, US). 
The distribution of each exposure variable was examined separately for cases and 
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controls. Outliers were checked against original questionnaire and errors corrected 
before data analysis. Quantitative variables were grouped into known categories of 
the variable or into categories commonly used in the STI literature. 
3.12.1 Data analysis 
3.12.1.1 Case control study 
The data was analysed as an unmatched study. Unmatched analyses was done due to 
practical difficulties, as controls were the following two consecutive women 
attending the clinic after each case and were not matched on age or any other 
potential confounding factors. As these potential confounders could distort the size 
of any measure of effect, logistic regression methods were used to control for this. 
- Baseline, variables were usually taken as the lowest quantile of exposure or group 
considered to be at lowest risk of Tvaginalis infection. Proportions were compared 
using the Xý, and Fisher's exact tests. Using logistic regression, odds ratios (OR) and 
their 95% confidence intervals (95% CI) were estimated for exposure variables with 
a diagnosis of Tvaginalis as outcome. The statistical significance of associations 
between exposure and risk of Tvaginalis infection was determined using Likelihood 
Ratio Tests (LRT) of homogeneity and of trend. 
Again, using multiple logistic regression, models were developed to examine factors 
associated with Tvaginalis infection on univanate analysis at p<=O. 1. For the 
modelling strategy, a conceptual framework 305 was used to explore the inter- 
relationships of exposures thought to lie at different positions on the same causal 
pathway. Variables were categorised according to their proximity to the risk of 
T vaginalis infection and were added in turn to the model starting with the distal 
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variables and ending with the proximal ones. Figure 3.6 illustrates what was done in 
this study. 
Figure 3.4 Modelling strategy for variables independently associated with TV 
infection 
Distal -S oci odemo graphic variables i. e. age, educational status, 
occupation of partner, ethnicity, religion, mantal status 
I Intermediate - Genital hygiene variables i. e. menstruation,, douc 
Proximal - Variables related to sex and sexually transmitted infections i. e. vaginal 
discharge, past treatment for vaginal discharge, time since last sexual intercourse 
I. First, the association between the socio-demographic factors and TV infection were 
investigated. Variables were kept in the model at each stage if they remained 
significantly associated with Tvaginalis infection at p<=O. I. Next, the association 
between each variable in the other categories and TV infection was assessed by 
adding the variable into the above model one by one in order to adjust for the socio- 
demographic variables. A composite multivanate model, consisting of all distal, 
intermediate, and proximal category variables associated with TV infection at p<=O. I 
was formed. The final multivanate logistic regression model was reached by 
dropping factors in the composite model one at a time until all remaining factors 
were significantly associated with infection at p<=O. I using the likelihood ratio test 
(LRT). This model estimated the independent effects of all variables on Tvaginalis 
infection. 
An investigation of whether the factors independently associated with infection, 
either singly or in combination could be used as a tool to predict TV infection in the 
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study population was done. To do this, binary scores were developed for each factor 
independently predicting infection on multivariate analysis in the final model. Two 
approaches in developing the scores were followed. In the simple approach scores of 
I and 0,, were given to each study subject, with the score of I for subjects with the 
factor and 0. those without. This system, it was believed, would be easy to apply in a 
field setting. This was compared to a second scoring system where weights were 
given to individual factors associated with infection in the final model depending on 
their odds ratios (OR); score I for OR between 1-2,2 for OR between 2-3, score 3 
for OR between 3-4 and score 5 for OR between 5-6, and 0 if no association existed. 
A combined score, the sum of all the factors independently associated with infection 
present in each subject was calculated using both systems 
Using these scores as cut-offs, the diagnostic values (sensitivity, specificity, and 
pfedictive values) of various combinations of the factors in predicting Tvaginalis 
infection was calculated. As only the selected case-control cohort had been tested 
with the gold standard TV diagnostic test, an estimation of the number of women in 
the target population who would have tested positive on the gold standard (and hence 
those testing negative) was done. In doing this, it was assumed that women in the 
target population who were not selected for the case control study would not differ in 
terms of the gold standard tests from those selected. 
Finally, the diagnostic values when the scoring systems of the socio-demographic 
and clinical parameters predicting infections were combined, was investigated. 
3.12.1.2 Diagnostic comparison 
Using a combination of wet prep and/or culture as expanded gold standard, the 
perforinance of the various diagnostic tests for TV (latex agglutination, wet prep, 
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culture, enzyme immunoassay, lateral flow and PCR) was done. Sensitivity, 
specificity, and predictive values of the tests in the target population were estimated. 
The Kappa index of test agreement between the individual tests and the expanded 
gold standard was calculated. 
3.12.1.3 Are trichomonads other than T. vaginalis involved in the aetiology of 
vaginal trichomoniasis? 
To answer whether trichomonads other than Tvaginalis are involved in the aetiology 
of vaginal trichomomasis, a comparison was made between the results of traditional 
TV tests (wet prep and culture) and PCR results of vaginal swab eluates using 
specific primers for P. hominis, T tenax and Tvaginalis. 
3.12.1.4 Presence of trichomonads in various body sites 
Frequencies were used to estimate the presence of trichomonads in various body 
sites. The trichomonads were identified from vaginal, rectal and oral swabs by PCR. 
3.12.1.5 Clinical efficacy of single 2g metronidazole therapy in pregnant women 
Frequencies of women testing positive for Tvaginalis at test of cures were compared 
with those testing negative. 
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4. RIFSULTS: DEMOGRAPHIC AND BEHAVIOURAL 
PREDICTORS OF VAGINAL TRICHOMONIASIS IN 
PREGNANT WOMEN 
4.1 Study Population 
A total of 3807 women consented to participate in the study. This included all those 
testing positive for TV by the latex agglutination test (LAT), and the randomly 
selected women testing negative. 
All women meeting the inclusion/exclusion criteria agreed to participate in the study. 
However,, there were 9 women who after initially obtaining their self administered 
vaginal swabs for latex agglutination testing (4 positives, 5 negatives) could not be 
traced for subsequent parts of the study i. e. interviewing, clinical examination and 
obtaining further vaginal, oral and rectal swabs. They were dropped and substituted. 
4.2 Prevalence of TV infection 
Of the 3807 women, 206 were positive on LAT testing, giving a prevalence of 5.4%. 
All the 206 women and 427 women negative on LAT were selected as the cohort for 
the case control study. Using the expanded gold standard of wet prep and/or culture 
(see 4.3), the prevalence of TV was 4.93% (188/3807) when estimated for the study 
target population. 
4.3 Case and control group 
The decision to use the LAT for screening was based on its reported sensitivity and 
specificity 8. It was believed that the accuracy of the LAT would be good enough in 
sele I same day interviewing and cting patients with trichomoniasis so that subsequent 
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examination of the participants could be done, instead of recalling them after a week 
when gold standard test results were available. Many of them could then be lost to 
follow up. 
Due to the fact that the LAT was being evaluated against an expanded gold standard 
(EGS) TV diagnostic and the performance of the LAT in this population was 
unknown , it was decided rather to use results of the EGS in defining cases and 
controls for the case control study. All the 633 women selected on the basis of the 
LAT result were also tested with the other TV diagnostics. Cases were thus defined 
by an expanded gold standard (EGS) as wet prep and/or culture positive. Controls 
were negative for both tests. 
4.4 Univariate and age-adjusted analysis 
4.4.1 Sociodemographic characteristics of cases/controls 
4.4.1.1 Age 
The age of participants ranged between 15 and 44 years, with a median age of 26 
years. The cases were younger on average than the controls, and there was a strongly 
significant association between age and infection (p=0.0001). Subsequently, all 
analysis of the association between TV infection and all variables was age adjusted 
(Table 4.1). 
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Variable Cases Controls n(%) Crude 95% CI Age 95% CI p (age- 
n(%) OR Adjusted adjusted, 
OR LRT) 
Age (years) #0.0001 
>30 34(19.7) 123(26.8) 1 *0.005 
25-29 47(27.2) 153 (33.3) 1.11 0.6-1.8 **0.07 
20-24 61 (35.3) 154(33.5) 1.43 0.8-2.8 
<20 31 (17.9 30(6.5) 3.73 2.0-7.0 
*0.03 
Educational **0.06 
status 
None 27(15.6) 62(13.5) 1 1 
Primary 24(13.9) 74(16.1) 0.74 0.4-1.4 0.64 0.32-1.2 
Jun Sec 87(50.2) 264(57.4) 0.75 0.4-1.2 0.73 0.43-1.2 
>Jun Sec 35(20.2) 60(13) 1.33 0.7-1.3 1.45 0.77-2.7 
Occupation 0.4 
Trader 75(43.3) 230(50) 1 1 
Housewife 30(17.3) 67(14.6) 1.37 0.8-2.3 1.31 0.8-2.2 
Professional 56(32.4) 132(28.7) 1.30 0.8-1.9 1.20 0.7-1.8 
Student 9(5.2) 24(5.2) 1.15 0.5-2.6 0.54 0.2-1.3 
Fanner 3(l. 8) 7(l. 52) 1.31 0.3-5.2 1.53 0.4-6.1 
Religion C", 08 
Christian 142(82) 379(82.4) 1 1 
Moslem 25(14.4) 77(16.7) 0.86 0.53-1.4 0.78 0.5-1.3 
No religion 6(3.5) 4(0.9) 4.00 1.1-14.4 3.58 
_1.0-13.0 Ethnicity 0.005 
Akan 125(72.2) 356(77.4) 1 1 
Northerner 29(16.8) 85(18.5) 0.97 0.6-1.5 0.81 0.5-1.3 
Other 19(11) 19(4.1) 2.84 1.4-5.5 2.89 1.4-5.6 
Marital status 0.03 
Monogamous 143(83.6) 418(90.9) 1 1 
Polygamous 15(8.7) 34(7.4) 1.28 0.7-2.4 1.42 0.7-2.7 
Single 15(8.7) 8(1.7) 5.48 2.2-13.1 3.18 1.2-8.4 
Age at first 
marriage 1.0 
(years) 
_ <20 60(34.7) 132(28.7) 1 1 
>=20 113(65.3) 328 (71.3) 0.75 0.5-1.1 1 0.67-1.5 
Table 4.1. Association between Socio-demographic variables and TV Infection. 
Likelihood ratio test (LRT), # unadjusted, p value for trend *categorical and "linear 
models. 
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4.4.1.2 Educational status 
Number of years of formal schooling was comparable among cases and controls. 
15.6% and 13.5% of cases and controls respectively had no forinal education. Whilst 
13.9% of cases had been up to the basic primary level (6 years schooling) only, 
16.1% controls had similar attainment. 50.2% cases and 57.4% controls had attained 
up to the Junior secondary school (9 years schooling). 20.2% cases and 13% controls 
had some education after Junior secondary level. This included those attaining senior 
secondary and tertiary education levels. 
In general, education was significantly associated with infection (p=0.03). For those 
having some formal education, infection was associated with increasing number of 
years schooling at significant levels (p=0.03). 
4.4.1.3 Occupation 
Occupations of the women illustrate the Kumasi, metropolis as the hub of trading 
activities in the region, country and the West Africa sub-region. The most common 
occupation of the women was trading; 43.3% cases and 50% controls. Housewives 
made up 17.3% and 14.6% of the population of cases and controls respectively, 
whilst an equal proportion (5.2%) of both cases and controls were students. 
Hairdressers, dressmakers and their apprentices, office assistants, classified as 
professionals, represented 32.4% cases and 28.7% controls. There is hardly any 
farming activity in the metropolis, residents relying on food from nearby villages. 
Farmers among the women were 1.8% of cases and 1.5% of controls. There was no 
association between infection and occupation (p=0.4) 
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4.4.1.4 Religion 
Christianity was the professed faith among 82% cases and 82.4% controls, whilst the 
Islamic faith was represented by 14.4% and 16.7% of cases and controls respectively. 
3.5% cases and 0.9% controls said they had no religious faith. The odds ratio for 
infection of having no religious faith was 3.58. Religion was associated with 
infection at borderline significance (p=0.08) 
4.4.1.5 Ethnicity 
As expected, 72.2% of cases and 77.4% controls were Akans. 16.8% cases and 
18.5% controls were Northerners. Other ethnic groups represented II% and 4.1 % 
cases and controls respectively. The odds ratio for infection of being neither Akan 
nor Northerner was 2.89 (95% CI 1.4-5.6). Ethnicity was significantly associated 
with infection at p=0.005 
4.4.1.6 Marital status 
The majority of women were in monogamous relationships (83.6% cases, 90.9% 
controls). 8.7% and 7.4% of the women had polygamous partners. There were more 
single women among the cases (8.7%) than the controls (1.7%). The odds ratio for 
infection of being single was 3.1 S. Marital status was significantly associated with 
infection (p=0.03). 
4.4.1.7 Age at first marriage 
Whilst 34.7% of cases were married before the age of 20 years, this was the case for 
28.7% of controls. Amongst those being married at age 20 years or more, 65.3% 
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were cases and 71.3% controls. There was no association between age at first 
marriage and TV infection (p=1.0). 
In summary, for the socio-demo graphic factors studied, age, education, marital 
status, and ethnicity were significantly associated with infection. Religion was of 
borderline significance. 
4.4.2 Maternal factors 
Table 4.2 shows the associations between maternal factors and TV infection. 
Table 4.2. Association between maternal factors and TV infection 
Variable Cases 
n(%) 
Controls 
n(%) 
Crude 
OR 
95% CI Age 
Adjuste 
d OR 
95% Cl p (Age 
adj usted 
LRT) 
Gestation 0.85 
Stage 
(Trimesters) 
First 32 (18.5) 91 (19.8) 1 1 
Second 81 (46.9) 206 (44.8) 1.18 0.7-1.8 1.14 0.7-1.9 
Third 60(34.6) 163(35.4) 1.04 0.6-1.7 1.08 0.65-1.8 
Circumcision 0.82 
No 169 446(97.0) 1 1 
(97.7) 
Yes 4(2.3) 14(3.0) 0.75 0.2-2.3 0.88 0.3-2.7 
4.4.2.1 Stage of gestation 
18.5% of cases as against 19.8% controls were in their first trimester of pregnancy 
while 46.9 cases and 44.8% controls were in the second trimester. Study subjects in 
the third trimester comprised 34.6% cases and 35.4% controls. In Ghana most 
pregnant women start attendances at antenatal clinics from the second trimester. 
Gestation stage was not associated with infection. 
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4.4.2.2 Circumcision 
2.3% cases as against 3% controls said they had been circumcised. All those 
circumcised did not know why they were circumcised as it was done when they were 
children. Age at circumcision for both cases and controls ranged 2 years - 14 years, 
with a mean age of 6.2 years for cases and 7.3 years for controls. Circumcision was 
not associated with infection. 
None of the maternal variables studied were significantly associated with infection 
(Table 4.2). 
4.4.3 Partner related factors 
Table 4.3. Association between partner related factors and TV infection 
Variable Cases Controls Crude 95% CI Age 95% CI p (Age 
n(%) n(%) OR Adjusted adjusted, 
OR LRT) 
Partners' 0.45 
occupation 
Non- 145 391 (85) 1 1 
professional (83.8) 
Professional 28 16.2) 69(15) 1.09 0.7-1.7 1.20 0.73-1.1 
Partner ever 0.17 
treated for 
STI 
No/don't 168 454(98.7) 1 1 
know (97.1) 
Yes 5(2.9) 6(l. 3) 2.25 0.7-7.5 2.40 0.7-8.1 
Partner 0.42 
having extra 
marital sex 
No 129 352(76.5) 1 1 
(74.6) 
Yes 44 108 (23.5) 1.11 0.7-1.6 1.13 0.7-1.7 
(25.4) 
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4.4.3.1 Partners' occupation 
83.8% of partners of cases as against 85% controls were non-professionals. This 
included students, fanners, traders, artisans, drivers and the unemployed. 
Professionals, who included teachers, bankers, and lawyers, fon-ned 16.2% and 15% 
of cases and controls respectively. Partners' occupation was not significantly 
associated with infection. 
4.4.3.2 Past treatment for sexually transmitted infections (STI) 
Only 2.9% of cases and 1.3% of controls said they knew their partners had ever been 
treated for a sexually transmitted infection. The rest did not know whether this was 
the case . Past treatment for STI was not significantly associated with infection 
(p=O. 17) 
4.4.3.3 Extra marital sexual activities of Partner 
25.4% of cases and 23.5% of controls said their partners were cheating on them. This 
difference was not statistically significant (p=0.4). 
Again, none of the partner related factors were significantly associated with infection 
(Table 4.3). Even though the OR of a partner ever being treated for STI was 2.4 (age 
adjusted), this was not statistically significant (p=O. 17). 
4.4.4 Anogenital hygiene practices (Table 4.4). 
Devices used by the women to protect menstrual flow were; sanitary pad (46.2% 
cases, 37.1% controls), toilet roll (24.9% cases, 34.4% controls), clean washed 
folded cloth (21.9% cases, 24.4% controls) and cotton wool (7% cases, 4.1% 
controls). 52.6% and 54.7% of cases and controls respectively changed whatever 
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device they used twice in the day. While 44.5% cases and 43.5% controls changed 
more than twice in the day, 2.9% cases and 1.8% controls changed their devices only 
once in the day. Whilst the use of toilet roll compared to the commonly used sanitary 
pad seemed protective of infection (OR=0.58,95% Cl 0.4-0.9), the use of cotton 
wool was associated with infection (OR==1.64,95% CI 0.75-3.6) (Table 4.4). There 
was no significant association between how often the "devices" were changed and 
infection (p=0.7). 
After defecation, the women used toilet roll, paper other than toilet roll (newspaper 
mainly) or other device (dry corn cob, hand and water) to clean up. Toilet roll was 
used by 36.4% cases and 33.7% controls, other paper by 57.2% cases and 58.3% 
controls and other device by 6.4% and 8% cases and controls respectively. The use 
of any of these "sanitary aids" at defecation was not significantly associated with 
infection (p=0.4). 
80.3% of cases and 82.4% controls cleaned themselves from front to back (away ' 
from the vagina) after defecating. While cleaning from back towards the front 
(towards vagina) was done by 17.9% and 15.2% cases and controls respectively, 
cleaning in either direction was done by 1.8% of cases and 2.4% controls. The 
direction of cleaning was not significantly associated with infection (p=0.8) 
39.9% of cases and 45.7% controls did not wipe their genitalia after urinating. At 
p=0.21, wiping the genitalia after urinating was not significantly associated with 
infection 
Douching was practised by 13.3% of cases and 7.8% controls. Reasons for douching 
were to clear a vaginal discharge (47.8% cases, 73% controls), to feel clean generally 
(39.1% cases, 21.6% controls) and feel clean after menstruation and/or sexual 
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intercourse (13% cases, 5.4% controls). This practice was significantly associated 
with infection (OR=: 1.94,95%Cl 1.1-3.4, p==0.02) 
Table 4.4. Association between ano-genital hygiene practices and TV infection 
Variable Cases Controls Crude 95% CI Age 95% CI p (Age 
n (%) n (%) OR Adjuste adj usted 
d OR 
ILRT) Menstruation 0.02 
"device" 
Sanitary pad 80(46.2) 171(37.1) 1 1 
Toilet roll 43(24.9) 158(34.4) 0.58 0.4-0.9 0.58 0.4-0.9 
Folded cloth 38(21.9) 112(24.4) 0.72 0.5-1.1 0.77 0.5-1.2 
Cotton wool 12(7.0) 19(4.1) 1.35 0.6-3.0 1.64 0.75-3.6 
Number of 0.70 
times 
"device" - 
changed 
daily 
Once 5(2.9) 9(l. 8) 1.53 0.5-4.7 1.62 0.52-5.05 
More than 77(44.5) 200(43.5) 1.06 0.74-1.5 1.05 0.73-1.5 
twice 
Twice 91(52.6) 251 (54.7) 1 1 
Defecation 0.4 
hygiene 
Toilet roll 63(36.4) 155(33.7) 1 1 
Paper other 9957.2) 268(58.3) 0.90 0.62-1.3 0.79 0.5-1.1 
than toilet roll 
Other 11(6.4) 37(8.0) 0.73 0.35-1.5 0.69 0.3-1.5 
Direction of 0.8 
cleaning at 
defecation 
Front to back 139 379(82.4) 1 1 
(80.3) 
Back to front 31 17.9) 70(15.2) 1.20 0.7-1.9 1.10 
Either 3 (1.8) 11(2.4) 0.74 0.2-2.7 0.72 
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Wiping after 0.21 
micturition 
No 104 250(54.3) 1 1 
(60.1) 
Yes 69(39.9) 210(45.7) 0.78 0.5-1.1 0.79 0.5-1.1 
Douche 0.02 
No 150 424(92.2) 1 
(86.7) 1 
Yes 23 (13.3) 36(7.8) 1.80 1.0-3.1 1.94 1.1-3.4 
4.4.5 Factors relating to sex and sexually transmitted infections (STI) 
Age at initiation of sexual intercourse ranged 12-31 years with a median of 18 years. 
There was no association between age at initiation of sexual intercourse and 
infection. 
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Table 4.5. Association between variables relating to sex and STI and TV infection. 
Variable Cases Controls n(%) Crude 95% CI Age 95% CI p (Age 
n(%) OR Adjusted 
OR adj uste 
d, LRT) 
Age at first 0.93 
sexual 
intercourse 
(years) 
<19 150 410(89.1) 1 1 
(86.7) 
>=19 23 (13.3) 50 (10.9) 1.25 0.74-2.1 0.97 0.5-1.7 
Time since 0.005 
last sexual 
intercourse 
Within 2 93 (53.8) 308 (66.9) 1 1 
weeks 
Over two 
weeks 80 (46.2) 152 (33.1',., L74 1.68 1.1-2.4 
Vaginal 0.001 
discharge 
symptom 
No 71(41) 262(57) 1 1 
Yes 102(59) 198(43) 1.90 1.3-2.7 1.80 1.2-2.6 
0.93 
Vuval itch 
No 119 326(70.9) 1 1 0.66-1.45 
(68.8) 
Yes 54(31.2) 134(29-1) 1.10 0.7-1.6 0.98 
Dysuria 0.4 
No 148 388(84.4) 1 1 
(85.5) 
Yes 25(14.5) 72(15.6) 0.91 0.55-1.5 0.83 0.5-1.3 
0.006 
Past 
treatment for 
vaginal 
discharge 
No 147 (85) 425 (92.4) 1 1 
Yes 26(15) 35(7.6) 2.10 1.25-3.7 2.20 1.2-3.8 
0.5 
Genital ulcer 
symptom 129 
No 152 1 1 
(87.9) 398(86.5) 
53.8% and 66.9% of cases and controls respectively had had their last intercourse 
within 2 weeks of being enrolled into the study. The rest had had their last sexual 
intercourse more than 2 weeks before interview. 
Significantly more cases (59%) than controls (43%) had symptomatic vaginal 
discharge on questioning (p=0.001). While 31.2% of cases complained of a vulval 
itch, this was so for 29.1 % of controls. Symptomatic genital ulceration was alluded 
to by 12.1% and 13.5% cases and controls respectively. Dysuria was complained of 
by 14.5% cases and 15.6% controls. On past treatments for vaginal discharge, 15% 
cases as against 7.6% controls admitted such treatments. 
Table 4.5 shows the associations between infection and variables related to sex and 
sexually transmitted infections. A presenting symptom of vaginal discharge was 
strongly associated with infection (OR 1.80.95%Cl 1.22-2.6, p=0.001), as was past 
treatment for vaginal discharge (OR 2.20, p=0.006). Women whose last time of 
having intercourse was more than 2 weeks before being seen at the clinic, were 
significantly more likely to have TV infection than those who had had sex within 2 
weeks of being seen (OR 1.68, p=0.005). Age at initiation of sexual intercourse, and 
STI related symptoms such as genital itch, and genital ulcer were not significantly 
associated with TV infection. 
4.4.5.1 Sexual practices 
Questions on sexual practices included oral and anal sex from partners and the 
practice of women lubricating their vaginas with saliva prior to penetration due to 
vaginal dryness. 18.6% of cases and 16.1% controls reported receiving oral sex from 
their partners. 4% of cases and 5.7% controls had anal intercourse with their partners. 
Due to problems of vagina dryness, 11.6% and 13.5% of cases and controls 
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respectively lubricated their vagina with saliva either themselves or from their 
partners. 
Both oral and anal sex from the participants' partners were not significantly 
associated with infection , just as was whether or not they lubricated their genitalia 
with saliva prior to intercourse (Table 4.6). 
Table 4.6 Association between sexual practices and TV infection. 
Variable Cases Controls Crude 95% CI Age 95% Cl p (Age 
n(%) n(%) OR Adjuste adj usted 
d OR 9LRT) Lubricating 0.67 
vagina with 
saliva during 
sexual 
intercourse 
No 15(88.4) 398 (86.5) 1 
Yes 20(11.6) 62 (13.5) 0.83 0.5-1.4 0.89 0.5-1.5 
Oral sex 0.43 
from 
partner 
No 142 (82) 386 (83.9) 1 1 
Yes 31(18.6) 74 (16.1) 1.13 0.7-1.8 1.20 0.7-1.9 
Anal sex 0.43 
with partner 
No 166 (96) 434 (94.3) 1 1 
Yes 7(4) 26(5.7) 0.70 0.3-1.6 0.71 0.3-1.7 
4.5 Multivariate analysis 
To determine which of these factors best predicted women most likely to have TV 
infection,, a logistic regression analysis allowing for adjustment of all factors 
associated with infection at p<=O. I was performed in 2 stages. First a composite 
model was built by fitting variables from all categories. A final model was then fitted 
by adjusting for all variables in the composite model. 
Socio-demographic variables selected for multivanate analysis were; age, 
educational status, ethnicity, marital status and religion. "Devices" used to protect 
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menstrual flow and douching were the ano-genital hygiene variables selected. 
Factors relating to sex and sexually transmitted infections , including self report of 
symptomatic vaginal discharge, past treatment for a vaginal discharge and time since 
last sexual intercourse were also put in the multivariate model. None of the variables 
studied under partner related factors, maternal factors and sexual practices attained 
significance at p<=O. l when adjusted for age and so were not included in model 
(Table 4.7). 
Table 4.7. Multivariate analysis of factors predictive of TV infection 
Variable Adjusted OR* 95% CI P (LRT) 
Age (years) 0.005 
>=30 1 
25-29 1.09 0.6-1.8 
20-24 1.47 0.8-2.4 
<20 3.45 1.6-7.1 
Educational status 0.04 
None 
Primary 0.59 0.3-1.2 
Junior secondary 0.71 0.4-1.3 
>Junior secondary 1.35 0.7-2.7 
Ethnicity 0.007 
Akan I 
Northerner 1.04 0.5-2.0 
Other 3.13 1.5-6.0 
Marital status 0.04 
Monogamous I 
Polygamous 1.50 0.7-3.0 
Single 3.02 1.1-8.1 
Religion 0.08 
Christian I 
Moslem 0.66 0.35-1.2 
No religion 3.36 0.8-13.5 
"Device" for 0.04 
menstruation 
Sanitary pad 1.00 
Toilet roll 0.57 0.4-0.9 
Folded cloth 0.80 0.5-1.4 
Cotton wool 1.50 0.7-3.4 
Douche . 0.02 
No 1.0 
Yes 2.0 1.1-3.6 
132 
Symptomatic 0.003 
vaginal discharge I 
No 1.78 1.2-2.6 
Yes 
Past treatment for 0.12 
vaginal discharge 
No I 
Yes 1.63 0.9-3.0 
Time since last 0.007 
sexual intercourse 
Within 2 weeks I 
Over 2 weeks 1.71 1.1-2.5 
* adjusted tor all vanables in table 
In multivariate analysis (Table 4.7), young age i. e. less than 20 years, neither being 
Akan nor Northerner (the predominant ethnic groups in Ashanti) (OR=3.0, 
95%CI=1.5-6.5), and being single (OR=3.0,9% CI=1.1-8-1) were independently 
associated with infection. Having no religious faith was also independently 
associated with infection at borderline significance (OR=3.36,95% CI=0.8-13.5, 
P=0.08). 
When adjusted for other factors, the use of cotton wool appeared independently 
associated with infection (OR=1.50), whilst using toilet roll was protective of 
infection (OR=0.57). 
Even though educational status was associated with infection (p=0.04), there was no 
overall trend in the association. 
Also independently associated with infection were douching, symptomatic vaginal 
discharge, and if time between examination and last sexual intercourse was more 
than 2 weeks. Past treatment for vaginal discharge was not independently associated 
with infection on multivariate analysis (OR 1.6, CI=0.9-3.0, p=0.12). This was 
excluded from the model. 
Thus, the composite multivariate model covering all factors studied comprised the 
following factors; age, educational status, ethnicity, marital status, religion, sanitary 
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device used during menstruation, douching, complaining of a vaginal discharge, and 
having had sexual intercourse 2 or more weeks prior to being seen by study 
investigators. 
4.5.1 Final multiple logistic regression model 
The final model was reached after adjusting for all variables associated with 
infection at p<=O. I in the compodsite model, and removing factors no longer 
statistically significant (Table 4.8); 
Table 4.8. Final multiple logistic regression model of factors independently 
associated with TV infection (* adjusted for all variables in final model) 
Factor *Adjusted OR 95% CI p(LRT) 
Age 0.001 
>=30 1 
25-29 1.04 0.6-1.7 
20-24 1.33 0.8-2.2 
< 20 years 3.36 1.5-7.1 
Ethnicity 
Akan 1 0.008 
Northerner 0.92 0.4-1.7 
Other 3.18 1.4-6.8 
Religion 0.03 
Christian 1 
Moslem 0.61 0.31-1.18 
No religion 4.45 1.0-19.1 
"Device" for 0.02 
menstruation 
Sanitary pad I 
Toilet roll 0.53 0.3-8.5 
Folded cloth 0.76 0.4-1.3 
Cotton wool 1.53 0.6-3.5 
Douche 0.05 
No I 
Yes 1.84 1.0-3.37 
Vaginal discharge 
symptom 0.003 
No I 
Yes 1.78 1.2-2.6 
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Last sexual 0.007 
intercourse 2 or 
more weeks ago 
No 
Yes 1.71 1.1-2.5 
neing singie ýp=v. i /) was aroppect because it was no longer significantly associated 
with infection. Educational status was also dropped (p=O. 12) 
4.6 Deriving binary variables from factors independently predicting infection 
The possibility of using the variables independently associated with infection either 
singly or in combination in an algorithm fashion to predict TV infection in the study 
population was explored. To this end, binary variables for all the factors were 
derived, and their odds ratios for infection calculated. For devices used during 
menstruation, all devices except toilet roll use were deemed positively associated 
with infection. The use of toilet roll was protective of infection. Results are. shown in 
Table 4.9. 
Table 4.9. Odds ratios and 95%, Cl of generated binary variables predictive of TV 
infection 
Factor Adjusted Odds ratio* 95% Cl 
Age <20 years 3.10 1.7-5.5 
Ethnicity other than Akan 3.05 1.5-6.0 
or northemer 
No religion 4.97 1.2-19.8 
Douche 1.78 1.0-3.2 
No toilet roll use at 1.66 1.1-2.5 
menstruation 
Vaginal discharge 1.87 1.3-2.7 
symptom 
Last sexual intercourse 2 1.75 1.2-2.5 
or more weeks ago 
* adjusted for all other binary factors 
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4.7 Diagnostic values of factors independently associated with infection 
The sensitivity, specificity and predictive values of the factors independently 
predicting TV infection were calculated for the target population. As seen In Table 
4.10, sensitivities ranged between 3.7% -75.5%, and positive predictive values 5.6- 
18.4%. The highest sensitivity, 75.5%, was shown by the non-use of toilet roll for 
menstrual hygiene. This also had the least specificity (34.3%) 
Table 4.10. Diagnostic values of factors independently associated with TV infection 
Factor Sensitivity Specificity Positive 
predictive 
value (%) in 
target 
population 
Negative 
predictive 
value (%) 
in target 
population 
Age < 20 years 18.0 93.5 12.5 94.7 
Ethnicity other 
than Akan or 1 112 95.8 12.3 95.4 
Northerner 
No religion 3.7 99.1 18.4 95.1 
No toilet roll 75.5 34.3 5.6 96.4 
use at 
menstruation 
Douche 13.2 92.1 8.1 95.3 
Vaginal 59.0 56.9 6.6 96.3 
discharge 
symptom 
Last sexual 
intercourse 2 or 46.3 66.9 6.8 96.0 
more weeks ago 
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4.8 Binary scoring 
Two scoring systems - simplified and weighted systems, were developed. 
4.8.1 Simplified scoring system 
Sores of I and 0 were assigned to each of the 633 women depending on whether or 
not they had any of the factors independently associated with TV infection, with I 
for having the factor and 0 if it was absent, and the total score per subject calculated. 
A score of I for a subject meant they had only I of being of a young age, neither 
being Akan nor northerner, of no professed faith, not using toilet roll to protect 
menstrual flow, practicing douching, having sexual intercourse more than 2 weeks 
before being seen, and complainIng of a vaginal discharge. A score of 2 Indicates 
they had 2 factors etc. The maximum possible score with this system is 7. 
Distribution of the simple scoring system among cases and controls is shown in 
Table 4.11. Whilst the lower end of the scoring system (0-1) predominantly 
comprised controls, cases predominantly made up scores 3-6. Score 2 appeared 
evenly distributed amongst cases and controls. 
Table 4.11. Distribution of scores among cases and controls 
Score Cases Controls Total 
0 4(2.3) 53(11.5) 57 
1 35(20.2) 163(35.4) 198 
2 63(36.4) 165(35.9) 228 
3 56(32.4) 68(14.8) 124 
4 14(8.1) 11(2.4) 25 
6 1 (0.6) 0(0) 1 
Total 173(100) 460(100) 633 
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4.8.2 Weighted scoring system 
Weights given to variables independently associated with II ir infection depended on thei 
odds ratios for TV infection; I if OR =1-21,2 if OR =2-3,3 if OR = 3-4,, and 4 if OR 
= 4-5. These are as listed in Table 4.12. 
Table 4.12. Weighted scores depending on Odds ratios 
Factor Adjusted OR Weighted score 
Age < 20 years 3.10 3 
Ethnicity other than 3.05 
Akan or Northerner 3 
No religion 4.97 4 
Douche 1.78 1 
No toilet roll use at 1.66 1 
menstruation 
Vaginal discharge 1.87 1 
symptom 
Last sexual 1.75 1 
intercourse 2 or 
more weeks ago 
A maximum 14 scores is obtainable by a subject with this system. Table 4.13 shows 
the distribution of weighted scores among cases and controls 
Table 4.13. Distribution of weighted scores among cases and controls 
Score Cases Controls Total 
0 4(2.3) 53(11.5) 57 
1 32(18.5) 159(34.6) 191 
2 53(30.6) 146(31.7) 199 
3 30(17.3) 49(10.6) 79 
4 13(7.5) 22(4.8) 35 
5 28(16.2) 22(4.8) 50 
6 10(5.8) 8(1.7) 18 
7 1(0-6) 1(0.2) 2 
9 1(0.6) 0(0) 1 
13 1 (0.6) 0(0) 1 
Total 173(100) 460(100) 633 
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Mirroring the simple scoring system is the predominance of controls among the 
lower scores (0-2). 9% of the 633 participants did not register any score. 
4.9 Diagnostic value of scoring systems in study population 
Using each score as a cut-off point, the sensitivity, specificity and predictive value of 
a positive score for the selection of a woman with T vaginalis infection was 
determined (Table 4.14). The percentage of women in the study population who 
would have been selected for screening and/or treatment identified by each cut-off 
score was also calculated. 
Table 4.14. Diagnostic value of simplified scoring system 
Cut-off Sensitivity Specificity Positive Negative Women in 
score predictive predictive study 
value (%) in value population 
target in target selected 
population population n=3807 
>=1 97.7 11.5 5.4 99.0 3386 
(88.9) 
>=2 77.6 46.9 7.0 97.6 2066 
(54.3) 
>=3 40.9 82.8 11.0 96.4 699(18.3) 
>=4 8.5 97.5 15.5 95.3 103(2.7) 
6 0.5 100 100 95.0 1(0.03) 
Sensitivity of the cut-off scores in the simplified system for the diagnosis of TV 
infection decreased with increasing scores. The proportion of subjects with various 
combined scores who would have Trichomonas vaginalis infection as per the gold 
standard test (positive predictive value) increased with increasing combined scores. 
The highest positive predictive value was attained when subjects had a score of 6. 
This would have meant a selection of only I out of 3807 women in the population for 
treatment or screening. The combination with the greatest sensitivity (97.7%) had a 
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positive predictive value of only 5.4%. With this cut-off, up to 89% of the study 
women would be selected for screening/treatment. 
As in the simplified system, the sensitivity of each cut-off point for TV diagnosis 
decreased with increasing weighted scores (Table 4.15). The positive predictive 
values increased likewise. The highest PPV achieved with higher scores selected 
only up to 2 subjects for the desired objectives. In similar vein to the simplified 
system, the combination with the greatest sensitivity (score >=I) had the lowest PPV 
(5.4%) and selected the majonty of women (88.9%). 
Table 4.15. Diagnostic value of weighted scoring system 
Cut-off 
score 
Sensitivity Specificity Positive 
predictive 
value (%) in 
target 
o ulation 
Negative 
predictive 
value 
in target 
population 
Women in 
study 
population 
selected 
n=3807(%) 
> ='I 97.7 11.5 5.4 98.8 3386(88.9) 
>=2 79.2 46.0 7.0 97.7 2100 (55.1) 
>=3 53.2 77.8 11.0 97.0 903(23.7) 
>=4 31.3 88.4 12.3 96.1 476(12.5) 
>=5 23.9 93.2 15.6 95.9 289(7.6) 
>=6 7.4 98.0 16.5 95.3 85(2.2) 
>=7 1.6 99.7 27.2 95.1 11 (0.3) 
>=9 1.0 100 100 95.1 2(0.05) 
13 0.5 100 100 95.0 1(0.03) 
For both scoring systems, the combination of variables independently associated with 
infection was good at ruling in infection with the higher scores (4-6 simplified 
system, 5-13 weighted system) but poor at ruling out infection, as expected in this 
low TV prevalent population. 
Distribution of scores among TV symptomatic and TV asymptomatic subjects in the 
case-control cohort was examined (Table 4.16 and Table 4.17). Within each score 
band (for those registering 2 or more scores in the simplified system and score 2-6 in 
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weighted system), there were significantly more symptomatics than asymptomatics 
(p<0.0001). Asymptomatic cases represented the majority registering I score or less. 
Thus, patients were more likely to be symptomatic for TV infection if they had a 
combined score of 2 or more and asymptomatic if their combined score was less than 
2. 
Table 4.16. Score distribution among case-control women symptomatic and 
asymptomatic for TV infection (with simplified scoring system) 
Score Symptomatic n (%) Asymptomatic 
n(%) 
Total 
0 3 (5.3) 54(94.7) 57(100) 
1 65 (32.8) 133(67.2) 198(100) 
2 136(59.6) 92(40.4) 228(100) 
3 109(87.9) 15(12.1) 124(100) 
4 
6 
24(96.0) 
1 (100) 
1(4.0) 
0(0) 
25(100) 
1 (100) 
Total 338 295 633 
Table 4.17. Score distribution among case-control women symptomatic and 
asymptomatic for TV infection (with weighted scoring system) 
Score Symptomatic n (%) Asymptomatic 
n(%) 
Total 
0 3(5.2) 54(94.8) 57(100) 
1 64(33.5) 127(66.5) 191(100) 
2 129(64.8) 70(35.2) 199(100) 
3 72(91.9) 7(8.9) 79(100) 
4 17(48.6) 18(51.4) 35(100) 
5 35(70.0) 15(30.0) 50(100) 
6 15(83.3) 3(16.7) 18(100) 
7 1 (50.0) 1(50.0) 2(100) 
9 1(100) 0(0) 1(100) 
13 1 (100) 0(0) 1 (100) 
Total 338 295 1 633 
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For scores with observations, the odds ratio of being symptomatic increased with 
increasing score for both the simplified (OR 3.92,95% CI 3.0-4.9, p<0.001) and 
weighted systems (OR 1.75,95%Cl 1.5-2.0, p<0.001). 
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4.10 DISCUSSION: DEMOGRAPHIC AND BEHAVIOURAL PREDICTORS 
OF INFECTION IN PREGNANT WOMEN 
Reported prevalence rates of Tvaginalis infection in pregnancy vanes between 3- 
48% 306,307,308 
. The wide range could be due to differences in study population, 
geographic areas and importantly, the diagnostic criteria used. The 4.9% prevalence 
obtained in this study by the expanded gold standard test mirrors closely that found 
in the neighbouring West African country, Benin, where the prevalence rate in 
women in the general population is 3.2% by TV culture test. In general, prevalence 
rates of all STIs in West Africa are much lower than found in Eastern and Southern 
Africa. 
It is estimated that 25-50% of women positive for Tvaginalis do not have any 
symptoms 
1 0", 05,110. The presence of infection is usually established in many centres 
by the saline wet prep method, a test which detects infection only in approximately 
65% of infected women 1 
96,197 
. Culture, the most sensitive diagnostic test for TV 
infection is not cost effective as a screening procedure. It would therefore be of 
benefit to identify factors that could predict women at greatest risk of Tvaginalis 
infection. Such factors would be particularly useful in identifying subgroups of 
women to screen with the most sensitive test, and in settings where no laboratory 
testing can be done, in treating women most likely to have infection. 
The objective of this part of the study was to determine such soclodemographic, 
maternal, and partner related factors associated with TV infection. It was also to 
detennine the association between infection and factors related to ano-genital 
hygiene, sexual practices and sex and sexually transmitted infections. These factors 
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would aid the selection of subjects either for screening for infection or treatment of 
infection. 
Key findings were the association of certain factors independently with infection. 
These were; young age (less than 20 years), being of neither Akan nor Northern 
ethnicity, and not of the Christian or Moslem faith. Douching, having a vaginal 
discharge and not having had sexual intercourse recently were also independently 
associated with infection. A complex relationship was observed for devices used to 
clean up menstrual flow; compared to using the sanitary pad (commonest device 
used by study population), the use of cotton wool was associated with infection, 
while using toilet roll was protective of infection. This is difficult to explain. 
In many studies on the epidemiology of female trichomoniasis, one demogTaphic 
factor that has differed from that observed in other sexually transmitted infections 
has, been age. Trichomoniasis has been associated with increasing age, unlike 
gonorrhoea and Chlamydia infection 
65,116,309 
. This present study 
however found ar: 
association between younger age and infection, and concurs with that found in the 
four city study, where trichomonas infection decreased with increasing age in all 
cities except Yaounde 10. Young age (<20 years) in Ndola, Zambia remained 
independently associated with infection on multivariate analysis. 
Unlike in Ndola where there was an inverse relationship between TV infection and 
increasing years spent in formal education (also seen in Zimbabwe 
116), this 
association was not very clear in the Kumasi population where the odds ratio of 
infection seemed to increase for those being educated for 12 or more years compared 
to no education, and decrease for those educated less than 12 years compared to the 
uneducated. Education in Ghana for more than 12 years implies some amount of 
tertiary education. It is possible that such women could have been married to men 
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with the same kind of education or even better. With more earning power, these men 
could have multiple partners from whom they acquire STIs and subsequently pass 
this on to their spouses. When adjusted for other variables independently associated 
with infection, educational status of the Kumasi women was not significantly 
associated with infection (p=O. 12). In consonance with other sexually transmitted 
infections,, women not married were at increased risk of TV infection 315 . In this 
population, this did not reach statistically significant levels when controlled for 
factors independently predicting infection. 
Can religion with its moral teachings protect against acquisition of sexually 
transmitted infections? In this study, not professing any faith was associated with 
over 3 times the odds of infection and was also predictive of infection, reaching 
statistical significance (p=0.003) when controlled for other factors independent of 
infection. However the numbers involved are small. - 
It has been suggested that ano-genital hygiene could be associated with the risk of 
TV infection 100. In attempting to look at the role of menstrual hygiene in this 
respect, the use of various devices in protecting menstrual flow was examined. A 
complex relationship ensued. The use of toilet roll and clean cloth was protective of 
infection (OR=0.6 and 0.8 respectively) compared to the sanitary pad, whilst using 
cotton wool was associated with infection (OR=1.5), all at a statistically significant 
level (p=0.04). This is difficult to explain. 
The practice of douching has been reported to be associated with 
HIV infection and 
other STDs in many studies 
310 , 311,312, 
. Myer et al reported recently 
from South 
Africa that women who douched were significantly more likely to show evidence of 
trichomoniasis than those not douching (p=0.03) 
313 
. In 
Ghana, the practice of 
douching generally refers to the use of any substance within the vagina either by 
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insertion or washing. Such substance can include water alone, water with added 
chemicals, soap, herbs, or chemicals in rock forin eg saltpetre. In this Kumasi study, 
douching was significantly associated with infection (OR=2.0, CI=1.1-3.6, p=0.02), 
and was an independent predictor of infection. Douching in Ghana is practiced for 
several reasons including for general genital hygiene. There have been anecdotal 
reports that in situations when abrasive herbs and detergents have been used, a 
detrimental effect on the health of the woman has ensued. These have included 
vaginal stenosis and the introduction of infection into the vagina. In recent times 
health education messages given to women have stressed the self cleansing nature of 
the vagina and the risks in douching. It is thought that as a practice, douching is 
losing its proponents and younger women are abandoning the practice. Further 
research on the practice and its effects on reproductive health would better clan y the 
situation. 
Also for poor ano-genital hygiene, the study looked at the possible role of the 
direction of cleaning the ano-genital area after defecation. It was hypothesised that if 
rectal trichomonads were involved in the aetiology of vaginal trichomoniasis, then 
cleaning the anogenital area after defecation from the anus towards the vagina (back 
to front) could introduce rectal trichomonads into the vagina and this would increase 
rates of trichomoniasis in those involved in this practice. This practice however was 
reported by only a few study participants and no such association was observed. 
In this population of women studied, past treatment for a vaginal discharge even 
though significantly associated with infection, was not an independent predictor of 
ictive of infection. infection when adjusted for other factors predi II 
The diagnostic values of all factors predicting TV infection was poor. Even the 3 
strongest predictors of infection, age less than 20 years, no religion and being of an 
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ethnic group other than the predominant groups in the study area, had poor 
sensitivities (3.7%-18.0%), and positive predictive values (12.3%-18.4%). Cotch and 
colleagues studying over 13000 pregnant women in the US have found similarly that 
demographic and behavioural factors predictive of TV infection were poor at 
selecting those who would be at high risk for infection. In their study, the 
sensitivities of the predictive factors smoking, black race and single marital status for 
TV infection were 42%, 68% and 75% respectively. However the positive predictive 
values for infection were 17.6%, 2.4% and 16.7% respectively 76 
All the variables independently predictive of infection were used in the definition of 
scores to determine the diagnostic value of a combination of such scores. Two 
scoring systems were investigated, one giving a unitary score for the presence of 
factors predicting infection, and the other, a weighted score depending on the odds 
ratio for infection of the factors. In generai, both systems had poor predicLI-ve values 
for TV infection in the study population. 
Even though the sensitivity of a score of I or more combinations for trichomoniasis 
was 97.7% using both scoring systems, the proportion of women who had this 
score(s) and who had trichomoniasis was only 5.4%. However, as many as 88.9% 
(3386 out of 3807) of women would have been selected for screening/treatment. This 
would not be cost effective. There would be significant over-treatment of the 
uninfected with cost implications, and worry over possible unwarranted adverse drug 
effects and antimicrobial resistance development. Similar sentiments have been 
expressed with the use of the syndromic approach for the management of cervicitis in 
populations with a low prevalence of sexually transmitted cervical infections 
314 
. 
Having high scores (6 in the simplified system, and 9 or more in weighted system) 
produced excellent predictive values. However in this population, a maximum of 2 
147 
out of the 3807 women would have been selected for testing and/or treatment, thus 
leaving out many infected women who would need treatment 
In tenns of good predictability for the selection of women most likely to be at risk 
for TV infection, there is not much to choose between the 2 scoring systems. Though 
the simplified system, needing less calculations would be easier to apply in a field 
setting, its outcome for the selection of infected women is minimal. 
Women who were syTnptomatic for TV infection had significantly higher scores 
using both scoring systems than those asymptomatic. This unfortunately does not 
help the selection of those infected as a large proportion (38%) of the infected 
women were asymptomatic. 
Although the variables identified as predictive of TV infection present a general 
profile of the women most likely to be infected with TV in this studv, in such a low 
TV prevalent population, the utility of these variabl6s as a basis for the selection of 
women for screening for TV or treatment is minimal. 
One reason for the poor positive predictive values with these variables for 
trichomonas infection could be that individual factors such as complaint of vaginal 
discharge, young age, and douching have also been recognised with other 
reproductive tract infections in women,, and alone would be poor predictors of TV 
infection. As these other infections were not controlled for in this study, it is difficult 
to judge their relative contributions. 
Studying the relationship between socio-demogaphic, sexual behaviour and physical 
examination variables and TV infection among family planning clients in Kenya, 
Dally et al identified factors including unmarried status, more than I sexual partner 
in the past year, and vaginal discharge to be predictors of infection. Combinations of 
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these factors however, were poor at predicting infection and hence the selection of 
clients for testing for TV 315 
Only 2.3% (4/173) of the women testing positive for tnchomoniasis did not fit any of 
the factors used in calculating the scores. This confinns the usefulness of the factors 
in ruling in infection. 
Even though highly desirable, the unavailability of facilities and personnel and the 
cost of microbiological screening of vaginal trichomoniasis and other sexually 
transmitted infections in many developing countries including Ghana, currently 
precludes the use of the laboratory for the identification of STD related pathogens. In 
low STD prevalent settings, also with low prevalence of risk factors associated with 
vaginal/cervical infections, the development of treatment algorithms which could 
predict infection based on these risk factors for their empirical and/or syndromic 
management is next to impossible. A recent study from Ghana reported the 
prevalence of gonorrhoea and chlamydia infection at - 1.5% and 0% respectively in 
non high risk women in the general population 316 . The present study has also 
highlighted the difficulty in identifying epidemiological factors that could predict TV 
infection. In such a population, the rational approach to management of vaginal 
discharge would be the identification of those infected through microbiological 
screening. With present laboratory tools for the diagnosis of TV and other STDs 
being relatively technologically demanding and not being affordable or with poor test 
performances, the need for cheaper alternatives is paramount. 
4.11 Limitations to the Study 
Inter-obseirver variability may bias any study if different study subjects are seen by 
different interviewers. The study tried to avoid or reduce this variability by pre-study 
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training of interviewers, "quality controlling" their work as detailed in Section 3.5, 
and also blinding them to the case/control status of the study participants. 
Nonetheless subjectivity in interpreting some of the responses of study subjects can 
not be ruled out. 
Responses to aspects of the questionnaire examining sexual practices of the women 
(oral and anal sex) and their partners' fidelity, especially in face to face interviews as 
used in this study may not have been correctly given. Not only is it commonplace in 
many African societies for women to want to profess to society nornis (that their 
partners are not seeing other women), they also believe it is an indictment on them 
personally and their marriage if their partners are seeing other women and so would 
not admit to it. 
It is not unusual for women not to know ývhether -or not their spouses have been 
treated for STIs in the past. Probably on the contrary, many men would not divulge 
this to their spouses. A difficulty for women in answering this could bias their 
responses. 
The study could also suffer from recall bias as in all questionnaire based studies 
where responses rely on recalling past events. 
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5.0 RESULTS: CLINICAL CORRELATES OF VAGINAL 
TRICHOMONIASIS IN PREGNANT WOMEN 
Clinical variables elucidated on genital examination were studied for their 
associations with Tvaginalis infection. The parameters examined were; presence of 
ý11 abnormal vaginal discharge, yeast-like discharge, offensive vaginal odour, the 
amount o ischarge, colour of discharge and pH of the discharge. Vulva erythema, 
colpitis macularis (strawberry cervix), and faecal staining of the perineurn were 
looked for. 
Circumcision status of the women was checked and the amine test performed on 
vaginal discharges. As in the previous study all analyses were age adjusted for 
similar reasons. 
A Gram stain also was done from one of the vagina swabs and Nugent's scoring 
criteria for the diagnosis of Bacterial . vaginosis 304 detennined. Using characteristics 
of the discharge, and clue cell results from above, the diaposis of Bacterial 
vaginosis by Amsel's criteria 176 was also carried out. 
5.1 Univariate and age-adjusted analysis of associations between Clinical 
parameters and Trichomonas vaginalis infection (Table 5.1) 
Forty-three out of the 173 cases (24.9%) had an abnormal vaginal discharge, 
compared with the 13.1% of controls (p=0.001). A yeast-like discharge was found in 
17.9% cases and in 9.8% controls (p=0.01). An offensive vaginal odour was present 
in 12.1 % cases and 8.7% of controls (p=0.26). 
The amount of vaginal discharge observed was categorised as normal (no obvious 
discharge seen), discharge seen within the vagina only and discharge seen at the 
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introitus/externally. In 76.3% of cases and 87.6% controls, no obvIous discharge was 
seen. Discharge was seen within the vagina of 21.4% cases and 9% controls. 
Extemally observed discharge (or at introitus) was reported from (2.3%) cases and 
(3.5%) controls. The amout of vaginal discharge was significantly associated with 
infection (p=0.004). 
While 78.6% of cases had a non-nal coloured discharge (absent or colourless), this 
was the case for 89.6% of controls. A whitish, greyish, yellowish or greenish 
discharge was seen in 20.2% cases and 10.2% controls. The discharge was blood 
stained in 2 cases and I control respectively. An abnon-nally coloured (non-clear) 
discharge was significantly associated with infection (OR 2.19,95%C1 1.3-3.5, 
P=0.001). 
A reddened vulva was observed in 3 (1.7%) cases and none of controls, whilst the 
pathognomonic sign of strawberry cervix was seen in 6 (3.5%) of cases and no 
controls. 
There was no faecal staining of the penneum of any case. This was seen in only I 
woman in the control group. 
73.4% of cases and 82.4% of controls had a vaginal pH up to 5. Vaginal pH>5 was 
found in 26.6% of cases and 17.6% of controls. This (pH>5) was significantly 
associated with infection (OR 1.72,95% Cl 1.1-2.6, p=0.01). 
Circumcision was not significantly associated with infection (OR=0.8,95%CI 0.3- 
2.7, p=0.8). Of the circumcised, type I circumcision (only tip of clitoris cut) was 
observed in 4 cases (100%) and 11 controls (91.67%) whilst type 3 (excision of 
clitoris and part of labia) was observed in 1 control alone (8.3%). 
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A positive amine test was observed in 30% of cases and 22% of controls. This was 
associated with infection at borderline significance (OR 1.43,95%C1 0.95-2.1, 
p=0.08) 
By Amsel's criteria, 85.6% cases against 91.7% controls had bacterial vaginosis, 
whilst in using Nugent's criteria 83.8% cases as against 84.7% controls had bacterial 
vaginosis. Whilst the diagnosis of bacterial vaginosis by Amsel's criteria was 
significantly associated with TV infection (OR=1.78,95%Cl 1.0-3.2, p=0.04), 
diagnosis by Nugent's scoring system was not significantly associated with infection 
(OR=0.99 Cl 0.6-1.6, p=0.9). 
Table 5.1. Crude and age-adjusted analysis of association between TV infection and 
various clinical criteria on genital examination 
Variable Cases Controls Crude 95% CI Age 95% CI 
n (%) n (%) OR adjusted 
OR 
Abnormal 
vaginal 
discharge 
No 130 400 1 1 
(75.1) (86.9) 
Yes 43(24.9) 60(13.1) 2.20 1.4-3.4 2.10 1.3-3.2 
Yeast-like 
discharge 
No 142 415 1 1 
(82.1) (90.2) 
Yes 31(17.9) 45(9.8) 2.01 1.2-3.3 1.92 1.1-3.1 
Offensive 
vaginal 
discharge 
No 152 420 1 1 
(87.9) (91.3) 
Yes 21(12.1) 40(8.7) 1.45 0.8-2.5 1.39 0.7-2.4 
Amount of 
discharge 
Nonnal 130 400 1 1 
(76.3) (87.6) 
Within vagina 37(21.4) 41(9) 2.75 1.7-4.5 2.66 1.6-4.3 
At introitus 4(2.3) 16(3.5) 0.76 0.25-2.3 0.66 0.2-2.1 
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Colour of 
discharge 
Nonnal 136 412 1 1 
(clear) (78.6) (89.6) 
White/ ev/ gr , 
37(20.2) 48(10.2) 2.33 1.4-3.7 2.19 1.3-3.5 
Yellow/green 
pH>5 
No 127 379 1 1.1-2.5 1 
(73.4) (82.4) 
Yes 46(26.6) 81 (17.6) 1.69 1.72 1.1-2.6 
Circumcision 
No 169 448 1 1 
(97.7) (97.4) 
Yes 4(2.3) 12(2.6) 0.80 0.3-2.7 0.80 0.3-2.7 
Amine test 
Negative 121 (70) 359(78) 1 1 
Positive 52(30) 101(22) 1.52 1.0-2.2 1.43 0.95-2.1 
Bacterial 
vaginosis 
(Amsel) 
No 25 (14.4) 38 (8.3) 1 1 
Yes 148 422 . 1.88 1.0-3.2 1.78 1.0-3.1 
(85.6) (91.7) 
Bacterial 
vaginosis 
(Nugent) 
No 28(16.1) 70(15.2) 1 1 
Yes 145 390 0.92 0.57-1.50 0.99 0.6-1.6 
(83.8) (84.7) 
5.2 Multivariate analysis 
Due to co-linearity between abnonnal vaginal discharge and variables such as yeast- 
like discharge, increased quantity of discharge, white/grey/yellowish/geenish 
discharge, only abnonnal vaginal discharge, discharge pH>5, and amine test were 
entered into the multivariate model. 
On multivariate analysis, only abnonnal vaginal discharge (OR=1.8, p=0.005) and 
pH >5 (OR=1.5, p=0.05) remained independently associated with infection. Table 
5.2 shows the final multiple logistic regression model. 
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Table 5.2. Final multiple logistic regression analysis of Clinical factors associated 
with TV infection 
Variable Adiusted OR 95% CI p 
Abnormal 0.005 
vaginal 
discharge 
No I 
Yes 1.87_ 
pH >5 0.05 
No I 
Yes 1.50 
Amine test 0.7 
Negative I 
Positive 1.09 1 0.7-1.7 
5.3 Diagnostic value of factors predictive of infection 
The sensitivity, specificity and predictive values of the factors independently 
predicting TV infection were calculated for the target population. As shown in Table 
24, individually, each of the factors predictive of TV infection had a poor positive 
predictive value for infection in the study population (Table 5.3). 
Table 5.3. Diagnostic value of clinical factors independently predictive of TV 
infection 
Factor Sensitivity Specificity Positive Negative 
predictive predictive 
value in target value in target 
population population 
Abnormal 25.0 86.9 9.0 95.7 
vaginal 
discharge 
pH >5 26.6 82.4 7.3 95.6 
5.4 Binary scoring 
Sores of I and 0 were assigned to each of the women examined in respect of whether 
or not there was the presence of any of the clinical parameters independently 
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associated with TV infection, with I for the presence of the factor and 0 if it was 
nil absent. Total score per subject was calculated. A score of I for a subject meant they 
had only one out of the 2 factors independently associated with infection etc (Table 
5-4). A maximum score of 2 is the maximum score attainable. 
Distribution of scores among cases and control cohort is shown in Table 5.4. 
Table 5.4. Score distribution among cases and controls. 
Score Cases (%) Controls Total 
0 104(60.1) 33773.2) 441 
1 49(28.3) 105(22.8) 154 
2 20(11.6) 18(3.9) 38 
Total 173(100) 460(100) 633 
About 60% (104/173) of women with trichomonlasis did not have any of the 
parameters independently predicting infection. While 39.9% of cases (69/173) had 
one or both of the 2 factors associated with infection, this was the case for 26.7% of 
controls. 
5.5 Diagnostic value of scoring system 
Cut-off score points from the combination of scores, was used to calculate the 
sensitivity, specificity and positive predictive value for the selection of patients with 
T. vaginalis infection (Table 5.5). Calculation of the diagnostic values was adjusted 
for all women in the study population. The number of women selected for each cut- 
off point is also shown. 
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Table 5.5. Diagnostic value of cut off combination scores of Clinical factors 
Cut-off Sensitivity Specificity Positive Negative Number of 
score predictive predictive women 
value in value in selected in 
target target study 
population population population 
(%) (%) n=380 
39.9 73.2 7.1 95.9 1043(27.4) 
2 11.7 96.0 13.4 95.4 164(4.3) 
The clinical utility of these scores is limited for the selection of patients with 
trichomoniasis. For subjects with scores, the highest sensitivity was 39.9% and the 
highest positive predictive value of a score was 13.4%. Though the proportion of 
subjects with various combined scores who would have Trichomonas vaginalis 
infection (positive predictive value) increased with increasing combined scores, the 
percentage of women in the population who would have been selected for treatment 
or screening based on these scores decreased with increasing score. The combination 
with the greatest sensitivity if a score was recorded (39.9%) suggests that women 
who have at least 1 of the 2 variables scored should be selected; this subgroup 
represented 27.4% of the study population. 
The use of the parameters in ruling in disease was good for scores of 2 (96%) but 
poor for the presence of only I factor (73%). 
Table 5.6. Score distnbution among women in the case-control cohort who were 
symptomatic and asymptomatic for TV infection 
Score Symptomatic 
n(%) 
Asymptomatic 
n(%) 
Total 
205(46.9) 236(53.5) 441(100) 
98(63.6) 56(36.4) 154(100) 
2 35(92.1) 3(7.9) 38(100) 
Total 338 295 633 
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Significantly more symptomatic women had scores (1 or 2) compared to 
asymptornatics (p<0.0001). The odds ratio of being symptomatic with a score was 
2.48 (95% Cl 1.8-3.3, p<0.0001). 
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5.6 DISCUSSION: CLINICAL CORRELATES OF VAGINAL 
TRICHOMONIASIS IN PREGNANT WOMEN 
As a sequel to the identification of epidemiological factors for the prediction of TV 
infection, this part of the study was undertaken to identify clinical parameters that 
could also predict infection with the same aim as previously Le for the selection of 
subjects for screening and /or treatment of infection. 
There have been conflicting reports of the association between trichomoniasis and 
signs of abnon-nal vaginal discharge. Studying high risk populations, Spence et al 224 
and Fouts and Kraus 101 did not find this association. However, McLelan et al 91 and 
Wolner-Hansen et al 317 reported finding this association in similar populations 
at-tending STI clinics. Importantly in all these studies has beer, the different definition 
for abnon-nal vaginal discharge used. This has meant various combinations of 
increased quantity, frothiness, colour, offensive odour and itch. Different 
combinations used in different studies could alter associations. In this present study, 
a more liberal definition encompassing one or more of the above signs was used. A 
significant association was detected between infection and abnonnal discharge. On 
testing associations between these individual constituents of abnonnal discharge and 
TV infection, all but offensive vaginal odour remained significantly associated with 
infection. An offensive vaginal odour, though not significantly associated with TV in 
this study (p=0.2), has been significantly associated with TV in other studies 317 . 
In this study, a yeast-like discharge was documented more frequently in women with 
trichomoniasis (OR=2). The finding of co-infections with multiple reproductive tract 
pathogens is not unusual, and especially in this population of pregnant women, could 
be expected, as yeast infections are quite common in pregnancy due to changing 
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hon-nonal levels. In non-pregnant women, yeasts have been detected less frequently 
in those with trichomoniasis, a possible mechanism being an alkaline environment 
created by the trichomonads, which ecology is not favoured by yeasts which thrive in 
an acidic environment 318. 
Colpitis macularis or strawberry cervix was identified in 6 (3.5%) of cases and none 
of the controls. Lang and Ludmir in 1961 described this sign as pathognomonic for 
trichomoniasis having found it in 78% of women with trichomoniasis and none of 
319 319,320 controls . Increased yield of this sign is observed when a colposcope is used 
This study's findings are in conforinity with Fouts and Kraus and Wolner-Hanssen 
who reported a 2.3% and 1.7% rate among cases with the unaided eye 
101,317 
. 
Though the finding of strawberry cervix was highly significant for TV infection, 
(p<0.001, Fishers exact test) its clinical utility for the prediction w' imection was 
low. This sign had a 73.37% sensitivity (95%CI=69.7-76.8) and 100% specificity 
(95%CI=54-100), and a positive predictive value of only 3.5% in this low TV 
prevalent population. Using this sign alone, only 0.95% of the study subjects would 
have been selected. In Wolner-Hanssen's study of the population attending a 
sexually transmitted diseases clinic in the US with 15% TV prevalence, the 
sensitivity and specificity of colpitis macularis was reported as 44% 317 and 99% 
respectively. Its positive predictive value for TV infection was 90%. The high 
positive predictive value in this population compared to that of the pregnant women 
in Kumasi could be due most likely to the symptomatic status of the selected patients 
attending the STI clinic. 
The association between TV infection and ano-genital hygiene was further explored, 
by examining faecal staining of the perineal region in the women. The prevalence of 
TV has been related to poor sanitary facilities 321 and it has also been suggested that 
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poor ano-genital hygiene could be a reason for the differential racial prevalence of 
TV infection 100. Unfortunately, this study population could not be used to study this 
assertion as the perineum. of almost all study participants was "clean" on 
examination. It is a common practice in Ghana for women attending health facilities 
where there is the possibility of genital examination not only to wash and clean the 
genital area before attending but also to use new underwear. Also health education 
talks given by midwives at antenatal clinics stress to the women the importance of 
general and genital hygiene. 
This study with others confirms the association between TV infection and a shift of 
vaginal pH towards alkalinity (pH>5). 
Together with a pH>5, a homogenous vaginal discharge, a positive amine test and 
the finding of clue cells on microscopy of vaginal discharge are components used in 
the diagnosis of bactenal vaginosis (BV) by Amsel's criteria 176 . The presence of 3 
out of these 4 criteria constitutes a diagnosis. Another diagnostic criterion, Nugent's 
304 - scoring system is based on morphological types of organisms found in the vagina. 
A shift of these morphotypes from the normal Gram positive lactobacilli 
predominant flora to one of Gram variable rods (Gardnerella sp) and Gram negative 
curved rods (Mobiluncus sp) informs the diagnosis of BV. Most often these abnormal 
morphotypes are found cluttered on and around the edges of vaginal epithelial cells, 
thus obscuring the fine edges. Referred to then as "clue cells", some authors deem 
their presence alone indicative of BV 
322 
. 
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This study demonstrated the association between TV and BV as defined by Amsel . 
Similar associations have been reported previously 
317,323 
. However as defined by 
Nugent, the association was not observed. In comparing 5 different criteria for the 
diagnosis of BV (including Amsel and Nugent systems) and assessing their 
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association with TV infection in an antenatal setting, James et al reported that TV 
was not frequently associated with BV, saying the women had some of the 
characteristics that met the criteria for BV such as profuse discharge and elevated 
vaginal pH (Amsel), but that they usually had no clue cells 324. Clue cells 
identification could be the reason behind discordancy between the associations of TV 
and the 2 BV diagnostic systems in the Kumasi study. A pH>5, and a positive amine 
test, both components of Amsel's criteria were significantly associated with TV 
infection in the Kumasi study. Homogenous vaginal discharge, the third criterion 
could pass for increased amount of discharge and/or a non-clear discharge both of 
which were significantly associated with TV infection. With these 3 criteria 
associated with TV infection, a diagnosis of BV according to Amsel can be made. 
The identification of clue cells and sconng on Nugent's critena can be technically 
demanding, requiring an experienced microscopist. Any misreading of smears would 
have an impact on BV diagnosis by this criterion, as correctly identifying and scoring 
the morphotypes is the sole criterion for diagnosis. In the study laboratory in 
Kumasi, Ghana, this was the first time people had been trained to score BV by this 
system. Even though a quality control system was in place where 10% of slides were 
re-read and judged satisfactory, it is not unusual that mistakes and misreading could 
occur. 
An exploration of the clinical utility of these signs independently associated with 
infection (abnormal vaginal discharge and pH >5) revealed poor predictability for the 
selection of TV infected patients. The relatively low positive predictive value of the 
signs (9.0% and 7.3%, respectively) could partly be explained by the frequent 
occurrence of these signs among women who may have other reproductive tract 
infections apart from trichomoniasis. For example abnormal vaginal discharge in the 
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study women was not only associated with trichomoniasis, but was also highly 
associated with a yeast-like discharge (OR=7.2,95% CI=3.8-13.7, p<0.001). Also in 
this study population, factors such a pH>5, positive amine test and increased amount 
of discharge all of which were significantly associated with TV, could collectively 
176 pass for a diagnosis of Bacterial vaginosis . Simultaneous occurrence of more than 
one reproductive tract disease in an individual is not uncommon 101. 
The scores derived in this study selects a maximum of 39.9% of those infected for 
the objectives of this study. This is far lower than the least sensitive laboratory test 
currently used for detecting TV infections. For women in this study, the wet prep 
technique had a sensitivity of 81.5% (141 of 173). The target population positive 
predictive value is also poor at selecting TV infected women. 
, Several studies among pregnant women in developing countries have evaluated the 
use of scoring systems for the diagnosis of cervical infection 
325,326,327 
. Some of 
, these studies have included the use of clinical signs. Unfortunately as seen in the 
present study, the performance of these algorithms has not been encouraging. 
In conclusion, even though certain clinical parameters i. e. an abnormal vaginal 
discharge and pH>5 have been found to be independently associated with TV 
infection in this group of pregnant women, their utility for the prediction of infection 
in order to allow for the selection of potentially infected women in this population 
for screening and/or treatment of infection is limited. The search for simple, reliable, 
rapid and developing country- friendly diagnostics for detection of infection remains 
a priority for the control of vaginitis due to Tvaginalis. 
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5.7 Limitations to this study 
Two female examiners, who were blinded to the case-control status of the women, 
were trained and examined the women reporting on a uniform pro-forma. Inter- 
observer variability can not be ruled out. There could also have been some 
subjectivity in the definitions given to some of the parameters studied e. g. vaginal 
odour and amount of discharge. These did not depend on any objective criteria, and 
for example there could be a fine line between a normal vaginal discharge (no 
discharge seen) and a scanty vaginal discharge (discharge in the vagina) which could 
be reported differently. 
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6.0 RESULTS: COMBINED SCORES USING SOCIO- 
DEMOGRAPHIC, BEHAVIOURAL AND CLINICAL 
PARAMETERS PREDICTING TV INFECTION IN PREGNANT 
WOMEN 
In trying to improve the predictive value for TV infection, a combination of scores of 
factors predicting infection (socio-demographic, behavioural and clinical) was 
investigated. The weighted scoring system for the socio-demo variables was used. A 
maximum score of 16 is attainable. 
Table 6.1 shows distribution of cases and controls in the combined scores. 
Table 6.1. Score disthbution among cases and controls combining socio- 
demographic and clinical factors predicting TV infection. 
Score Cases Controls Total (%) 
0 4(8.0) 46(92.0) 50(100) 
1 21(13.5) 135 (86.5) 156(100) 
2 39(24.1) 123(75.9) 162(100) 
3 35 (31.5) 76(68.5) 111(100) 
4 25(38.5) 40 (61.5)_ 65(100) 
5 24(50.0) 24(50.0) 48(100) 
6 13(54.2) 11(45.8) 24(100) 
7 8(72.7) 3(27.3) 11(100) 
8 1 (33.3) 2 (66.7) 3(100) 
9 2(100) 0(0) 2(100) 
14 1(100) 0(0) 1(100) 
Total 173(27.3) 460(72.7) 633(100) 
As seen with the previous systems, the lower end of the combined scores (0-4) was 
predominantly controls (77.2%), whilst the upper end (6-14) was made up mostly of 
cases (70%). Equal proportions of cases and controls scored midway (score 5) 
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6.1 Diagnostic value of combined scores 
The sensitivity, specificity and target population predictive values of each cut-off of 
the combination of scores (Table 6.2) was deten-nined as previously. 
Table 6.2. Perfonnance characteristics of combined cut-off scores 
Cut-off Sensitivity Specificity Positive Negative Number 
score predictive predictive of women 
value in value in selected in 
target target study 
population population population 
n=3807 
>=1 97.3 10.0 5.31 98.6 3440 
(90.5) 
>=2 85.6 39.3 6.8 97.8 2356 
(61.8) 
>=3 62.8 71.5 8.1 97.3 1149 
(30.2) 
>=4 42.5 82.6 11.3 96.5 706(18.6) 
>=5 28.2 91.2 14.4 96.0 368(9.7) 
>=6 14.4 96.5 17.6 95.6 153(4.0) 
>=7 7.0 98.9 25.0 95.3 52(1.4) 
>=8 2. .1 99.6 20 95.1 20 (0.5) 
>=9 1.9 100 100 95.1 3 (0.08) 
14 0.53 100 100 95.0 1 (0.03) 
Whilst the sensitivity of the cut-off scores decreased with increasing combined 
scores, the positive predictive value increased likewise. The combinations achieving 
the highest PPV (>=9->=14) were poorly represented in the study population (1-3 
women). In contrast, a large representation of women in the study population was 
observed in combinations of scores with low PPV. 
6.2 Score distribution among women symptomatic and asymptomatic for TV 
infection 
About 8% (50/633) of the women did not achieve any score with the combination. 
Within each score, asymptomatics were the majority among lower scores (0- 1), while 
women with symptoms were the majority from score 2 or more (Table 6.3). 
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Table 6.3. Score distribution among case-control women symptomatic/asymptomatic 
for infection. 
Score Symptomatic n Asymptornatic 
n(%) 
Total 
0 1(2.0) 49(98.0) 50(100) 
1 52(33.3) 104(66.7) 156(100) 
2 85(52.5) 77(47.5) 162(100) 
3 87(78.4) 24(21.6) 111(100) 
4 45(69.2) 20(30.8) 65(100) 
5 32(66.7) 16(33.3) 48(100) 
6 20(83.3) 4(16.7) 24(100) 
7 11(100) 0(0) 11 (100) 
8 2(66.7) 1 (33.3) 3(100) 
9 2(100) 0(0) 2(100) 
14 1(100) 0(0) 1(100) 
Total 338(100) 295(100) 633(100) 
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6.3 DISCUSSION: COMBINED SCORES USING SOCIO- 
DEMOGRAPHIC, BEHAVIOURAL AND CLINICAL 
PARAMETERS PREDICTING TV INFECTION IN PREGNANT 
WOMEN 
As in the 2 preceding chapters, both socio-demographic and clinical parameters 
which independently predicted TV infection, performed poorly when combined and 
their diagnostic value for infection calculated. 
With 90.5% of the study population having at least I of an attainable 16 scores, the 
majority of the women qualified to be selected for the purposes of being screened or 
treated for TV infection, a situation which would not give value for money. Reasons 
for this poor predictability of infection could be the low prevalence of TV in the 
population. It could also be due to the association of these factors with other 
reproductive tract infections in the women as discussed previously. Infection could 
be predicted in women who had up to 9 or the maximum 14 scores. These women 
however made up less than I% of the population of women studied. 
Thus again, the utility of selecting subjects for screening and/or treatment of TV 
infection based on a combination of demographic and clinical factors predicting TV 
infection was minimal. The use of these scoring systems for the screening and/or 
diagnosis of TV infection in this group of women is thus not worthwhile. 
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7.0 RESULTS: COMPARISON OF DIAGNOSTIC METHODS 
FOR THE DETECTION OF TV 
Various diagnostic tests were compared for the detection of Trichomonas vaginalis 
infection. These included 2 traditional diagnostic tests (wet prep examination and 
culture) and 3 others ; latex agglutination (LAT), Enzyme immunoassay(EIA), and 
PCR. Towards the end of the study, Kalon Biological (Surrey, UK) sent in their 
newly developed lateral flow dipstick test also for evaluation. 
An expanded gold standard (EGS) of culture and/or wet prep was used as the 
reference test. 
7.1 Test results among selected women 
Of the 3807 women in the target population who had LAT done, or, their vaginal 
swabs, 206 and 3601 were positive and negative respectively. However, only 633 
samples (all 206 positives and 427 negatives) were selected for the case control study 
and these samples were subjected to testing by wet prep, culture, EIA, PCR and 
lateral flow techniques. 
A 2X2 table of results of the EGS and LAT for the case-control group is shown in 
Table 7.1. 
Table 7.1. Results of LAT and expanded gold standard in case-control population 
LAT EGS Total 
Positive 
_Negative Positive 171 35 206 
Negative 2 425 427 
Total 173 460 1 633 
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7.2 Estimated gold standard results in target population 
In estimating the predictive values of LAT in the target population, an estimate of the 
number of women in the target population who would have tested positive on the 
EGS was done. In doing this, it was assumed that women in the target population 
who were not selected for the case control study would not differ in terms of the gold 
standard tests from those selected. 
Of the 427 women testing negative for LAT in the case-control cohort, 2 were 
positive by the EGS tests. Thus it was estimated that for the 3601 women in the 
target population testing negative for LAT, 2x (3601/427) =17 would be positive by 
the gold standard test. This implies that 3584 would be true negative (=3601- 17). 
Putting these estimated figures into a table, Table 7.2 is derived. 
Table 7.2. Estimated results of LAT and the EGS in the target population 
LAT EGS Total 
Positive Negative 
Positive 171 35 206 
Negative 17 3584 3601 
Total 188 3619 1 3807 
Thus , in the target population, an estimated 188 and 
3619 women would be positive 
and negative respectively by the EGS. Hence, the estimated population prevalence of 
TV by the EGS would then be 188/3807 = 4.93% (95%C1 4.3-5.7). 
The sensitivity, specificity, and predictive values of the diagnostic tests compared are 
derived for the study target population. Target population adjusted figures are 
therefore made from results of the case control cohort. 
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7.3 Sensitivity, specificity and predictive values of the Latex agglutination test 
(LAT) 
From Table 7.1, of the 633 vaginal swab eluates, 206 (32.54%) were positive and 
427 (67.46%) negative on latex testing. 83% (171) of the positives were study cases 
and 35 (17%) were controls. Whilst 98.9% (171) of cases were latex positive, 
(1.1 %) were latex negative. 
Significantly more women who were symptomatic were latex positive (p-=0.04) 
Of the 35 samples which were false positive by LAT, all but 5 were negative by 
other TV diagnostic tests - EIA and PCR. All the 5 were positive by PCR, and 2 of 
the 5 were also positive by EIA. None of the 35 samples was also positive by EIA 
alone. 
The sensitivity of LAT in the target population was 91.0% (95%Cl 85.9-94.6%), and 
specificity 99.0%'(95% CI 98.7% --- 99.3%). The predictive value of a positive test 
was 83.0% (95% Cl 77.1% - 87.91//o), and that of a negative test was 99.5% (95%Cl 
99.2% - 99.7%). 
Within tests agreement (Kappa statistic) of the LAT and the EGS was 0.93 (95%Cl 
0.91-0.95) 
7.4 Sensitivity, specificity and predictive values of the Wet prep test 
141 of the selected 633 swabs were positive and 492 negative on wet prep direct 
microscopy. All those testing positive were cases. By definition of the EGS, none of 
the controls were test positive (Table 7.3). Of the study cases, 141 (81.5 %) were wet 
prep positive and 32 (18.5%) wet prep negative. 63% of wet prep positive subjects 
were symptomatic and 37% asymptornatic (Xý =6.9, p=0.009). 
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Table 7.3. Comparison of the wet prep with the expanded gold standard in the case- 
control cohort 
Wet prep EGS Total 
Positive Negative 
Positive 141 0 141 
Negative 32 460 492 
Total 173 460 633 
Target population test results are compared with the EGS in Table 7.4. 
Table 7.4. Estimated results of wet prep and the EGS in the target population 
Wet prep EGS Total 
Positive Negative 
Positive 154 0 154 
Negative 34 3619 3653 
Total 188 3619 3807 
Wet prep test perfon-nances were: sensitivity 7 7.8% (95%Cl 71.3-83.4), specificity 
100% (95%C1 99.99-100), positive predictive value 100% (95%CI 97.6-100), and 
negative predictive value 98.8 (95%C1 98.4%-99.1 %) 
The Kappa statistic for wet prep and the EGS was 0.94 (95%Cl 0.93-0.95) 
7.5 Sensitivity, specificity and predictive values of Culture 
170 of the 633 swabs were positive on InPouch culture (Table 7.5). These made up 
98.26% (170/173) of the study cases. 3 study cases were negative by culture, but wet 
prep positive. 2 of these 3 samples were also positive by latex agglutination, EIA and 
PCR. The third was positive by PCR, but negative on testing by the 2 
immunologically based assays - LAT and EIA. 
Of the women testing positive on culture, significantly more were symptomatics 
compared to asymptornatics ( 62% vrs 38%, p=0.01). 
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Table 7.5. Comparison of culture with the expanded gold standard in the case-control 
cohort 
Culture EGS Total 
Positive Negative 
Positive 170 0 170 
Negative 3 460 463 
Total 173 460 633 
The target population perforinance of culture compared to the gold standard is shown 
in Table 7.6. 
Table 7.6. Estimated results of culture and the EGS in the target population 
Culture EGS Total 
Positive Negative 
Positive 185 0 185 
Negative 3 3619 3622 
Total 188 3619 3807 
The sensitivity of culture was 98.4% (95%C1 95.4-99.7) and specificity 100% 
(95%CI 99.9-100). Mirroring specificity was a positive predictive value of 100% 
(95%CI 97.8-100). The predictive value of a negative test was 99.9% (95%C1 99.7- 
99.9). 
A kappa index of 0.98 (95%C1 0.97-0.988) was observed between culture and the 
EGS. 
7.6 Sensitivity, specificity and predictive values of the EIA test 
Due to loss from spills and other circumstances, only 560 test samples (153 cases, 
407 controls) were available for EIA testing. Of these, 119 tested positive and 441 
negative. 113 (95%) of the positives were samples from cases and 6 (5%) from 
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controls. Of the 153 cases, 40 (26 %) were negative by EIA testing and 74% (113) 
positive on testing. 6 (1.5%) women without infection were positive on testing. 
EIA test perfonnance is shown in Table 7.7. 
Table 7.7. Comparison of EIA test with the expanded gold standard of study cohort 
EIA EGS Total 
Positive Negative 
Positive 113 6 119 
Negative 40 401 441 
Total 153 407 560 
Adjusted figures for the target population are shown in Table 7.8. 
Table 7.8. Estimated results of EIA and for the EGS in the target population 
EIA EGS Total 
Positive Negativý e 
Positive 139 53 192 
Negative 49 3566 3615 
Total 1 188 3619 1 3807 
Sensitivity of EIA as a TV diagnostic in this population was 73.9 (95%CI 67.0-80.0) 
and specificity 98.5% (95%Cl 98.0-98.9). The PPV was 72.4% (95%Cl 65.5-78.6) 
and NPV 98.6% (95% CI 98.2- 99.0) 
The Kappa index between EIA and the EGS was 0.9 (95%Cl 0.89-0.91). 
7.7 Sensitivity, specificity and predictive values of the PCR 
The quality of vaginal swabs for PCR assays was detennined by the presence of 0-2 
microglobulin gene in each swab sample. 0-2 microglobulin was present in 600 of 
the 633 swabs when assayed neat. 33 swabs were negative for this assay. When a 
1: 10 dilution of these 33 swab samples were assayed, this had diluted out the PCR 
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inhibitors and 0-2 presence was confirmed in 2 1. The rest (12) were deemed either as 
having inhibitors of PCR assay or not having adequate samples for analysis. Thus 
621 samples were available for PCR analysis for the presence of Tvaginalis. The 
621 samples comprised 161 cases and 460 controls (Table7.9). 
There was a 100% agreement between results of the 2 PCR assays for Tvaginalis ie 
using Kengne and Shaio primers respectively. All 191 samples positive on screening 
with the Kengne primers were confin-ned as positive with the Shaio primers. Similar 
results were obtained with samples testing negative (430). 
Table 7.9. Comparison of results of PCR assay with the expanded gold standard in 
the case-control group 
I EGS Total 
PCR Positive Negative 
Positive 14,42 49 191 
Negative 19 411 430 
Total 161 460 621 
142 (88.2%) of cases were PCR positive and 19 (11.8%) were PCR negative. 49 
uninfected women by the gold standard test were PCR positive. 
Respective figures for the target population with TV prevalence at 4.93% are (Table 
7.10): 
Table 7.10. Estimated results of PCR and the EGS in the target population 
EGS Total 
PCR Positive Negative 
Positive 165 384 549 
Negative 22 3224 3246 
Total 187 3608 3795 
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Whilst the sensitivity of the PCR assay was 88.2% (95%Cl 82.7- 92.4), the 
specificity was 89.4% (95%Cl 88.3-90.3). The positive and negative predictive 
values for infection were 30% (95%CI 26.3-34) and 99.3% (95%C1 98.9-99-6) 
respective y. 
The Kappa index of test agreement between PCR and the EGS was 0.89 (95%Cl 
0.88-0-90) 
7.8 Lateral flow (Dipstick) 
Evaluation of the performance of the Kalon lateral flow kit was incomplete. This was 
due to poor results obtained early on in the evaluation. 
150 test samples made up of 75 cases and 75 controls were selected for the 
evaluation. Analysis of the results after 100 samples (70 cases and 30 controls) had 
been evaluated showed all negative samples (controls) tested negative. However, 48 
I 
of the 70 case samples (68.6%) tested negative. A decision to tenninate further 
evaluation was taken in order to conserve vaginal swab eluates which were running 
low. 
7.9 Summary of comparison of test performances of the TV Diagnostic tests. 
Table 7.11 is a composite table showing the perfonnances of all the diagnostic tests 
Table 7.11. Summary of performance characteristics of diagnostic tests for 
T vaginalis. 
Diagnostic test Sensitivity % Specificity % Positive predictive Negative 
(95% CI) (95% CI) value % (95% CI) predictive value 
% (95% CI) 
Latex 91.0 (85.9-94.6) 99.0 (98.7-99.3) 83.0 (77.2-87.9) 99.5 (99.2-99.7) 
a lutination 
Wet prep 77.8 (71.3-83.4) 100 (99.2-100) 100 (97.4-100) 98.8 (98.4-99.1) 
Culture 98.4 (95.4-99.7) 100 (99.9-100) 100 (97.8-100) 99.9 (99.7-99.9) 
Enzyme 73.9 (67.0-80.0) 98.5 (98.0-98.9) 72.4 (65.5-78.6) 98.6 (98.2-99.0) 
Immunoasay 
Polymerase chain 88.2 (82.7-92.4) 89.4 (88.3-90.3) 30 (26.3-34) 99.3 (98.9-99.6) 
reaction 
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7.9 DISCUSSION: COMPARISON OF DIAGNOSTIC METHODS 
FOR THE DETECTION OF TV 
Results from the previous chapters have highlighted the importance of laboratory 
support in the diagnosis of TV infection to accurately identify infected individuals. In 
a low TV prevalent population as that studied, this could be important in overcoming 
problems of over-treatment and under diagnosis. 
The reference test used in this study was a combination of wet mount microscopy 
and/or culture. Even though culture of TV is the recognised gold standard in TV 
diagnosis, in situations where transportation of samples for culture over a long period 
has to be done before incubation, the delay could render trophozoites previously 
viable, unviable. To circumvent this, an experienced microscopist read wet mount 
preparations of swabs shortly after collection, and these results together with results 
of cultures carried out within I hour of sample collection informed the expanded 
gold standard. 
All the tests evaluated had good specificities ranging from 90-100%. This is as 
reported in the literature 1 96 . By 
definition of the reference standard, the specificities 
of wet prep and culture were excellent. 
The 98.4% sensitivity of culture in reality compares it to wet prep results in the 
reference standard. This result is in consonance with others published on the InPouch 
212,328 
and confirrns the superiority of culture against other diagnostics for TV. 
However, TV culture is not in generalised use worldwide due to reasons discussed 
earlier. 
The 77.8% sensitivity of wet prep is also in conformity with other published studies 
101,196,197 
confirming its relative poor performance at detecting TV. Despite this, the 
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technique continues to be widely used in TV diagnosis because it can be done in a 
short time to allow same day treatment. Its performance however is highly dependent 
on the skills of the technician. 
Three samples with flagellates having the characteristic morphology and motility of 
TV did not grow in culture. A probable reason could be loss of viability with delays 
in incubation. This was confinned by the detection of TV by PCR genomic analysis 
in these 3 samples. This finding upholds the use of the expanded gold standard of 
wet prep and/or culture as reference the test. 
EIA of vaginal swab eluates is one of the immunological techniques used in TV 
diagnosis. Its most appealing feature is the batch processing of samples which could 
be useful in field research situations. Even though the assay takes only about an hour 
to perform, as a day to day TV diagnostic tool its use may not be feasible dlue to the 
batch processing. The 74% sensitivity found in this study follows closely the 
reported pooled sensitivity of 82% (95%CI 74-90) in a recent review of diagnostic 
tools for TV 198 . Processing samples for EIA could be technically 
demanding, 
requiring trained technicians. In resource poor settings such personnel may not be 
available. 
The latex agglutination test (LAT) performed creditably in this diagnostic 
comparison of TV tests. With a sensitivity of 91%, it compares favourably with 
culture. Carney et al reported 95% sensitivity (gold standard - wet prep and/or 
culture) using the LAT in a STI based population in the UK 
22 
, which population 
would presumably be more symptomatic of infection than the pregnant women in the 
Kumasi study. Again, whilst vaginal swabs in the UK study were physician obtained 
via specula, those in Kumasi were self obtained by the women. The 35 women who 
had false positive results by this test dropped the positive predictive value of LAT to 
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83%. However, 5 of these women tested positive by the nucleic acid based PCR 
assay. Taking account of this would raise the positive predictive value marginally to 
86%. 
Compared to the commonly used wet prep examination, the LAT detected more 
women infected with TV (13% more). Its detection rate fell 7.4% behind culture. 
Various attributes of the LAT should make its use more widespread than the wet 
prep, especially in resource poor settings. The test is simple to perform, requiring no 
equipment other than a glass slide and mixing sticks, all of which are included in the 
kit. Results are obtainable within 3 minutes of sample and reagent addition, which 
should enable early and same day treatment of cases, a measure important in STI 
control. Skills to perform the test are minimal. Secondary school graduates have been 
trained to perfonn and read the test with. little supervision At a present cost of fI 
per test, it is cheaper than other rap; d tests for reproductive health use e. g. rapid 
Chlamydia trachomatis point of care tests. With bulk purchasing and use, it could 
even be cheaper. One other important issue is that the vaginal swabs were self 
obtained by the women for the LAT, removing issues of "invasive procedures". This 
should appeal in clinical settings where female genital examination is impossible or 
not needed. 
These attributes again make the use of the LAT more favourable than culture, which 
apart from requiring trained and skilled technicians does not allow same day 
treatment, thus allowing infected asymptomatic people to transmit infection whilst 
awaiting results. The cost of return for culture results could also be a disincentive for 
people awaiting results. Thus even though culture detects 7.4% more infected people, 
its use could result in few patients being treated because they may not turn up for 
their results. Indeed work by Mukenge et al and Gift et al have demonstrated that a 
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low sensitivity point of care diagnostic tool can result in more Infected people being 
treated than laboratory tests which involve a return visit to the health facility 
329,330. 
This has often been tenned the rapid test paradox. 
In its quest for rapid diagnostic tests for use in STI settings in resource limited areas, 
the Sexually Transmitted Diseases Diagnostic Initiative (SDI) of the WHO lists 7 
main qualities of such tests 331 ; affordable, sensitive, specific, user friendly, rapid, 
robust and easy delivery to the setting. The LAT meets many of these criteria. Its 
sensitivity, specificity, user friendliness, and rapidity in performance have been 
discussed. Its present cost of f 1, which could be lowered further, is not far from 
being affordable. Presently the unused kits are stored at 4'C. However they have 
been used under field temperatures of up to 28'C for 3-4 hours with no reports of 
underperfom-lance, though the long tenn effects are unknown. 
The good performance characteristics of the LAT in a resource limited setting make 
it an ideal choice in screening and/or diagnostic programmes for TV in the 
developing world. With demographic and clinical parameters being poor predictors 
of infection, such a laboratory diagnostic tool could be helpful in TV control 
programmes. 
The PCR assay perfon-ned poorly compared to culture and the reference standard. 
Some reasons can be adduced. The reference standard definition inherently biased 
and made false positive all samples which were PCR positive but reference standard 
negative. The difficulty in evaluating a technique such as PCR using a traditional 
reference standard to which PCR may be more sensitive is recognised. Such were the 
difficulties in the early days when molecular diagnostic tests for Chlamydia 
trachomatis were being evaluated. 49 such samples were positive on analysis by 2 
different PCR assays with primers targeting different parts of the genome of TV. in 
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some studies comparing PCR to the traditional tests, wet prep and culture using 
clinical samples, the gold standard has been positivity with the traditional tests 
and/or 2 PCR assays (with 2 different sets of primers) 
256,257 
. The sensitivity and 
specificity of PCR in this study could have been greatly improved if such definition 
was incorporated. 
19 samples positive by the traditional tests were negative on PCR. In companng 5 
different PCR assays for the detection of TV, Crucitti et al 257 showed that samples 
did not amplify unifonnly with all pnmer sets. While some samples amplified with 
certain primer sets, others did not. Genetic variability could be responsible. In the 
Kumasi study, samples which amplified with Kengne primers, also amplified with 
Shaio primers. It is however not inconceivable that some samples in which there 
were no amplification with either primer- sets are strains in which the target 
-11 sequences werC ausent. One other possibility is inadequate sampling of the swabs for 
PCR analysis. Even though the human 0-2 gene from cellular material could be 
amplified in these samples, inadequate sampling could arise from no TV on swab 
stick. Finally, the possibility of laboratory errors leading to misdiagnosis cannot be 
discounted. The 88.2% sensitivity of PCR in this study however, is generally 
250,251,252,256,332 
consistent with other studies 
It was unfortunate the decision to tenninate evaluation of the lateral flow kit. This 
was basically due to declining test sample volumes in the presence of an apparently 
poor performing kit. One reason for poor performance could have been degradation 
of protein antigens in the positive samples due to repeated freeze-thaw procedures. 
After immediate performance of the LAT on sample collection in Kumasi, samples 
stayed in the tropical sun for about 30 minutes -I hour before being stored at -20 T. 
They were then transported on ice to London, where there were several freeze-thaw 
181 
procedures for the performance of EIA and the lateral flow testing. Proteins are 
known to degrade during such procedures and this could have affected test 
perfonnance. The poor perforinance could also be due to poor sensitivity of the 
dipstick in detecting TV from swab eluates arising from low concentration of 
monoclonal antibodies for detection of the TV antigens. 
Another antigen-based rapid point of care lateral flow kit, similar to that evaluated 
nu WOW, has been approved by the Food and Drugs Administration (FDA) of the US 
with purported sensitivity and specificity of 100% 
333 
. There has been no reported 
evaluation outside the US. Currently a test costs in the order of $10. Its perforniance 
in the developing world could further inform choice and expand the gamut of TV 
rapid tests available for use worldwide. 
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8.0 RESULTS: ARE TRICHOMONADS OTHER THAN TV 
INVOLVED IN THE AETIOLOGY OF VAGINAL 
TRICHOMONIASIS? 
In this investigation, all samples for which TV was diagnosed by traditional tests i. e 
wet mount and/or culture were also subjected to testing for Rhominis, Ttenax and 
Tvaginalis by specific PCR assays. 
All the 3 species specific PCRs for each sample were done from eluates of a single 
vaginal swab collected at the same time as swabs collected for wet prep and culture. 
Of the 173 samples in which TV was detected by wet prep and/or culture, only 161 
could be evaluated by PCR. This is because the human 0-2 gene, the presence of 
which attests to sample collection adequacy and/or absence of PCR assay inhibitors, 
could not be amplified even after dilution in 12 samples. No PCR analysis with any 
of the trichomonad pnmers was carried out on these 12 samples. 
1n 152 of the 161 samples, PCR analysis for TV was positive. Rhominis and Ttenax 
were not detected by PCR in any of the samples, including the 9 samples for which 
PCR for T vaginalis was negative, though wet prep and/or culture detected 
T vaginalis by moiphological appearance. 
Table 8.1. Comparison of TV detection by traditional methods and specific 
trichomonad PCR assays of vaginal swab eluates. 
TV PCR Ph PCR Tt PCR 
Positive Negative positive positiv 
TV detected by 152 9 0 0 
Wet prep/culture 
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In summary (Table 8.1), 87.9% of samples positive for TV by wet prep and/or 
culture were also positive by TV PCR. No sample positive for TV by wet 
prep/culture was positive for Rhominis or Ttenax by PCR. 
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8.1 DISCUSSION: ARE TRICHOMONADS OTHER THAN TV 
INVOLVED IN THE AETIOLOGY OF VAGINAL 
TRICHOMONIASIS? 
There have been speculations since the 1940s of the probable involvement of other 
human trichomonads (especially rectal trichomonads) in the aetiology of vaginal 
trichomoniasis 1 88 . However laboratory methods used to study this have relied on 
differentiating these trichomonads by their morphological appearance 334 . Though 
earlier investigators thought this forin of species differentiation possible, 335 and 
recent epidemiological data in which TV has been found in women denying ever 
having sex 10 and also laboratory finding of Rhominis in the vagina 11 have lent some 
credence to the probability of this phenomenon, other studies have questioned the use 
of morphological and physiological criteria in trichomonad species identification ". 
In the present study using primers specific for vaginal, rectal and oral trichomonads 
in PCR assays on vaginal swab eluates from women in whom TV had been detected 
by morphology, no evidence was found for the involvement of human trichomonads 
other than TV in the aetiology of vaginal trichomoniasis. 
The transient presence of Rhominis in the vagina is not improbable. As to whether 
this could establish infection making Rhominis a vaginal pathogen other than a mere 
"passenger" is not known. Stabler and Feo and Rakoff 
335,336,337 
showed in 1941 and 
1942 that the intravaginal survival time of Rhominis was only rarely as long as 24 
hours, and that in most cases all intestinal flagellates implanted in the vagina were 
dead within half an hour. 
Rhominis, with its traditional site in the large intestines, could find its way into the 
vagina by being transferred via the penneum in situations of poor ano-genital 
185 
hygiene such as faecal staining or soiling of the perineum, cleaning away from the 
anus towards the vagina after defecation, or if vaginal intercourse follows a prior 
rectal penetration by a woman's spouse. It is probably one of these circumstances 
that led to the contamination of the vagina by Rhominis and its subsequent detection 
by PCR as reported by Crucitti et al 11. Ano-genital and sexual behaviour data 
obtained from the Kumasi study participants indicated that these situations were 
uncommon and not associated with TV infection; 17% cases and 15% controls 
cleaned towards the vagina, and only 4% cases and 5.7% controls ever had rectal 
intercourse with their partners. The study did not ascertain whether or how often 
vaginal intercourse followed rectal intercourse. Genital examination of the women 
found no faecal staining of the perineum among any of the infected women and only 
I of 460 uninfected women. 
There have been no published clinical reports of the finding of Tlenax, whose habitat 
is the mouth, in the vagina. Theoretically, during oro-vaginal contact, this could 
happen if Ttenax is present in the mouth. In studying this phenomenon, Stabler and 
Feo 338 , 
inoculated human vagina with concentrated laboratory cultures of Ttenax. 
Whereas no perinanent infections were established, T. tenax survived in the vagina 
for periods ranging 48-432 hours, with the majority surviving only up to 48 hours. 
Attempts at inoculating Ttenax directly from the mouth into human vagina however 
failed. None survived up to 48 hours. 
This study looked at probable ways in which Ttenax could naturally be seeded into 
the vagina, including women receiving oral sex from their partners and also using 
their saliva to lubricate their va ina in situations of vagina dryness during sex. None 9 
of these practices were associated with TV infection. 
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In brief, with the use of molecular diagnostic techniques, no evidence for the 
involvement of trichomonads other than TV in the aetiology of vaginal 
trichomoniasis was found in this population of pregnant women. This probably re- 
echoes what was written by Feo and Stabler in 1942 338 to wit ".. more certainly than 
ever may we now say that the mouth, intestine and genital tracts of man are inhabited 
by 3 separate species of Trichomonads". They continue, "it might be suggested that 
as long as medical men refuse to accept this fact, just so long will the problem of the 
transmission of Trichomonas vaginalis remain in an unsatisfactory state". 
Unfortunately, what they did not appreciate then, and which is also the case now, is 
that a major problem with uncontrolled TV transmission is its asymptomatic 
presentation and the lack of a simple and affordable laboratory diagnostic which 
could be used in control programmes. Again and importantly, apparently unresolved 
issues such as the involvement of other trichomonads in the aetiology of TV 
infection warrant studying in the light of developments: in science and technology, 
more so as a similar phenomenon occurs in veterinary practice. 
8.2 Limitations to the study 
The presence of Rhominis and T. tenax in this study was ascertained by PCR and not 
by morphology (eg microscopy and cultures). This was done to circumvent the 
problem of possible species misidentification with TV due to their similar 
morphologies. However, it would not be unusual that PCR assays could be negative, 
whilst morphological identification is positive, as was shown for TV in this study. 
This could have been noticed if parallel morphological identification was carried out. 
Possible factors that could predispose the study women to Rhominis and Ttenax 
colonisation of the vagina was largely absent in the prepant women studied, as 
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discussed earlier. In a different population with poor ano-genital hygiene etc, results 
could be different. 
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9.0 RESULTS: PRESENCE OF TRICHOMONADS IN THE 
VAGINA, RECTUM AND MOUTH 
The presence of the 3 trichomonad. species in each of the 3 body sites i. e. vagina, 
rectum and mouth was investigated. From vaginal swab eluates, species specific 
PCRs for TV, Rhominis and Ttenax were done. From rectal swab eluates, PCR for 
Rhominis, Ttenax and TV was done,, and from oral swab eluates, PCR for Ttenax 
and TV was done. 
To establish the quality of material being processed in terms of adequacy of sample 
collection, the vaginal and oral swab eluates were checked for the presence of the 
human gene, 0-2 microglobulin, and rectal swab eluates checked for the presence of 
E. coli, a commensal of the gUt 
277. 
0-2 microglobulin was present in all the 633 oral swabs. 0-2 microglobulin 
amplification was not possible in 12 of the 633 vaginal swabs after a 1: 10 dilution. 
Thus only 621 vaginal swab eluates had trichomonads PCR assays done on them. 
E. coli was detected in all rectal swab eluates. 
In this group of women, Rhominis was not detected in any site including the rectum. 
Also, Ttenax was not found in any site including the mouth. Tvaginalis was found 
in 161 of the 621 vaginal swab eluates only and none in the rectal or oral swab 
eluates. P. h om in is and T tenax were not found in vaginal swab eluates. 
In summary, apart from the vagina, where Tvaginalis was found, no trichomonads 
were detected in any other site, even including their traditional sites. 
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9.1 DISCUSSION: PRESENCE OF TRICHOMONADS IN THE 
VAGINA, RECTUM AND MOUTH 
Apart from the finding of Tvaginalis in its traditional site (vagina), not only was 
there no evidence of trichomonad cross contamination, Rhominis and Ttenax were 
also not detected in the rectum and mouth respectively, of women in the study. 
Rhominis is acquired by faeco-oral transmission. Its prevalences have been reported 
between 0.1%-3 0% 339 in various population groups, and when present in the human 
gut, is regarded as a commensal 339. Occasionally though, it has been found in 
diarrhoeic stools and its role in the disease process has been argued 
340,341. It is not 
unusual that in this adult population Rhominis was not found, as most infections 
transmitted faeco-orally tend to predominate in children. Crucittl et al, using a 
similar assay also did not find any P. hominis in 112 adult stool samples submitted for 
routine parasitological and bacteriological analysis 11 
The negative results cannot be ascribed to poor DNA extraction procedures or 
inhibition in the PCR assay, as all the samples tested positive in the E. coll PCR assay 
which assessed the quality of sampling. However, in situations of low numbers of 
Rhominis in the host, sampling inadequacy cannot be ruled out. 
Only one study has reported finding Rhominis in vaginal swab eluates 
11. Working 
on 3077 self collected vaginal swabs from women in Tanzania, Crucitti et al reported 
the finding by PCR assay of Rhominis in 2 samples. What this means in practice is 
not certain and the probability of peri-anal contamination of these non-health worker 
collected swabs cannot be ruled out. No Rhominis was found in the Kumasi study, 
where the vaginal swabs were nurse obtained after passage of a speculum. 
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The results of this study also discount speculations of the rectum being the source of 
Trichomonas vaginalis 10 , 
from where the vagina is colonised. 
Ttenax is found frequently in the mouth of persons with poor oral hygiene and those 
170,342 
with advanced periodontal disease . The oral hygiene of study participants was 
apparently good and it is not unusual that the protozoon was not found in them. As 
with Rhominis, the integrity of the sampling process was ascertained by assaying the 
human cellular 0-2 gene which was present in all the samples, thus ruling out 
inhibition of the PCR assay. 
This study, like others 338 could also not find Ttenax naturally implanted in the 
vagina of women. 
In conclusion, in this study, TV was found only in its traditional habitat. There was 
no finding of Rhominis and T. tenox either in or outside their traditional sites. 
9.2 Limitations to the study 
As in the previous chapter, factors that could predispose the study women to 
Rhominis and/or Ttenax colonisation, either in their traditional habitats or in 
situations of cross infection were largely absent. There was no evidence of faecal 
staining of the perineurn of the women, they had good oral health, and the vast 
majority of the women did not receive oral sex from their partners. The situation 
could be different in another population group. 
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10.0 RESULTS: CLINICAL EFFICACY OF SINGLE DOSE 
METRONIDAZOLE THERAPY IN PREGNANT WOMEN 
10.1 Metronidazole therapy 
A total of 173 women positive for TV on wet mount microscopy and/or culture were 
treated with 2g single dose metronidazole. This was given to them in the clinic under 
the supervision of a nurse. They were asked to return to the clinic after a week for 
tests of cure. 
10.1.1 Follow up rate 
85% of the women (147) returned for their tests of cure as scheduled. The remaining 
26 defaulters were followed up at the addresses given on enrolment. 2 11 women were 
traced to the addresses, but 5 could not be traced and were lost to follow up. Of the 5, 
2 and 3 women were in the second and third trimesters of pregnancy respectively. 
97% (168) of the women were thus available for tests of cure. 
10.1.2 Symptomatology 
3% (3/102) of the women complaining of vaginal discharge at enrolment still 
complained of the discharge at the test of cure. There were no new cases of vaginal 
discharge and no complaints of dysuria. 32 of 54 women still complained of genital 
itch. There were no complaints of genital ulceration even though previously 12% 
(2 1) of the women said they had a genital ulcer. 
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10.1.3 Sexual intercourse during treatment 
All the women denied any sexual intercourse with their spouses during the week. 
This they did because of the counselling given before therapy. When asked what 
their partners' responses were, two-thirds of the women in the third trimester of 
pregnancy said they were "too pregnant" anyway and won't allow sex, and the others 
told their spouses they had been told so at the clinic in order to let the drug they had 
been given work properly and also not to endanger the pregnancy. 
10-1.4 Sexual partner treatment 
90% of the women (152/168) did not give/tell their partners of the prescriptions for 
metronidazole given them to be given to the partners, as this could lead to marital 
dishannony. 
10.1.5 Drug adverse effects 
Single dose metromdazole was well tolerated by 110 (65.5%) of the women. Side 
effects reported by the remaining women (58) included nausea (22.4 %), gastro- 
intestinal disturbances (36.2%) and metallic taste in the mouth (72.4%). One woman 
complained of dark urine. None of these was severe enough to send them back to 
hospital, or prevent activity. By the end of day 2, all the side effects had abated. 
10.1.6 Cure rate 
Of the 168 test of cure samples, TV was detected by wet prep and Inpouch culture in 
only I sample, giving a 99.4% cure rate. This woman denied any sexual intercourse 
during the intervening I week period. She was retreated with a further 2g single dose 
daily for 3 days, after which a test of cure was negative a week later. 
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10.2 DISCUSSION: CLINICAL EFFICACY OF SINGLE DOSE 
METRONIDAZOLE THERAPY IN PREGNANT WOMEN 
Metronidazole has been used extensively worldwide for over 30 years, and continues 
to be a valuable antimicrobial agent in treating anaerobic obstetric and 
gynaecological infections and also protozoal infections. It is the drug of choice in 
many countries for the treatment of vaginal trichomoniasis and bacterial vaginosis. 
Even though there have been reports of resistance development to it 
268,286,287,288,289, 
290,291 
, this has not been enough to warrant delisting it for such use. 
A 99.4% cure rate at I week, defined as lack of positive TV cultures, was obtained in 
this group of women with the single 2g dose. Cure rates of 82-88% 
114,272,273,274 have 
been reported using this regimen. The 99.4% cure rate in this study could be the 
result of the directly observed manner metronidazole was given. Also, none of the 
women vomited the drug, as it was in general well tolerated. The women were also 
observed up to a week only. Re-infection from partners after prolonged periods of 
observation may have increased the failure rate. Thin et al reported a doubling of re- 
infection rates (1.4 to 3.8) between 7 days and 14 days observations 343 
One worry even with this high cure rate is the inability of the women to give their 
partners the free prescriptions for metronidazole. As most of the women were in 
monogamous relationships and either did not know whether their husbands were 
having sexual relations outside marriage or said emphatically that their husbands 
were not seeing other women, a prescription for a sexually transmitted agent could 
endanger marital harmony. The men could even be proven not to have TV infection 
after investigations, as again, the natural history of trichomoniasis in men suggests 
that it is of short duration and can be self-limiting 94 . However, if the men were the 
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sources of infection and still harboured the parasite, the result could be a vicious 
cycle of infection and treatment for the women. 
Partner notification is an important aspect of STI control. Unfortunately in many 
male dominated societies which also happen to be societies where women are not 
empowered to make decisions on sexual matters including whether or not or when 
sex takes place, and where there is the possibilityof marital disharmony or even the 
woman being subjected to marital violence and thrown out of the house, partner 
notification is a taboo subject. Women find it increasingly difficult to tell their 
partners to attend clinics for investigation and treatment of STI. That is the situation 
in many traditional parts of Ghana, and this hampers STI control efforts. This is even 
made more difficult when the men, on realising they have any STI related 
symptomatology, attend chemist shops where they buy antimicrobials without the 
knowledge of their spouses. With a cure in sight, they argue with their spouses over 
them not being the sources of infection. 
Even though adverse events were reported from 35% of the women, this was not 
severe enough to restrict its use. Hager et al also reported similar minor adverse 
events in his study population where 21 % of patients receiving 2g metronidazole had 
4: ýp_CtS 114. side eff-F, 
This is the first time that this 2g single dose regimen of metronidazole has been 
evaluated in Ghana. The excellent cure rate and tolerability warrant a consideration 
of its use for such indication in the country. This compared to the multi dose regimen 
minimises non-compliance, uses 62% less drug, and seems more practical for 
treatment of sexual partners who could be harbouring Tvaginalis. 
Genital ulceration which had been complained of by 21 of the 168 at initial 
enrolment (although at clinical examination no ulcers were seen) seemed to have 
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disappeared even without specific treatment. In the Akan language, the word ulcer as 
used in the medical sense can translate into soreness (as in discomfort), burning pain 
or irritation. Though attempts were made during interviewing to convey the medical 
meaning, it is not improbable that the cultural and/or literal Akan meaning was 
assumed by the women. Indeed this difficulty has always been pointed out to clinical 
staff adopting the syndromic approach to management of STIs, emphasising the 
importance of genital examination. 
This study has demonstrated the clinical efficacy of metronidazole therapy in Ghana 
for the treatment of vaginal trichomoniasis. The single case that was a failure 
responded to treatment with increased and prolonged metronidazole treatment, 
underscoring the fact that most situations of apparent metronidazole resistance in TV 
infection could be overcome with increased doses. However, for surveillance 
purposes a study of the minimum inhibitory concentration of metronidazole to this 
isolate would be important to assess the degree of in-vivo resistance. An attempt to 
do this failed as the isolate stored at -70' C could not be revived from its frozen state. 
10.3 Limitations to the study 
This was an observational study and did not compare any treatments. The clinical 
performance of this single dose regimen with the multi-dose regimen in Ghana could 
be better made in a comparison study of both regimens. However in studies from 
other countries there has been no significant difference in the clinical efficacies of 
both regimens. 
Observing the I week treatment successes for longer, could have given an indication 
of whether the drug had been lethal or only inhibitory to the trichomonads. Also, the 
women were able to abstain from intercourse with their partners for a week, giving 
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various reasons why abstinence was necessary. The test of cure rates may have been 
different if the women were observed for longer as re-infections could have taken 
place. 
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11.0 CONCLUSIONS AND RECOMMENDATIONS 
Prevalence data from various population groups underscore the fact that numerically, 
Trichomonas vaginalis infection has not been a minor STI, at least in the case of 
women. Estimates from the WHO confirm that it is the most common curable STI 
among sexually active women. Unfortunately unlike its counterpart sexually 
transmitted infections, gonorrhoea and chlamydia infection, important aspects of its 
epidemiology and clinical presentation have not been worked out. Again, even 
though an effective antimicrobial against it has been available for more than 30 
years, which drug is still clinically efficacious today, many women are not treated, 
one reason being the absence of a good laboratory diagnostic test which can meet the 
needs of resource poor settings where infection prevalences are high. The absence of 
TV control programmes including screening for infection could be partly due to this 
lack of a good and feasible laboratory diagnostic test. 
As well as being a common STI, trichomoniasis could also contribute to long lasting 
reproductive health morbidity for women and children bom to infected women. 
Limited data is available suggesting a role for TV in the causation of prematurity and 
delivery of low birth weight infants. These same sequelae of TV infection have been 
used to argue for the importance of control of other treatable STIs. In recent times 
the role of TV in facilitating the acquisition of HIV has been recognised. it is 
probably time more effort was put into the control of TV. 
This study has looked at some aspects of the epidemiology of TV infection in an 
urban population in Ghana, West Africa with a view to increasing our understanding 
of TV infection in order to help with its control. 
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In the group of pregnant women studied, various socio-demo graphic, behavioural 
and clinical parameters were found to be independently associated with infection. 
These included young age, being of neither Akan nor northern extraction, having no 
religious faith, douching and not using toilet roll for menstrual hygiene. Also, 
complaining of a vaginal discharge, clinically having an abnormal vaginal discharge, 
and a vaginal pH more than 5 were independently associated with infection. 
However, singly or in combination, these factors were not useful for the prediction of 
TV infection in this low TV prevalent antenatal population, their predictive values 
being less than the least sensitive laboratory diagnostic for TV currently used in 
many settings i. e. the wet prep. 
Scoring systems and algorithms based on sociodemographic, historical and clinical 
parameters predicting sexually transmitted infections have been proposed for use in 
resource limited areas of the world where specific laboratory diagnosis of Infection is 
either unavailable or too expensive. Though they may be useful, such systems have 
their limitations. They are population specific, useful only in those populations in 
which the factors were studied, as for example a risk factor for infection in a 
commercial sex worker population may not pertain among women in the general 
population. Also, some of these factors are static e. g ethnicity and religion, never 
changing for an individual through their life time, and thus wrongly profiling 
individuals. 
Traditional laboratory diagnostic tests for TV, the wet prep examination and culture, 
and relatively new tests, enzyme immunoassay, latex agglutination, lateral flow 
dipstick, and PCR were compared for the detection of TV. The LAT with sensitivity 
and specificity of 91 % and 99% respectively compared favourably with the most 
sensitive and specific test, culture (sensitivity 98.4%, specificity 100%) with a kappa 
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statistic of 0.93. In view of the many practical advantages of LAT over culture in 
tern-is of its use in a resource poor setting - same day test to allow for early 
treatment, ease of test training and perforinance, no other equipment needed, and 
relatively cheap, it has the potential for use in TV control programmes. 
The LAT has the potential for use in public health programmes. First and foremost, 
the presently used syndromic approach for the management of vaginal discharges as 
used in many resource poor countries is useful in situations when women are 
symptomatic. However, adequate control of these infections needs the identification 
of infected women who are asymptomatic. In TV infection, as many as 50% infected 
women could be asymptomatic. Use of the LAT in screening programmes could 
identify such asymptornatic infections for cheap metronidazole therapy, 
cornplementing the syndromic approach. Secondly, even for symptomatic women, 
with a vaginal discharge in low TV prevalent settings, the use of the syndromic 
approach can result in overtreatment of women. Incorporating the use of the LAT 
could augment and improve specificity for the management of TV infection. 
In analysing a model of treatment interventions for trichomoniasis, Bowden and 
Garnett 12 indicate that identifying the infected (both symptomatic and 
asymptomatic) and giving appropriate treatment could be the most efficient means of 
controlling TV. Identification of TV infected subjects would be greatly augmented 
by a good screening tool that would detect most infections and allow prompt 
treatment. Currently available diagnostic tools do not allow for this. The LAT could 
fill this void. In high TV endemic areas which unfortunately are also often HIV 
prevalent settings, this simple and easy to use TV diagnostic would go a long way 
towards the control of HIV/AIDS and possibly reduce pretenn, premature low birth 
weight delivenes. 
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This study also found no evidence implicating human trichomonads other than TV in 
the aetiology of vaginal trichomoniasis. It also confinned the vagina as the sole 
origin of TV. Thus until there is evidence to the contrary, the addition of genital 
hygiene measures solely as a measure to contribute to TV control is unwarranted and 
could lead to anxiety. 
In Ghana today, metronidazole still remains clinically efficacious in the treatment of 
vaginal trichomoniasis. Only low level resistance, which was adequately treated with 
increased doses of metronidazole, seems to exist. Surveillance of this situation 
though, is important. 
In summary, demographic, behavioural and clinical factors have not been found 
useful in the prediction of TV infection. Also, the involvement of other human 
,,. trichomonads apart 
from TV in the aetiology of vaginal trichomoniasis is 
questionable. We have in our hands a potentially good screening and diagnostic tool, 
the LAT for detecting Tvaginalis infection and there is already available a cheap 
single dose antimicrobial with cure rates over 80%. Is it not time routine screening 
and treatment programmes for TV evolved? This would not only lead to the 
reduction of adverse pregnancy outcomes in high TV endemic populations but could 
also be important in the control of HIV/A11DS in these countries. 
1.1 Suggestions for further research 
1. Even though this study found no evidence for the involvement of 
trichomonads other than Tvaginalis in the aetiology of vaginal 
trichomoniasis in this group of pregnant women, evidence from veterinary 
practice and some circumstantial evidence from man indicate the possibility 
of this phenomenon. Research in a different population group, especially in 
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the geographic area (East Africa) where such circumstantial evidence has 
emanated could shed more information on the subject. 
2. That the latex agglutination test for the detection of T. vaginalis has the 
potential for use in resource poor settings is exciting. Evaluation of its use in 
other reproductive health settings, and also in tropical settings other than 
West Africa where enviromnental conditions are different e. g. higher 
temperatures would further inform on its stability and use. 
3. Operational research incorporating the use of the LAT in the management of 
vaginal discharges may help inform its use. 
4. The lateral flow dipstick could similarly have the advantages of the LAT for 
the detection of TV infections. Possible reasons have been given for its poor 
perfonnance in this -Dresent evaluation. Further evaluations under appropriate 
conditions would inform its diagnostic value. 
5. The evidence base for the epidemiologic treatment of male partners of 
women with trichomoniasis (using metronidazole) to prevent re-infection is 
not strong, as most of these come from observational studies. Not only are 
most TV infections in men asymptomatic, infections are also thought to be of 
short duration and self-limiting. Such men may therefore not be reservoirs of 
infection for subsequent transmission. A randomised controlled trial of 
metronidazole and placebo in partners of women treated for TV infection 
with an endpoint of infection status of the women 2-4 weeks after partner 
treatment, would inform this practice which is touted in all guidelines on the 
management of partners of women with TV in ection. 
6. The prevention of a STI within a stable relationship as in this group of mostly 
married women studied, is only as good as partners being notified, 
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investigated and treated similarly, otherwise the women find themselves in a 
vicious cycle of infection and treatment. It is worrying that in most situations 
in Africa, partner notification for STI prevention is less than adequate, due 
mostly to cultural factors. Also, women are not adequately empowered to 
make sure this happens. An in-depth anthropological and social science study 
into these and other reasons for poor partner notification and probable 
measures to deal with it would help greatly in STI control. 
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Appendix 1 
FEMALE ENROLMENT QUESTIONNAIRE 
ID STUDY NUMBER 
INTERVIEWER'S INITIALS 
FE 10 1 INTERVIEW DATE 
ANC/OPD NUMBER 
How can we find you? (Positive landmarks) 
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2.1 want to ask you some questions about yourself 
FE201 How old are you? years 
1= Nil; 2=Primary; 
FE202 Number of years of formal 
education 3= JSS; 4= SSS 
5=Tertiary; 6=Other 
I =student; 2--trader 
FE203 What is your main occupation? 
3=housewife; 4=farmer; 
5=professional 
FE204 What is your partner's I =student; 2=trader 
occupation 
3=farmer; 4=artisan 
5=professional; 
6=driver 
7=uneniployed 
8=other ............... 
I=Nil; 2=Christian; 
FE205 Religion 
3=Moslem 4=African 
traditional; 5=other 
1 =Akan; 2=Ga; 
FE206 Ethnic origin 
3= Ewe; 
4=Northemer; 5=other 
specify ............ .. 
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3.1 would like to ask you some questions about your health and previous 
pregnancies 
FE301 How many times have you been 
pregnant including this one? If answer is 1 FE307 
FE302 How many of your children are 
alive? 
FE303 Have you ever had a I=yes; 
miscarriage? 
2=no FE305 
FE304 If yes, how many 
FE305 Have you ever had a still birth? 1=yes; 2=no - --0' FE307 
FE306 If yes, how many? 
I =first trimester; 
FE307 How many weeks pregnant are 
you? 2=second 
trimester; 
check ANC card to help work 
this out) 3=third trimester 
FE308 Do you currently have a vaginal I=Yes; 
discharge? 
2=No 
FE309 Have you been treated for a I =Yes; 
vaginal discharge before 2=No FE312 
FE310 If yes, when was this 
1 =within the past 3 
months 
2= within the past 
6 months 
3=more than 6 
months ago 
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How were you treated 
FE311 I =tablets/capsules 
2=local application 
(herbs) 
3=pessaries/suppos 
itories 
4=douching 
5=other ............. 
FE312 Do you currently have pain I=Yes; 2=No 
passing urine? 
FE313 Do you currently have genital I=Yes; 2=No 
itching? 
FE314 Do you currently have genital I=Yes,, 2=-Nc, 
ulcer/vesicles? 
Have you ever been treated for I=Yes 
FE315 a genital ulcer 
2=No OTE318 
FE316 If yes when was this I= in the last 3 
months 
2=in the last 6 
months 
3=rnore than 6 
months ago 
I --tablets/capsules 
FE317 How were you treated? 2=local application 
(herbs) 
3=pessaries/suppos 
itones 
4=douching 
5=Other ............ 
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1==Yes; 
FE318 Has your partner ever been 2=No FE322 
treated fo ra sexually 
transmitted infection 3=don't know 
FE319 Was it for a urethral discharge? 1 =yes; 2=no 
FE320 Was it for a genital I =yes; 2=no 
ulcer/vesicles ? 
FE321 What was it? I =Don't know "88" , if not 2=Other 
...... applicable 3= 88 
FE322 What drugs have you taken in I =routine antenatal 
the past 2 weeks? ( help patient drugs (ie folic 
to identiýy drugs) acid, Iron, 
multivite,, Bco); 
2=analgesics; 
3=antiblotics; 
4=others 
(specify 
............ 
4. Now I want to ask to ask some questions about marriage 
I =single; P, FE501 
2==married 
FE401 What is your marital status? monogamously; 
3=married 
Polygamously; 
4=separated; 5=divo 
rced 
"88 if not 
FE402 How old were you when you years applicable 
first married? 
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5.1 would like to ask some questions about douching and menstruation 
FE501 Have you ever douched? I =Yes; 
2=No; 10 FE505 
3=don't know 
FE502 What do you use to douche I=plalnwater; 2=sal 
mainly? (don't prompt) ine water; 3=soap; 
4=dettol; 5=shampo 
o; 6=herbs 
7=other (specify.... 
FE503 Why do you douche( do not I =to feel clean 
prompt) generally; 2=to feel 
clean after 
menstruation; 3=to 
feel clean after sex; 
4--to clear a vaginal 
discharge; 5=to 
prevent pregnancy; 
6=other(specify 
.................. 
FE504 Have you douched today I=yes: 2=no 
FE505 What do you use when you I =sanitary pad; 
menstruate? (main method) 
2--tampon; 
3=cotton wool; 
4=folded cloth 
5--toilet roll 
6=other 
(specify ............ 
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FE506 How do you use it? I=insert in vagina; 
2=11ne underwear; 
3=both; 4=other 
1=never; 2=once; 
FE507 On average how often in the 
day do you change it 3--twice; 4=>twice 
1 =toilet roll; 
FE508 What do you use to clean after 
visiting the toilet? 2=newspaper; 
3=any paper(not 
toilet roll); 
4=hand and water; 
5=other 
(specify 
....................... 
I=front to back; 
FE509 Which way do you clean after , defecating? 2=back to front; 
3=either way; 
4=other 
(specify ............ 
I =don't wipe; 
FE510 Which way do you wipe after 
urinating? 2=front to back; 
3=back to front; 
4=either way; 
6. Finally I would like to ask you questions about sexual intercourse. You are 
assured that all you say is confidential and will not be disclosed to any other 
person 
I=Yes; 
FE601 Have you been circumcised? 
2=No 604 
3=don't know 
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FE602 At what age were you years 
circumcised? 
FE603 Why were you circumcised? I =don't know 
2=other (specify 
FE604 How old were you when you first years 
had sexual intercourse? 
1= 1-6 days ago 
FE605 When did you last have sex 
2=last week; 
3=two weeks ago; 
4=three weeks ago 
5=last month 
6= more than a 
month 
Do you think your partner could I =yes 
FE606 be having sex with somebody 2=no 
else apart from you 3= don't know 
FE607 Do you or your partner use saliva 1 =yes 
on genitals when sometimes your 
vagina is dry before sex? 2=no 
FE608 Does your partner sometimes I =yes 
give you oral sex? 
2=no 
FE609 Have you ever had anal sex? I =never- o End of 
questionnaire. 
2=sometimes; 
3=frequently 
FE61 0 When was the last time you had 1= This week; 
anal sex 2=this month; 
3=more than a 
month 
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FE611 Did your partner use a condom I=Yes; 2=No 
on this occasion? 
Thank you for your participation in this study. Your responses are confidential. 
Let participant see Study doctor 
Appointment datefor next visit (next week) 
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Appendix 2 
FEMALE CLINICAL EXAMINATION 
(Please explain procedure to study subject) 
ID Study number 
Examiner's initials 
FCIOI Date of Examination 
DY 
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1=Yes; 
FC201 Is patient circumcised? 
2=No- --o,. FC203 
3=can't tell 
1= type 1; 
FC202 Circumcision type 
2= type 2; 
3= type 3 
4=type 4 
5=can't tell 
1= yes; 
FC203 Abnormal vaginal discharge present? 
2= no FC208 
FC204 Does discharge look like yeast? 1=yes 
(clumpy, cheesy) 
2=no 
FC205 Discharge Odour 1=normal 
2=malodour 
FC206 Amount of discharge 1=normal 
2=scanty 
3=profuse 
FC207 Colour of discharge 1 =clear 
2=white/gre 
y 
3=bloody 
4=: green/yel 
low 
pH of discharge 
FC208 
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FC209 Amine test 1=positive 
2=negative 
I=Yes 
FC210 Vulval redness 
2=No 
I=yes 
FC211 Strawberry cervix 
2=no 
I =yes 
FC212 Is perianal region stained with faeces 
2=no 
FC213 Ano-vaginal distance 1-1 cm 
FC214 Treatment given I =metronidazole 
2=nil 
3=other 
Swabs taken and labelled: Ii HVSx 411 Rectal swab 
Oral swab 
Appointment dateforfollow up visit (within 7 days) 
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Appendix 3 
FEMALE LABORATORY FORM 
ID Study number 
Technician's initials 
FLSIOI Date samples brought in 
DMY 
Swabs received 
Results 
1_1 HVS x4 1_1 Rectal swab 1_1 Oral swab 
FLS201 TV latex I =positive; 2=negative 
FLS202 Wet prep I=positive; 2=negative 
FLS203 InPouch TV I=positive; 2=negative 
FLS204 If positive, on day 
FLS205 Candida I =positive; 2=negative 
FLS206 Nugent score 1-1 
FLS207 BV (Nugent) I =positive; 2=negative 
FLS208 BV (Amsel) 1=positive; 2=negative 
Swabs labelled and frozen 1_1 vagina swab PCR 1_1 rectal swab PCR 
1_1 Oral swab PCR 1_1 InPouch positive sample1_1 InPouch envelope 
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Appendix 4 
FEMALE FINAL VISIT 
ID STUDY NUMBER 
INTERVIEWER'S INITIALS 
FFVIOI INTERVIEW DATE 
ANC/OPD NUMBER 
FFV201 How old are you? years 
I =one week; 
FFV202 When were you last in the clinic? 
2=one month; 
3=other 
I =yes 
FFV203 Do you currently have a vaginal 
discharge? 2=no 
I =yes 
FF204 Do you currently have genital 
itching? 2=no 
1=yes; 
FFV205 Do you currently have pain 
passing urine? 2=no 
FFV206 Do you have genital I =yes; 2=no 
ulcer/vesicles? 
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How many times have you had 1 =nil; FFV21 0 
FFV207 sexual intercourse since we last 2=once 
saw you? (don't prompt) 3= twice 
4--thrice 
5=more than 3 
times 
FFV208 Did you use a condom? I =yes; 2=no 
I =--today 
FFV209 When did you last have sexual 2=yesterday 
intercourse? 3=two days ago 
4=three days ago 
5=four days ago 
6=five days ago 
7=more than 5 days 
ago 
FFV2 10 What was your partner's 
response ? 
FFV211 Did you have any problems 1 =no; 
when you took the medicine we 
gave you? 2=nausea; 
3=vomiting; 
4=dizziness; 
5=headache 
6=metallic taste in 
mouth 
7=other 
(specify ............. 
FFV212 Did your partner take his I=yes 
medication ? 2=no 
FFV213 If no, reason 
We will need to check if the infection for which you were given medication has 
cleared. The nurse will give you swabs to take the specimens 
1_1 SAVS x1 
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Appendix 5 
FEMALE LABORATORY (Final Visit) 
ID Study number 
Technician's initials 
FLFIOI Date samples brought in 
DMY 
Swabs received 
Results 
1_1 HVS xI 
I =Positive 
FLF201 InPouch TV 
2=Negative 
FLF202 If positive, on day 1-1 
Samples labelled and frozen 
InPouch positive sample 
Date frozen: 
1_1 InPouch envelope 
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Objectives: To compare the performance of three diagnostic methods for Trichomonas vaginall's 
infection-latex agglutination, saline wet mount, and culture. 
Methods: Vaginal swabs from 3807 women attending antenatal clinics were tested for the presence of T 
vaginalis by latex agglutination. All positives and the following two negatives were tested by wet 
preparation and culture. 
Results: The prevalence of infection by latex agglutination was 5.4%. Using an expanded gold standard 
based on the wet mount and culture results, the sensitivity of the latex agglutination test was 98.8% (95% CI 
95.9 to 99.9) and specificity was 92.1 (89.2 to 94.5). The kappa index for test agreement was 0.93 for 
latex and culture and 0.88 for latex and wet preparation. 
Conclusion: The latex agglutination test is a highly sensitive test for detecting T vaginalis infection. It is a 
simple rapid test and has the potential for use in screening and diagnostic settings. 
T riclionioiiiasis is a sexually tiansinitted infection caused 
by the protozoon parasite, Trichomonas vcýqinahs. It is the 
commonest curible sexually transmitted infection; the 
World Health Oýganization estimate,, that 170 million new 
infections occur each year. ' The hi, liest prevalence of 
infection has beeii reported froin rcsourcc constrained 
countrics2 ' and in disadvantaged populations in developed 
Countries. ' Infection with T vaginalis may facilitate the 
transmission of HIV` ' and is associated with adverse 
pregnancy and perinatal outcomes. ' Thus, the control of 7' 
v, ýqhzalis infection is important in reproductive health settings 0 
and also in the control of' HIV/AIDS. 
Diagnosis of T vaginalis infection in most parts ofthe world 
is carried out by the saline wet preparation ("wet prep") 
method, a tcchnique which has not changed since it was first 
reported by Donn6 in 1836. ' However, this technique has a 
low sensitivity of' 30-80%9 " and requires trained and 
experienced microscopists. The gold standard in T vaginalis 
diagnosis-culture-has a higher sensitivity of 71-100%, 12 r, 
but requires an incubator with a constant electricity supply 
and relatively expensive culture media, in addition to an 
experienced microscopist. Further, it can take tip to 7 days for 
results to be obtained, and currently is outside the reach of 
many health settings. In recent times, the sensitivity of T 
viý, jinahs diagnosis has been much improved by the use of 
nucleic acid amplification technology. '' " Non-invasive diag- 
nostic material (selfobtaincd swabs, tarnpons, and urine)" " 
appealing to patients, have also been used. Polymerase chain 
reaction (PCR) currently, however, is also outside the reach 
of' many diagnostic centres in resource poor settings. 
A less technologically demanding technique with good test 
performance characteristics is needed, especially in resource 
poor countries. We compared a latex agglutination test with 
culture and DonnCs wet prep technique for the diagnosis of T C, 
v, ý, Jinalis infection. 
PATIENTS AND METHODS 
A total of 3807 consecutive women attending antenatal 
clinics in Kumasi, Ghana, were screened for vaginal infec- 
tions bet%veen September 2002 and May 2003. Following 
informed consent, self administered vaginal swabs vvcrc 
screened for T vaginalis infection Using the Kalon TV latex 
ag, , qlutination 
test (Kalon Biological, Surrey, UK). In this test, 
vaginal swab,, were eluted by agitation in phosphate buffered 
salinc. One drop of this CiLlate %vas mixed with a drop of tesc 
latex on a reaction zone on a black glass slide, and the slid(- 
manUally rocked continuously for 2 minutes. Agglutination 
Of the test, but. not control latex, indicated presence of T 
vcýqinalis antigen. 
All study subjects testing positive for T mginalis on latex 
agglutination testing, and the following two consecutive 
women testing negative had two further vaginal swabs taken. 
The triplet of tests was not matched according to symptom 
presentation. The swabs were obtained by a nurse from the 
posterior fornix, after spcculum insertion and were tested for 
T vaginalis by wet prep and culture. In the wet prep technique, 
the swab was agitated in 0.9% saline and a drop of this was 
observed under wet mount microscopy at xIO0 for the 
characteristic morphology and motility of T vaginalis. Any 
observed trichomonad was confirmed at x400. Culture was 
undertaken using the T vaginalis InPouch system (Biomed 
Diagnostics, San Jos6, CA, USA) as previously described. " 
Latex agglutination and wet prep microscopy were done on 
site within 10 minutes of'specimen collection. Inoculation of 
the InPouch was also done on site within 10 minutes of 
specimen collection and incubated at 37C within an hour of 
specimen inoculation. All three tests were read independently 
and blind to the results of the other tests by different 
technicians. 
Test sensitiNity, specificity, and predictive values were 
compared. Kappa statistic for tests agreement between latex 
and wet prep, and latex and culture was also determined. 
RESULTS 
Of the 3807 prcgnint women, 206 (5.4%) were positive for T 
vaginalis on screening with the latex agglutination kit; 618 
women (206 latex positives, 412 latex negatives) were 
selected for wet prep and culture testing. At presentation, 
343 women (55.5%) were symptomatic for vaginitis (either 
vaginal discharge or itch) and 275 (44.5%), asymptomatic. 
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Table I Diagnostic comparison of latex agglutination, wet prep, and culture for 
detection of Trichornonas vaginalis 
Diagnostic test 
T vaginalis infedion 
(n = 618) Latex agglutination Wet prep Culture 
True positive* 171 (27.7%) 141 (22.8%) 170(27.5%) 
False positive 35(5.7%) 0(0%) 0(0%) 
False negative 2(0.3%) 32(5.2%) 3(0.5%) 
True negativet 410(66,3%) 445(72.0%) 445(72.0%) 
'Wet prep microscopy or InPouck culture positive. 
tBotk wet prep microscopy and Inpouck culture negative. 
Significantly more symptomatic subjects were positive on 
(, X2 = testing 10.3, p=0.001); 64.5% of the 206 subjects 
testing positive with the latex as against 51% of the 412 
testing negative, were symptomatic for vaginitis. 
All but one of the latex positive samples was positive on 
culture, and all but one sample positive on latex agglutina- 
tion testing was positive on wet prep. These two latex 
negaLive samples had discrepant results for wet prep and 
culture testing. Three samples with flagellates having 
characteristic morphology and motility of' T vaginalis in the 
direct smear did not grow in culture. 
Using an expanded gold standard for the comparison, 
patients were considered to have T vaginalis infection when 
either wet prep microscopy or InPouch culture were positive. 
They were considered negative for infection when both wet 
prep microscopy and Inpouch culture were negative. Table I 
shows the diagnostic comparison and table 2 test perfor- 
mance. 
The kappa indcx which measures agrecment between tests 
was 0.93 (95% CI 0.91 to 0.94) for latex and culture, and 0.88 
(95% CI 0.86 to 0.90) for latex and wet prep. 
DISCUSSION 
in this diagnostic comparison, the test performance of the 
wet prep and culture are in conformity with other published 
studies. " Sensitivity ot the latex agglutination test compares 
favourably with culture and is superior to the wet prep. 
Moreover, the test is simple to perform, requires no 
equipment other than a glass slide and mixing stick and 
gives a result in less than 3 minutes. This study is the second 
evaluation of the latex agglutination test and the first to be 
conducted in Africa. Carney et al" in their evaluation ofthis 
kit in the United Kingdom in 1988 reported a sensitivity and 
specificity of 95.2% and 99.4% respectively using wet prep 
and culture as reference Standards. In spite of these 
encouraging results, the test has not been widely used. 
Recent reports suggest that T vaginalis enhances the 
transmission of HIV, ' and that symptomatic T vaginalis 
infection increases the amount of HIV shed in semen. "' 
Moreover treatment of T vaginalis infection significantly 
lowers the vaginal and seminal HIV viral load in dually 
infected subjects. " " Given the Wgh prevalence of T vaginalis 
infection, its control could have a significant impact on the 
Table 2 Performance of the three diagnostic tests and 95% confidence intervals 
Latex agglutination Wet prep Culture 
Sensitivity 
Specificity 
Positive predictive value 
Negative predictive 
98.8 (95.9 to 99.9) 
92.1 (89.2 to 94.5) 
83.0 (77.2 to 87.9) 
99.5 (98.3 to 99.9) 
81.5 (74.9 to 87.0) 
100 (99.2 to 100) 
100 (97.4 to 100) 
93.3 (90.7 to 95.4) 
98.2 (95.0 to 99.6) 
100 (99.2 to 100) 
100 (97.9 to 100) 
99.5 (98.1 to 99.9) 
value 
HIV epidernic in Africa, and may reduce the incidence of 
adverse pregnancy outcome. ' 
Two ingredients important in the control of sexually 
transmitted infections are accurate diagnosis and prompt 
treatment. Properly done, this will reduce the reservoir of 
infection and thus reduce the incidence ofinfection. In rnaný 
health settings worldwide, wet mount microscopy is the 
preferred option for prompt diagnosis of trichomoniasis. This 
method, though timely and enabling patients to receive same 
day treatment, has a poor sensitivity-" and patients could 
remain infected and untreated. Culture, with a much better 
sensitivity, " does not allow same day treatment, and 
patients, especially if asymptornatic for infection may 
continue to transmit infection. In many developing countries 
where the cost of return to the health facility can be 
substantial, patients may not bother to return for their 
culture results, thus prolonging infection, leading to further 
transmission and the possibility of sequelae. Partner notifica- 
tion efforts would also be defeated. This latex agglutination 
kit allovv, s for prompt laboratory diagnosis of infcction and 
thus treatment. With a sensitivity of 98.8% and a kappa index 
of 0.93 it compares lavourably with culture, and its use could 
be more cost effective than culture. it provides same day 
results (test takes 2 minutes), thus saving time and costs due 
to incubation. At a present cost of El ($1.56) per test it 
compares with other rapid tests made for reproductive health 
settings. In resource poor settings where the cost of 
purchasing microscopes for wet prep and culture examina- 
tions may be prohibitive, and where trained and skilled 
personnel are unavailable, this latex agglutination test can 
fulfil such need. We have trained secondary school graduates 
to perform the test correctly. The kit as presently manufac- 
tured contains everything that is needed and no further 
purchases are needed. 
In analysing a model of treatment interventions for 
trichomoniasis, Bowden and Garnett" indicate that identify- 
ing individuals with both symptomatic and asymptornatic 
infection and giving appropriate treatment could be the most 
efficient method of controlling T v6(qinalis infection. This 
would be greatly augmented by a good screening tool that 
would detect most infections and allow prompt treatment. 
Currently available diagnostic tools do not allow this. The T 
vaginalis latex agglutination test could fill that void. in high T 
vaginalis endemic areas, which unfortunately are also often 
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Key messages 
" Present diagnostic tests for T vaginalis in resource poor 
settings are either insensitive or too expensive 
" The T vaginalis latex agglutination test is a2 minute test 
and Its performance compares favourably with culture, 
the current gold standard in T vaginah's diagnosis 
" It Is a simple to use kit, requires no equipment, and is 
suitable for developing country settings 
high HIV prevalence settir)gs, this simple and easy to use 
T vaginalis diagnostic would go a long way in the control of 
HIV/AIDS and possibly reduce prctcrm, premature low birth 
weight deliveries. 
About 6% (35) of samples Nvere latex positive but negative 
for the traditional tests. It would be important to establish 
whether these are false positives by latex agglutination or 
false negatives by the traditional tests. Recent studies using 
inoiccular methods for the diagnosis of' 7' vtýqinahs infection 
have shown culture to be less than 100% sensitive. Wendel et 
al comparing the polyinerase chain reaction (PCR) and 
culture, reported sensitivities of 84% and 78'Yo respectively" 
using an expanded gold standard of wet prep, culture, arid 
PCR. Also, in the series by Tabirizi ct al, T vaginalis infection 
prevalences of 9% by traditional tests as against 15% by PCR 
in the same population was reported. 14 This could also be 
iniportant in many areas of the world where women are less 
cinpowerccl because of dependence on their spouses. False 
positive results could lead to considerable adverse social and 
relationship effects during partner notification. 
Owing to the high sensitivity exhibited by nucleic acid 
aiiiplification tcsts, 2 "" the sensitivity of' T vzýqinalis PCR 
could well surpass that of the latex agglutination test, and 
there Could still be missed infections using the latex kit in 
resource poor centres where PCR is unlikely to be used for 
diagnosis. 
One of' the weaknesses of' the WHO vaginal discharge 
syndroinic management approach is its poor specificity. " This 
can be greatly improved by the availability of rapid tests for 
vaginal discharge diagnosis. The WHO has commissioned 
field trials for rapid tests for the diagnosis of gonorrhoca and 
chlarnydial infection. " When the results of these trials are 
favourable, and the diagnostics affordable, together with a 
rapid T v6ýqinalis diagnostic, vaginal discharge management 
would greatly improve. Even in very low T vqginalis prevalent 
populations in developing countries, the use of the T vcýqinalis 
latex could be useful in eliminating infection and for effective I 
partner notification. At a present cost of fl, this could be 
cheaper than the cost of blind therapy with iTietronidazole, 
unwarranted drug adverse effects, and the probable adverse 
social and marital outconics with partner notification. 
We have in our hands a good screening and diagnostic tool 
for T vaginalis. There is already available a cheap single dose 
antimicrobial against T vaginalis with cure rates over 80%. 2' It 
is time to evolve routine screening and treatment for T 
v, ýqinahs in reproductive health settings. 
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Trichomonas vaginalis infection 
David Mabey, John Ackers, Yaw Adu-Sarkodie 
Department of Infectious & Tropical Diseases, 
London School of Hygiene & Tropical Medicine 
Trichomonas vaginalis is a sexually transmissible protozoal parasite. It is the 
commonest curable STI; WHO estimate that about 170 million new cases occur 
annually (1). It is a common cause of vaginal discharge in women,, in whom it may 
also cause vulval irritation and inflammation, dysuria and inflammation of the exo- 
cervix. It has been associated with dysuria and urethral discharge in men; but 
asymptornatic infection also occurs in both sexes. T vaginalis infection is associated 
with low socio-economic status,, and is more prevalent in developing than in 
developed countries (2,3). Opinions vary concerning whether or not T vaginalis can 
be transmitted by non-sexual contact (4,5). A morphologically similar organism, 
Pentatrichomonas hominis, is a commensal of the human large intestine, but 
conventional wisdom has it that this organism does not multiply in the human 
reproductive tract. 
Recommended tests 
Microscopy of a wet mount preparation is the most commonly used diagnostic test 
for T. vaginalis infection. Characteristic motile flagellated protozoa are readily seen. 
Wet mount microscopy is approximately 70% sensitive compared to culture in 
women, and significantly less sensitive in men (6,7,8). At present, culture techniques 
are still regarded as the most sensitive and specific; they provide the "gold standard" 
against which other methods are judged. Level of evidence: III 
Culture media vary in efficiency but Diamond's TYM medium (9) (sometimes with 
minor modifications) is amongst the best (10,11). Most tubes will be positive within 
48 h but should be kept for 7 to 10 days before being finally discarded. A very 
convenient, but expensive, way of culturing specimens is the InPouchS system 
which appears to be at least as sensitive as conventional tubed media (12,13). Level 
of evidence: III. 
A latex agglutination test which detects T vaginalis antigen was described some 
years ago. This rapid and simple bedside test, which does not require electricity or 
special equipment, has been reported to have sensitivities of 95% and 98.8 % and 
specificities of 99% and 92.1 % compared to culture for the diagnosis of T vaginalis 
infection in women (14,15). This diagnostic test is available in kit form (TVIatex; 
Kalon Biological Ltd, Ash Vale, GU12 5QJ, UK). Level of evidence: III 
More recently, several protocols have been described for the detection 
of T. vaginalis DNA in clinical samples using the Polymerase chain 
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reaction (PCR) (16,17,18,19). Some of these assays appear to be more 
sensitive than culture although, as with PCR assays for Chlamydia 
trachomatis infection when they were first introduced, it is not 
immediately apparent whether samples positive by PCR and negative 
by culture represent false negatives by culture, or false positives by 
PCR. No PCR assay for T. vaginalis is currently on the market in the UK. 
Level of evidence: /11 
Who should be tested? 
Until recently T vaginalis has not been considered an important pathogen since, 
unlike other STIs , it was not believed to cause serious sequelae. Screening of 
asymptornatic individuals for T vaginalis infection is therefore not currently 
recommended. Level of evidence: III. However, its importance is now being 
reassessed in the light of recent evidence that it is associated with adverse pregnancy 
outcome, and facilitates the sexual transmission of HIV infection (20,21,22). 
Further research is needed to confirm these associations and to prove that the 
association is causal. Recent trials have found that treatment of TV infection in 
pregnancy does not improve pregnancy outcome, and may be harmful (23,24,25). 
Women attending clinics with a complaint of vaginal discharge should be tested for 
T vaginalis infection. Level'of evidence: Iff. It is generally recommended that sexual 
partners of infected women should be treated epidemiological 1-,, / (26,27,28,29). 
Level of evidence: 1b. Testing of male partners could in theory lead to further contact 
tracing in those who test positive. Level of evidence: IV 
Men with urethral symptoms which persist after infection with Neisseria 
gonorrhoeae, Chlamydia trachomatis and Mycoplasma genitalium have been 
excluded or treated should be tested for T vaginalis infection (30,31). Level of 
evidence: Iff. 
Test of cure is only recommended in those whose symptoms persist after treatment. 
Level of evidence: IV 
Recommended sites for testing 
In womený a swab should be taken from the posterior fornix at the time of speculum. 
examination. Level of evidence: Iff. Self-administered vaginal swabs have been used 
in many recent studies, and are likely to give equivalent results (32). Level of 
evidence: Iff. First catch urine specimens, with or without centrifugation, have also 
been tested in women, but the sensitivity is less than that achieved with vaginal 
swabs. Level of evidence: Iff 
In men, urethral swabs or first catch urine (FCU) samples are recommended. The 
sensitivity of FCU can be improved by testing the cell pellet after centrifugation. 
Sensitivity can be improved by testing both a swab and a FCU (33,34). Level of 
evidence: Iff Swabs from the sub-preputial space may also be tested, but this 
method of specimen collection has not been well validated. Level of evidence: IV. 
262 
Factors which alter tests recommended or sites tested 
Nil 
Search strategy 
A Pub Med search of the English language literature was conducted, using the key 
words Trichomonas vaginalis and trichomoniasis. Personal libraries and the 
abstracts of recent meetings of the International Society for STD Research were also 
scrutinised. 
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